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Regulation Of Genome Topology In Notch-Mutated Cancers
Abstract
Spatiotemporal regulation of gene expression governs cellular development and malignant
transformation. Compared to the understanding of cis-regulatory elements on the linear chromatin, our
knowledge about the three-dimensional (3D) organization of the human genome is still limited. Recent
advances in chromatin conformation capture techniques coupled with high-throughput sequencing and
fluorescence in situ hybridization combined with high-content microscopy greatly advanced the mapping
of 3D genome at kilo-base resolutions. However, the mechanisms of the establishment and maintenance
of genome folding and the implications of their disruption in cancer are largely unexplored. Moreover,
besides a few architectural proteins, the roles of other transcription factors in chromatin topology remain
elusive. Here, I used three cancer types with oncogenic mutations in the signaling-dependent
developmental transcription factor NOTCH1 as models to probe the contributions of genome misfolding
to oncogenesis and anti-cancer therapy resistance. By subjecting triple-negative breast cancer and
mantle cell lymphoma cells to short-term Notch inhibition and reactivation, I discovered that beyond its
known role in activating distal enhancers, Notch can dynamically reposition distal enhancers to the
promoters of pro-survival genes such as MYC but has limited impact on higher-order chromatin
structures including topologically associated domains (TADs) and compartments. Interestingly, in T-cell
acute lymphoblastic leukemia (T-ALL), short-term Notch inhibition only diminishes MYC enhancer activity
but not looping to the promoter, suggesting that Notch mediates chromatin loops in a lineage- and locusspecific manner. In contrast to short-term treatment, I identified widespread refolding of compartments,
TADs and loops in T-ALL cells that acquire resistance to long-term Notch inhibition. These events closely
coincide with redistribution of chromatin activity and architectural protein and are reversible when Notch
inhibitor is removed. Finally, using a combination of sequencing, imaging and genetics approaches, I
provided direct evidence that the B-cell lineage determining factor EBF1 is repositioned from the
transcriptionally repressive nuclear lamina to the interior during long-term Notch inhibition. Activated
EBF1 thus instructs reorganization of the linear and 3D genome to promote therapy resistance. My
studies in Notch-mutated cancers advanced the mechanistical understanding of non-architectural
transcription factors in cancer genome folding, which can potentially provide insights into their functional
roles during normal development.
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ABSTRACT
REGULATION OF GENOME TOPOLOGY IN NOTCH-MUTATED CANCERS
Yeqiao Zhou
Robert Babak Faryabi
Warren S. Pear
Spatiotemporal regulation of gene expression governs cellular development and
malignant transformation. Compared to the understanding of cis-regulatory elements on
the linear chromatin, our knowledge about the three-dimensional (3D) organization of the
human genome is still limited. Recent advances in chromatin conformation capture
techniques coupled with high-throughput sequencing and fluorescence in situ
hybridization combined with high-content microscopy greatly advanced the mapping of 3D
genome at kilo-base resolutions. However, the mechanisms of the establishment and
maintenance of genome folding and the implications of their disruption in cancer are
largely unexplored. Moreover, besides a few architectural proteins, the roles of other
transcription factors in chromatin topology remain elusive. Here, I used three cancer types
with oncogenic mutations in the signaling-dependent developmental transcription factor
NOTCH1 as models to probe the contributions of genome misfolding to oncogenesis and
anti-cancer therapy resistance. By subjecting triple-negative breast cancer and mantle cell
lymphoma cells to short-term Notch inhibition and reactivation, I discovered that beyond
its known role in activating distal enhancers, Notch can dynamically reposition distal
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enhancers to the promoters of pro-survival genes such as MYC but has limited impact on
higher-order chromatin structures including topologically associated domains (TADs) and
compartments. Interestingly, in T-cell acute lymphoblastic leukemia (T-ALL), short-term
Notch inhibition only diminishes MYC enhancer activity but not looping to the promoter,
suggesting that Notch mediates chromatin loops in a lineage- and locus-specific manner.
In contrast to short-term treatment, I identified widespread refolding of compartments,
TADs and loops in T-ALL cells that acquire resistance to long-term Notch inhibition. These
events closely coincide with redistribution of chromatin activity and architectural protein
and are reversible when Notch inhibitor is removed. Finally, using a combination of
sequencing, imaging and genetics approaches, I provided direct evidence that the B-cell
lineage determining factor EBF1 is repositioned from the transcriptionally repressive
nuclear lamina to the interior during long-term Notch inhibition. Activated EBF1 thus
instructs reorganization of the linear and 3D genome to promote therapy resistance. My
studies in Notch-mutated cancers advanced the mechanistical understanding of nonarchitectural transcription factors in cancer genome folding, which can potentially provide
insights into their functional roles during normal development.
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CHAPTER 1: INTRODUCTION
1.1 The Human Genome
The hereditary information of a multicellular organism is encoded in its genome. The
human genome consists of over 3 billion nucleic acid base pairs, which is equivalent to
around 2 meters in length. Protein-coding genes are the individual segments of DNA
sequences that can be transcribed into mRNA and translated into proteins. Although
around 20,000 protein-coding genes have been annotated in human, the sequences of all
these genes together only account for ~1.5% of the human genome (Lander et al., 2001;
Pennisi, 2001). The remaining of the human genome is composed of repetitive elements,
regulatory regions, regions that can be transcribed into RNA but do not code for proteins,
and regions without known function (Figure 1-1). In an individual human body, although
all somatic cells are descendants of one zygote and share the same genome, cells in
different tissues such as breast epithelial cells and B cells have drastically different
appearances and functions. The choices that cells make in their proliferation, development
and even malignant transformation are the consequences of which, when and how much
of the genes to express, and such intricate processes are tightly regulated by the noncoding sequences of the genome. Epigenetics is the study of heritable changes of the
genome that occur in addition to changes in the primary DNA sequence (Sharma et al.,
2010). As the sequencing of human genome gradually progress to completion, our
understanding of how gene expression is regulated also becomes increasingly
comprehensive (Gershman et al., 2022).
1

1.2 Epigenetic Transcription Regulation
The two best understood cis-acting regulatory elements controlling gene expression are
promoters and enhancers. Promoter sequences locate immediately upstream of the
transcription start sites (TSSs) of genes and are required to turn the genes on and off.
Enhancers can increase the expression of genes, and can be in proximity of, or as far as
a mega base pair away either upstream or downstream from their target gene promoters
(Ong and Corces, 2011). Without changing DNA sequences, direct chemical modifications
of DNA molecules at promoters can cause inheritable changes in gene expression (Moore
et al., 2013). For instance, cytosine methylation is widely associated with gene silencing
and plays a particularly important role in gene imprinting, which determines whether the
gene is expressed from the paternal or maternal allele (Moore et al., 2013).
Besides DNA, proteins are central players of gene expression regulation. To fit the meterslong DNA fiber into a 10 micro-meter-diameter human cell nucleus, DNA is clearly not
loosely and randomly placed. At the base level, DNA is wrapped around histone proteins
as nucleosomes, the units of chromatin. Each individual nucleosome consists of 147 DNA
base pairs and a protein core formed by eight histone proteins – two of each H2A, H2B,
H3 and H4, and a linker histone H1. The N-terminal amino acids of the core histones
extend out from the DNA-histone complex and are subject to a vast variety of covalent
modifications including methylation, acetylation, ubiquitylation, and phosphorylation on
specific residues (Sharma et al., 2010) (Figure 1-1). In the recent decade, chromatin
immunoprecipitation followed by sequencing (ChIP-seq) unveiled high-resolution
genome-wide positioning of histone tail modifications (Zhou et al., 2011). Different histone
2

marks are found to associate with the activation and repression of regulatory sequences
(Li, 2002). The three states of H3 lysine 4 methylations – H3K4me1, H3K4me2 and
H3K4me3 – are enriched at gene promoters, and H3K4me3 primarily marks actively
transcribed genes (Barski et al., 2007). Some histone modification can be present at
various regulatory elements, and the combinations of modifications can provide more
precise functional prediction of the elements. For instance, H3K4me1 is also present at
enhancers, but the enhancers solely enriched for H3K4me1 are unusually poised while
enhancers also marked with H3K27ac are active (Creyghton et al., 2010). H3K9 and
H3K14 acetylation co-occur at many gene regulatory elements including active promoters
and enhancers, suggesting a coordinated regulation of active histone marks (Karmodiya
et al., 2012). In contrast, while H3K27me3 and H3K9me3 are both enriched at silent
regions, H3K27me3 is often regarded as a temporary repression signal and H3K9me3 is
considered to be more permanent (Saksouk et al., 2015). Based on the enrichment,
depletion, and combination of nine chromatin marks across nine cell types, machine
learning algorithms have been developed to annotate 15 chromatin states including
strong, weak and poised enhancers and promoters, insulators, transcriptional transition,
elongation, weakly transcribed, polycomb repressed, heterochromatin, and weak or strong
repetitive regions / copy number variants (Ernst et al., 2011). Furthermore, databases
such as The Encyclopedia of DNA Elements (ENCODE) (Consortium, 2012) and Cistrome
Project (Liu et al., 2011) collectively produced, analyzed and visualized vast amounts of
candidate regulatory elements. These efforts allow query of available histone modification
ChIP-seq data and prediction of the function of elements in cell lines close to the
researchers’ interest. On the other hand, systematic mapping of histone modifications in
3

multiple normal and cancer cells revealed the highly dynamic, tissue- and disease- specific
cis-regulatory element activities (Ernst and Kellis, 2010). The multifaceted mechanisms of
distal enhancers activation and positioning, and the functional implication of their
dysregulation in caner, are the focus of my research.
In addition to histone tail modifications, another crucial aspect of linear chromatin structure
is the positioning of nucleosomes. Compact nucleosomes allow less exposure of the
wrapped DNA sequences and thus are usually associated with repressive histone marks.
These regions are referred to as closed, inaccessible chromatin, corresponding to
cytologically defined heterochromatin which appears darkly stained by DNA dyes on an
electron microscope (Brown, 1966). On the other hand, open chromatin or euchromatin is
lightly packed with nucleosomes and hence DNA sequences are more accessible to DNA
binding proteins and transcription machinery such as RNA polymerase. The positioning of
nucleosomes is dynamically regulated by chromatin remodelers that unwind and rewrap
DNA around histones through ATP hydrolysis, and the recruitment of such proteins to
targeted genomic regions is often achieved by transcription factors (Clapier et al., 2017).
1.3 Transcription Factors
Transcription factors (TFs) are proteins that can recognize and bind specific 6-12bp DNA
sequences. Some transcription factors such as the highly conserved zinc finger protein
CCCTC-binding factor (CTCF) are ubiquitously expressed, while many others are
activated only in specific stages of development or in specific tissues. ChIP-seq
experiments revealed that known TFs generally have a few thousand up to a hundred
thousand high-confidence binding sites on the genome out of the numerous putative
4

recognition sequences, suggesting that more complex rules are involved in determining
the occupancy of TFs (Spitz and Furlong, 2012). Moreover, the concentration of a
particular TF and the combination of different TFs vary at different genomic regions,
contributing to the precise control of functional outcomes.
Although heterochromatin is generally less accessible, a subset of transcription factors
termed pioneer factors can recognize the DNA sequences wrapped around nucleosomes
or certain forms of heterochromatin (Zaret, 2020). The binding of pioneer factors on
repressive chromatin can actively recruit ATP-dependent nucleosome remodelers that
reduce the compactness of nucleosomes, allowing other transcription factors to bind and
active the region (Zaret and Carroll, 2011). Other pioneer factors can stably bind
regulatory sequences and passively prime the region for activation (Zaret and Carroll,
2011). In either case, pioneer factors are crucial for the initiation of regulatory events and
hence determination of cell lineages. Hematopoiesis, for instance, is a well-established
system for understanding lineage-determining transcription factors and their roles in
establishing chromatin accessibility (Johnson et al., 2018).
The process of generating different blood cells relies on the relative expression levels of
lineage-determining transcription factors (Murre, 2009). In the adult bone marrow,
expression of Gfi-1 and E2A restricts cellular proliferation and maintains the hematopoietic
stem cell pool (Hock et al., 2004; Murre, 2009; Semerad et al., 2009). Hematopoietic stem
cell differentiates into multipotent progenitor cells, where the antagonizing factors GATA1
and PU.1 segregate the erythroid/megakaryocytic from the myeloid/lymphoid cell lineages
(Rekhtman et al., 1999). In the lymphoid-primed multipotent progenitor compartment,
5

PU.1 further acts with E2A and Ikaros to promote development towards the common
lymphoid progenitors (CLP). E2A induces the expression of Notch1 in CLP, which initiates
T cell lineage differentiation. T cell development is further substantiated by upregulation
of TCF1, GATA3, and Bcl11b (Rothenberg et al., 2008; Tydell et al., 2007). On the other
hand, PU.1 and FOXO1, together with IL7Ra-mediated signaling activate the expression
of early B cell factor 1 (EBF1) in CLP and determines the differentiation to B cells (Kee
and Murre, 1998; Medina et al., 2004). Once activated, EBF1 induces PAX5 to upregulate
the expression of B-lineage-specific genes and maintain B cell identity in later stages of B
cell development (Medina et al., 2004) (Figure 1-2).
To investigate the mechanistic roles of TCF1 in T-cell differentiation, Johnson et al.
compared chromatin accessibility at eight stages of thymic T cell development in mice at
bulk and single-cell resolutions (Johnson et al., 2018). They found that TCF1 is enriched
at genomic regions that become accessible at the earliest stage of T cell development and
persist until T cell maturation, and forced expression of TCF1 in fibroblasts globally
incudes TCF1-bound chromatin accessibility, suggesting that TCF1 is capable of de novo
opening chromatin. In our studies of T-cell acute lymphoblastic leukemia, depletion of
TCF1, together with another TCF family member LEF1 lead to loss of chromatin
accessibility at T-cell specific genes, supporting the role of TCF family proteins in
maintenance of chromatin accessibility in T cell lineage (Zhou et al., 2022). In the case of
B-cell lineage determining factor EBF1, work by the Grosschedl and Murre labs not only
showed that EBF1 is required for establishing chromatin accessibility landscape during B
cell differentiation (Boller et al., 2016), but also determined that EBF1’s C-terminal domain
6

recruits Brg1 (Wang et al., 2020), a component of the chromatin remodeler SWI/SNF
complex (Bossen et al., 2015), to actively reshape the chromatin.
In contrast to pioneer factors that can fundamentally reorganize the chromatin accessibility
landscape, signaling-dependent transcription factors are responsible for the rapid relay of
environmental stimuli such as hormone, cell-cell contact and small molecule drugs from
the cell membrane to the nucleus. They often bind readily accessible promoters or
enhancers and recruit histone modification proteins, such as histone acetyltransferase
p300 to deposit H3K27ac marks and activate targeted regions (Aster et al., 2017; Barolo
and Posakony, 2002). One of such signaling pathways and the focus of my study is Notch
signaling and will be discussed in section 1.6.
Besides transcription factors that modulate linear chromatin structures, architecture
proteins are known for their roles in enabling and maintaining proper folding of chromatin,
allowing contact of distal regulatory elements and gene promoters in the nuclear space,
which are discussed in the next section. Collectively, the timing, mode and cooperative
recruitment of different families of TFs at regulatory regions give rise to robust
spatiotemporal regulation of gene expression (Spitz and Furlong, 2012).
1.4 Genome Folding Structures
Having discussed the basic structures and functions of chromatin, I now turn to the higherorder organization of the human genome. On the finest scale, chromatin forms a series of
loops and coils that allows distal loci on the linear chromatin to be in proximity. Chromatin
loops are generally restricted within the sub-megabase scale topologically associating
7

domains (TADs) (Dixon et al., 2012; Dowen et al., 2014; Jin et al., 2013; Lupianez et al.,
2015; Nora et al., 2012; Phillips-Cremins et al., 2013; Rao et al., 2014; Tang et al., 2015).
Active and repressive chromatin preferentially associate with the same than the other
chromatin state, resulting in a general partition of active A and repressive B compartment
at sub-chromosomal scales (Johnstone et al., 2020). Finally, the bundles of tightly coiled
chromatin form the 23 pairs of human chromosomes, each occupying a specific region of
the nucleus called chromosomal territories (Rao et al., 2014; Yu and Ren, 2017) (Figure
1-3).
Architectural proteins are major contributors to the establishment and maintenance of
chromatin organization. One of the most well studied architectural proteins is CTCF. In
erythroid cells, the CTCF-binding sites flanking beta-globin locus were found to participate
in spatial interactions between the upstream locus control region and the active betaglobin genes. Depletion of CTCF disrupts these long-range interactions and causes local
gain of histone methylation, but interestingly has no significant impact on beta-globin gene
expression (Splinter et al., 2006). Globally, CTCF is found to co-localize at TAD
boundaries with the ring-shaped cohesin complex, serving as barriers that prevent
chromatin loop formation between DNA sequences from the two adjacent TADs (Dixon et
al., 2012; Dowen et al., 2014; Hnisz et al., 2016b; Ji et al., 2016; Nora et al., 2012; PhillipsCremins et al., 2013; Rao et al., 2014; Tang et al., 2015). Cohesin complexes are also
found at enhancers and promoters to stabilize their interactions (Mumbach et al., 2016;
Mumbach et al., 2017) (Figure 1-3). Despite the indispensable roles of cohesin in
maintaining chromatin loops and abundant example loci showing loss of cohesin in
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association with gene deregulation, genome-wide cohesin depletion does not globally
change transcription (Rao et al., 2017). Recently, the zinc-finger proteins such as ZNF143
and the ubiquitous transcription Yin Yang 1 (YY1) are found to function as architectural
proteins (Cubenas-Potts and Corces, 2015; Weintraub et al., 2017; Zhou et al., 2021).
ZNF143 co-localizes to CTCF-bound enhancer-promoter loops (Zhou et al., 2021), while
YY1 preferentially load at cohesin-bound enhancer-promoter loops but not CTCF-CTCF
loops (Weintraub et al., 2017). Other than proteins that directly serve as structural
regulators, an increasing number of factors with known functions in other cellular
processes are shown be involved in mediating chromatin loops. KLF4, one of the factors
shown to be able to reprogram somatic cells to pluripotent stem cells (Takahashi and
Yamanaka, 2006), is required for maintaining enhancer connectivity at preexisting
accessible regions and can induce chromatin loops at highly methylated inaccessible
regions (Di Giammartino et al., 2019). PU.1, a master TF controlling myeloid development
(Engel and Murre, 1999), has also been shown to mediate enhancer-promoter looping at
IL-1β locus in mouse macrophage (Ha et al., 2019) and genome-wide in neutrophil (Watt
et al., 2021). Together, these observations suggest that transcription factors, including
proteins with primary functions in orchestrating chromatin folding or those previously
identified as important participants of other processes, act concordantly on regulatory
elements distal or proximal to the promoters to facilitate proper gene activation.
The descriptive mapping and functional studies of successive layers of chromatin
organization have been facilitated by two major types of approaches: sequencing-based
chromatin conformation capture (3C) techniques and imaging-based fluorescence in situ
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hybridization (FISH) (Mateo et al., 2019; Yu and Ren, 2017) (Figure 1-4). 3C techniques
can be applied to a specific locus or the whole genome, enabling kilo-base resolution
views of the chromatin organizations in a population of cells. However, cell-to-cell
variability is usually not captured in 3C-based methods. On the other hand, imaging
methods directly measure the distances between DNA sequences and their placement
relative to other structures such as nuclear pore and lamina, yet they are limited in
resolution and throughput (Huang et al., 2010). Thus, 3C-based and imaging-based
methods can provide complementary, and sometimes interestingly contrasting information
about the three-dimensional genome organization.
3C-based techniques start with preserving the protein-mediated chromatin folding
structures with crosslinking, followed by fragmentation with restriction enzyme or
micrococcal nuclease. The fragmented but crosslinked segments, now containing DNA
sequences from two loci of the genome, are ligated and further prepared for downstream
assay. The earliest version of 3C uses qPCR to detect the enrichment of proximity ligation
products of the two regions of interest (Dekker et al., 2002). 4C-seq uses a set of primers
targeting a “viewpoint” locus of interest, e.g., a gene promoter, and all the ligation products
containing the region can be amplified and quantified by shallow sequencing (5-10 million
reads) (Cho et al., 2018). By adding biotinylated nucleotides during ligation, all the
possible interacting regions that are ligated can be captured and amplified. HiC directly
sequences such all-to-all contacts and thus provides an unbiased view of the chromatin
folding landscape, yet it requires billions of sequencing reads to reveal structures at 1Kb
resolution (Rao et al., 2014). HiChIP and PLAC-seq further subject HiC library to
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chromatin precipitation, and similarly high-resolution chromatin loops mediated by certain
transcription factors or chromatin modifications can be measured with less reads than HiC
(0.5 to 1 billion reads) (Fang et al., 2016; Mumbach et al., 2016).
HiC and HiChIP data are often displayed as heatmaps of matrices with the same
chromosome as the x- and y-axis. Each sequenced read that is mapped to two regions on
the chromosome is one entry for the matrix, and overrepresented regions form distinct
patterns on the heatmaps. Chromatin loops are shown as puncta, while TADs and subTADs are shown as continuous triangles of various sizes placed along the diagonal of the
heatmap (Crane et al., 2015; Rao et al., 2014). By transforming the contact matrix to a
correlation matrix, A/B compartments display a plaid pattern and can be computationally
delineated by applying eigenvector analysis (Lieberman-Aiden et al., 2009). Due to the
ChIP procedure, binding sites of the immunoprecipitated protein can be detected from
linearized HiChIP data and used to filter high-confidence interactions in the contact matrix
(Mumbach et al., 2016).
FISH imaging of large chromosomal regions has long been applied in diagnosis of genetic
diseases such as Down syndrome. Recent advances in FISH probe design and
hybridization procedure, together with increased resolution of microscopes have enabled
flexible applications of FISH in detecting chromatin structures. Oligopaint DNA FISH
probes are designed as a series of 30-80bp DNA oligos that are homologous to the
genomic region of interest with overhang sequences that can bind secondary oligos with
fluorescent molecules (Beliveau et al., 2018). The combination of multiple fluorophores at
different spectrums, such as Alexa-488, 565, 647 and DAPI, allows simultaneous labeling
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of a few genomic regions and measuring nanometer scale chromatin loops. Alternatively,
secondary oligos that can be exchanged by affinity allow sequential labeling of larger
chromatin structures with the same fluorophore. These techniques combined with superresolution and confocal microscopy have been applied in reconstructing folding structures
of TADs (Mateo et al., 2019; Sigal et al., 2018).
1.5 3D Genome Dysregulation in Cancer
Tumorigenesis is often attributed to the accumulation of somatic mutations. Gain-offunction mutations in oncogenes (e.g., MYC, RAS, WNT) and loss-of-function mutations
in tumor suppressors (e.g., BRCA1/2, p53) can both lead to aberrant activation of
pathways crucial for the homeostasis in multicellular organisms and eventually
uncontrolled cell proliferation. Gain of secondary mutations during treatment allows tumor
cells to circumvent their addiction to primary mutated pathways, rendering targetedtherapy ineffective (Herranz et al., 2015; Sanchez-Martin et al., 2017). Along with the
discovery of the importance of epigenetic regulation in normal cells, there is increasing
interest in understanding the contribution of epigenetic dysregulation in cancer and drug
resistance. Although global changes in the linear epigenetic landscape are now widely
accepted as a hallmark of cancer (Sharma et al., 2010), the role 3D genome misfolding in
cancer remain poorly understood. Mutations in histone proteins such as the linker histone
H1 reduces H1 to nucleosome ratio, allowing more bending of the chromatin and loop
formation. The decompaction of H1 deficient genome leads to increased accessibility to
early developmental genes and induces lymphomagenesis potentially through promoting
stemness (Yusufova et al., 2021). Mutations in histone modifiers, such as the histone
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lysine methyltransferase EZH2, can cause genome-wide increase of repressive histone
modification and intra-TAD conformation changes that associate with silencing of tumor
suppressors (Donaldson-Collier et al., 2019). Apart from mutations in proteins directly
interact with chromatin, mutations in metabolic genes such as IDH can also lead to global
hypomethylation that prevent binding of CTCF at the TAD boundary. Loss of boundary
insulation allows a distal constitutive enhancer to establish aberrant contact and hence
activate the expression of the oncogene PDGFRA, promoting the growth of gliomasphere
and fitness of tumor cells (Flavahan et al., 2016). The discoveries that mutations in
histones, chromatin enzymes and metabolic pathways can all contribute to not only
chromatin accessibility and modifications but also genome topology greatly advanced our
mechanistic understanding of gene dysregulation in cancer.
Unlike genetic mutations, epigenetic changes in cancer that are not attributed to mutations
in genes or copy number variants are likely to be reversible, making them clinically relevant
drug targets (Sharma et al., 2010). However, only a handful of papers, including our own,
discuss the roles of epigenetic adaptations in cancer genome topology. Mega-base scale
compartment reorganization associated with excessive cell division has been describe in
colon tumor in comparison to normal colon tissues (Johnstone et al., 2020). TAD boundary
disruption not attributed to mutations or changes in DNA hypermethylation but decreased
chromatin accessibility has been observed near the protooncogene MYC in T cell acute
lymphoblastic leukemia (T-ALL). This allows fusion of two adjacent TADs and increased
expression of MYC, potentially through increased looping to a distal super-enhancer
(Kloetgen et al., 2020). Reorganization of 3D genome in estrogen receptor α (ERα)13

positive breast cancer cells has been described during endocrine resistance acquisition
(Achinger-Kawecka et al., 2020; Zhou et al., 2019), yet the underlying mechanisms of
these events remain unclear. As discussed in detail in Chapter 3, we recently described
large-scale chromatin refolding events in NOTCH1-mutated T-ALL cells during their
acquisition of resistance to gamma-secretase inhibitor (GSI), a small molecule Notch
inhibitor. GSI-treatment leads to downregulation of the T lineage TFs while activates the
expression of B lineage genes. We further mechanistically showed that disassociation of
the B-cell lineage determining transcription factor EBF1 from the repressive nuclear
lamina to the interior activates its expression, which promotes a T-to-B lineage shift and
maintains oncogenic MYC expression to enable Notch-independent cell survival (Bayer
and Grosschedl, 2022; Zhou et al., 2022). Our data showed the possibility that cancer
cells transformed from healthy cells at a distinct stage of differentiation can maintain their
potential to switch lineage through epigenetic mechanisms and evade targeted therapy.
Future studies of these architectural changes and their association with normal cell lineage
determination could inform development of more precise detection or therapeutic options.
1.6 Notch Signaling Pathway in Normal and Malignant Cells
Notch receptors are a family of highly conserved single-pass transmembrane proteins.
Four different Notch receptors, Notch1-4, are expressed in mammals. The extracellular
domain of Notch contains a series of EGF-like repeats followed by a negative regulatory
region (NRR) and a heterodimerization domain. Intracellular Notch (ICN) consists of
RBPJ-associated molecule region, ankyrin repeats, transcriptional activation domain and
a C-terminus PEST degron domain. When the ligand of a signaling cell binds the
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extracellular domain of a mature Notch receptor, the transmembrane NRR domain is
exposed for two sequential cleavages by ADAM metalloproteases and gamma-secretase,
releasing ICN from the membrane (Gordon et al., 2015). ICN then translocates to the
nucleus and form Notch transcription complex (NTC) with its DNA binding cofactor RBPJ
and coactivator Mastermind-like MAML family. NTCs preferentially locate on enhancer
elements, and coregulators involved in the activation of Notch-bound enhancers include
the histone acetyl transferase p300 for deposition of H3K27ac (Oswald et al., 2001) and
mediator complex (Fryer et al., 2004) (Figure 1-1).
Notch signaling pathway is fairly simple compared to other pathways that rely on
secondary modifications or enzymatic amplifications. However, the functional outcomes
of Notch signaling in normal development are diverse, and mutations in components of
Notch signaling pathway including RBPJ, Notch1-3 and ligands are associated with
congenital disorders in multiple organs (Garg et al., 2005; Kamath et al., 2012). As briefly
mentioned in Chapter 1.3, activation of Notch1 is critical for early stages of T cell
development, and Notch1 is attenuated in later stages. Hence, dysregulation of the
dosage of Notch can have adverse effects on hematopoiesis and lead to cancer. Indeed,
gain-of-function mutation in Notch1 occurs in more than 50% of T-ALL patients and 1535% adult early T cell progenitor acute lymphoblastic leukemia (Weng et al., 2004).
Besides T cell, Notch1 is also mutated in ~10% of chronic lymphocytic leukemia and
mantle cell lymphoma (MCL) (Kridel et al., 2012). Notch1 and Notch2 mutations are also
identified in 5-10% triple-negative breast cancer (TNBC) (Robinson et al., 2011) and 7080% squamous cell carcinoma in skin (Wang et al., 2011b), highlighting the varied roles
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Notch family proteins play in normal development and their importance as diagnostic
markers and treatment targets. Small molecule inhibitors of Notch such as gammasecretase inhibitors (GSIs) have been developed, yet due to limited efficacy and severe
non-specificity (Sanchez-Martin et al., 2017), these drugs are largely limited as in vitro
reagents to study the function of Notch in cancer cell lines.
Although Notch target genes differ in cell lineages and tumor types, an important common
one is the protooncogene MYC that is crucial for tumor proliferation (Knoechel et al., 2014;
Ryan et al., 2017; Weng et al., 2006; Yashiro-Ohtani et al., 2014). As presented in detail
in Chapter 2, we identified five Notch-bound enhancers upstream of the MYC promoter
cooperate to regulate its expression in TNBC. I also contributed to a study where we
identified MYC enhancers in in MCL (Ryan et al., 2017). These two MCL-restricted Notchbound enhancers are also upstream of MYC. We showed that simultaneous silencing of
the two enhancers reduces MYC expression and MCL proliferation. In T-ALL, the Notchbound MYC enhancer is located ~1.3 Mb downstream of the MYC promoter. By GSI
treatment in TNBC, MCL and T-ALL, we and others found that Notch binding rapidly
activates these distal enhancers. More recently, we discovered that in TNBC and MCL,
contacts among the upstream enhancers and MYC promoter are dynamically regulated
by Notch (Chapter 2). In contrast, the Notch-bound enhancer remains in contact with the
MYC promoter when T-ALL cells are acutely treated by GSI (Kloetgen et al., 2020). In cell
line models of all three diseases, short-term Notch inhibition has neglectable impact on
the chromatin accessibility and TAD structures at both MYC locus and genome-wide
(Chapter 3). These observations suggest that in cooperation with different lineage-specific
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transcription factors that enabled accessibility of distal enhancers, Notch can dynamically
activate and/or reposition enhancers to drive the expression of crucial pro-survival genes
such as MYC.
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1.7 Figure Titles and Legends

Figure 1-1: The human genome and Notch transcription complex.
From left to right: the human genome is enclosed in the nucleus in an orderly manner, with
nucleosomes as the basic units. Compact arrangement of nucleosomes leads to low
accessibility and enrichment of repressive histone tail modifications. Loose arrangement
of nucleosomes often associates with active regulatory elements such as enhancers and
promoters. Notch signaling, which initiates from the cell membrane, can rapidly activate
distal enhancers and have varied functions in many developmental processes from wings
of fruit flies to human blood cells.
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Figure 1-2: EBF1 and TCF1 drive B and T cell differentiation, respectively.
Simplified schematic of hematopoiesis focusing on the development of T and B cells.
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Figure 1-3: Genome folding structures.
Point-to-point contacts between an enhancer and a promoter is the finest scale of
chromatin loop. These loops are usually constrained within a certain genomic region which
is termed topologically associated domains, contact domains, etc. On a higher level, active
chromatin and repressive chromatin preferentially associate with sequences of the same
chromatin state, resulting in a general segregation of active A and repressive B
compartment. The hierarchical order of genome folding is maintained by a subset of
transcription factors called architectural proteins, among which the most well-studied ones
are CTCF, cohesin complex and YY1.
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Figure 1-4: Techniques for studying 3D genome structures.
Majority of the chromatin conformation capture (3C) and DNA FISH techniques start with
preservation of chromatin loops with crosslinkers. Sequencing-based 3C techniques
capture genome-wide or locus-specific chromatin loops at kilobase resolution and can be
analyzed and compared with streamlined algorithmic and statistical methods. Imagingbased techniques allow direct visualization of DNA sequences within the nuclear space of
individual cells, yet they’re largely limited in resolution and throughput, and data analyses
are more likely to be manual and subjective.
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2.1 Abstract
Chromatin loops enable transcription factor-bound distal enhancers to interact with their
target promoters to regulate transcriptional programs. Although developmental
transcription factors, such as active forms of Notch, can directly stimulate transcription by
activating enhancers, the effect of their oncogenic subversion on the 3-dimensional (3D)
organization of the cancer genome is largely undetermined. By mapping chromatin looping
genome-wide in Notch-dependent triple-negative breast cancer and B-cell lymphoma, we
show that beyond the well-characterized role of Notch as an activator of distal enhancers,
Notch regulates its direct target genes through instructing enhancer repositioning.
Moreover, a large fraction of Notch-instructed regulatory loops forms highly interacting
enhancer and promoter spatial clusters, termed “3D cliques”. Loss- and gain-of-function
experiments show that Notch preferentially targets hyperconnected 3D cliques that
regulate the expression of crucial proto-oncogenes. Our observations suggest that
oncogenic hijacking of developmental transcription factors can dysregulate transcription
through widespread effects on the spatial organization of cancer genomes.
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2.2 Introduction
Folding of chromatin into structural and regulatory loops is emerging as an important
regulator of gene expression (Dixon et al., 2012; Hnisz et al., 2016a). Chromatin-folding
organization is often perturbed at different hierarchical levels in cancer (Flavahan et al.,
2016; Hnisz et al., 2016b; Jin et al., 2013; Misteli, 2010). Changes in spatial chromatin
organization due to genomic rearrangements or dysregulation of conformation-associated
proteins in cancer have been reported (Flavahan et al., 2016; Hnisz et al., 2016b; Katainen
et al., 2015; Lawrence et al., 2014; Taberlay et al., 2016; Wu et al., 2017), yet chromatinfolding reorganization in response to oncogenic subversion of developmental transcription
factors, a frequent class of oncogenic drivers, is not well understood. Notch transcription
complexes control cellular development and tissue homeostasis (Bray, 2016) and when
dysregulated contribute to the pathogenesis of multiple malignancies (Aster et al., 2017).
Here, we use Notch-dependent cancer cells to examine the role of oncogenic transcription
factors on repositioning of distal regulatory elements.
Notch target genes play crucial oncogenic roles in several hematologic malignancies and
solid tumors (Aster et al., 2017). Activating Notch mutations often disrupt the Notch
negative regulatory region (NRR) or C-terminal PEST degron domain, producing ligandindependent release of the Notch intracellular domain (NICD) or an increase in NICD halflife, respectively. NICDs translocate to the nucleus and form Notch transcription
complexes (NTCs) with the DNA-binding factor RBPJ and other co-factors. Oncogenic
Notch transcription complexes recruit histone acetyltransferase p300 (Oswald et al.,
2001), histone demethylase KDM1A (Mulligan et al., 2011; Yatim et al., 2012) and
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components of the Mediator complex (Fryer et al., 2004) to Notch-responsive elements to
regulate the transcription of target genes. In hematologic malignancies, Notch binding
events are often associated with increased histone acetylation and activation of distal
enhancer elements (Wang et al., 2014). Direct regulation of the proto-oncogene MYC in
both B- and T-lymphoid malignancies by Notch-activated enhancers, which are located up
to 1.5 Mb away from the MYC promoter, exemplifies Notch-dependent long-range gene
regulation (Fabbri et al., 2017; Herranz et al., 2014; Ryan et al., 2017; Yashiro-Ohtani et
al., 2014). Although looping of chromatin, which enables physical contact between Notchbound enhancers and promoters, is essential for proper and selective gene expression, it
remains unclear to what extent Notch transcription complexes influence long-range
regulatory contacts.
Chromatin loops, juxtaposing transcription factor-bound distal enhancers with the
promoters of target genes are facilitated by structural proteins, including the DNA-binding
insulator protein CCCTC-binding factor (CTCF) and cohesin (de Laat and Duboule, 2013;
Flavahan et al., 2016; Hnisz et al., 2016b; Hu and Tee, 2017; Katainen et al., 2015;
Lawrence et al., 2014; Spitz, 2016; Visel et al., 2009). Ring-shaped cohesin complexes
are loaded at active enhancers and promoters to stabilize their physical interactions
(Kagey et al., 2010; Phillips-Cremins et al., 2013; Schmidt et al., 2010; Watrin et al., 2016).
Enhancer-promoter loops are mostly constrained within larger genome organizational
structures, variably referred to as contact domains, interaction domains, topologically
associated domains (TADs), sub-TADs, loop domains, and insulated neighborhoods
(Dixon et al., 2012; Dowen et al., 2014; Jin et al., 2013; Lupianez et al., 2015; Nora et al.,
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2012; Phillips-Cremins et al., 2013; Rao et al., 2014; Tang et al., 2015), the boundaries of
which are occupied by cohesin complexes and CTCF (Dixon et al., 2012; Dowen et al.,
2014; Hnisz et al., 2016b; Ji et al., 2016; Nora et al., 2012; Phillips-Cremins et al., 2013;
Rao et al., 2014; Tang et al., 2015). More recently, it was shown that the ubiquitous
transcription factor YY1, in addition to a limited number of architectural proteins, binds to
enhancers and facilitates their looping to promoters, suggesting that enhancer-promoter
repositioning could be instructed by particular transcription factors bound at DNA elements
engaged in transcriptional regulation (Weintraub et al., 2017).
Oncogenic Notch transcription complexes bind distal enhancers (Ryan et al., 2017; Wang
et al., 2014), raising the question of whether oncogenic Notch regulates transcription by
instructing enhancers and promoters repositioning. To investigate the impact of oncogenic
Notch on the 3D genome organization of cancer cells, we generated cohesin HiChIP and
1D epigenomic data sets in two Notch-dependent cancer cell types, triple-negative breast
cancer (TNBC) and mantle cell lymphoma (MCL), in the Notch-on and -off states. We
report here that Notch transcription complexes control their direct target genes through
two distinct regulatory modes: either through existing loops or by facilitating new longrange regulatory interactions. This combination of pre-existing and Notch-instructed loops
coalesce enhancers and promoters to form highly interacting clusters, termed “3D
cliques”. In cancer cells, Notch preferentially activates enhancers and promotes looping
interactions within highly connected 3D cliques that regulate key oncogenes. These
observations suggest a general mechanism that oncogenic transcription factors can
exploit to induce the transcriptional outputs of cancer cells.
26

2.3 Results
Contact domains of Notch-mutated cancer cells are lineage invariant
Protein-centric genome-wide chromatin conformation capture methods such as HiChIP,
PLAC-seq and ChIA-PET were used to accurately map chromatin contact domains in
multiple cell types (Dowen et al., 2014; Fang et al., 2016; Mumbach et al., 2016; Mumbach
et al., 2017; Rowley et al., 2017). Given that the cohesin complex is loaded at enhancerpromoter loops and is involved in CTCF-mediated interactions, we first performed HiChIP
for the cohesin subunit SMC1a in MCL Rec-1 cells with an activating Notch mutation and
used chromosome-wide insulation potential (Crane et al., 2015) to systematically identify
high-confidence contact domain boundaries. To validate the sensitivity and specificity of
our cohesin HiChIP, we compared Rec-1 contact domains and contact domains
delineated by in situ Hi-C in the EBV-transformed GM12878 lymphoblastoid B cell line
(Rao et al., 2014). GM12878 cells express an EBV-encoded RBPJ-binding factor, EBNA2,
that mimics Notch activities (Henkel et al., 1994), and its genome organization is similar
to Rec-1 cells (Ryan et al., 2017). The contact domain boundaries identified in Rec-1 cells
using cohesin HiChIP (~760 million sequenced reads) were highly concordant with those
identified by in situ Hi-C of GM12878 cells (Rao et al., 2014) (~3 billion sequenced reads),
both at the level of a single chromosome (Figure S2-1A) and genome-wide (Fisher’s exact
p-value < 1E-15, Figure S2-1B). This level of concordance was similar to that observed
when the HiChIP (Mumbach et al., 2016) and in situ Hi-C of GM12878 were compared
(Fisher’s exact p-value < 1E-04, Figure S2-1C). Furthermore, A/B compartments
identified by in situ Hi-C and SMC1 HiChIP in GM12878 were indistinguishable (Spearman
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correlation p-value < 1E-15, Figure S2-1D) and showed a level of concordance similar to
that of A/B compartments identified by two independent in situ Hi-C experiments in
GM12878 (data not shown). These results demonstrate that our cohesin HiChIP data are
of high quality and provide an efficient method to accurately delineate chromatin contact
domains and compartments with ~4-fold lower sequencing depth than in situ Hi-C.
In addition to MCL, activating Notch mutations are frequent in TNBC (Choy et al., 2017;
Robinson et al., 2011; Stoeck et al., 2014; Turner et al., 2010; Wang et al., 2015). We
performed SMC1a HiChIP in the Notch-mutated TNBC cell lines HCC1599 and MB157
(Robinson et al., 2011; Stoeck et al., 2014), analyzing more than 1.5 billion read pairs. A
sizable fraction of contact domains is enclosed by a structural chromatin loop with CTCFbound and cohesin-occupied anchors (Dixon et al., 2012; Narendra et al., 2015; PhillipsCremins et al., 2013; Sofueva et al., 2013; Wendt et al., 2008). Examination of CTCF and
cohesin binding events showed that these proteins co-occupy 81.4% of MB157 contact
domain boundaries (proportion test p-value < 1E-15, Figure S2-1E). As expected for a
high-quality data set, more than 85% of the CTCF-bound contact domain boundaries in
MB157 cells had inward-oriented CTCF motifs (785 inward-oriented versus 2 outwardoriented, Figure S2-1F).
TNBC HCC1599 and MB157 contact domains showed highly similar organization, as
exemplified by the organization of chromosome 8 (Figure 2-1A). Genome-wide, out of
4,767 and 4,847 contact domain boundaries identified in HCC1599 and MB157 cells,
respectively, 4,223 domain boundaries were common to both (Fisher’s exact p-value <
1E-15, Figure S2-1G). Furthermore, most contact domain boundaries were also shared
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by MCL Rec-1 and TNBC cells, as exemplified by genomic region containing the MYC
locus on chromosome 8 (Figure 2-1B, 5 Kb genomic resolution). Genome-wide, nearly
70% of the identified contact domain boundaries were shared in these two different Notchmutated cancer cell lineages (Fisher’s exact p-value < 1E-15, Figure 2-1C), consistent
with the extent of concordance previously noted when other cell lineages were compared
(Dixon et al., 2015; Dixon et al., 2012; Nora et al., 2012; Rao et al., 2014). Thus, chromatin
contact domains are largely lineage-independent organizational features of Notchmutated cancer cell genomes.
Contact domains are insensitive to Notch signals
To test the effect of the binding of Notch transcription complexes on genome organization,
we first performed RBPJ ChIP sequencing (ChIP-seq) in MB157. We observed 19% of
RBPJ binding events localized to domain boundaries (Figure S2-1H) and, conversely,
43% of CTCF-bound, cohesin-occupied boundaries showed significant RBPJ binding
(permutation proportion 14%, proportion test p-value < 1E-15, Figures 2-1D and 2-1E).
To determine if Notch transcription complex binding influenced the insulation potential of
contact domain boundaries, we performed a gamma-secretase inhibitor (GSI)-washout
assay (Weng et al., 2006). This strategy enables rapid Notch activation and loading of
Notch transcription complexes onto chromatin (Wang et al., 2014), an event that also
increases the RBPJ occupancy at regulatory sites (Bailis et al., 2014; Wang et al., 2014).
By comparing the Notch active (GSI-washout, Notch-on) and inactive (GSI, Notch-off)
states in MB157 cells, we identified 3,216 Notch-responsive elements with a significant
and reproducible increase in NICD1 and RBPJ occupancy (Figure 2-1F). A stringent DNA29

binding motif search found at least one RBPJ consensus binding sequence in 99.3% of
the identified Notch-responsive elements. However, Notch- and RBPJ-bound contact
domain boundaries were, on average, unaffected by Notch activity, as shown by pile-up
plots of interactions centered on contact domain boundaries (Figure 2-1G). This
observation was confirmed by inspection of genomic-distance-adjusted chromatin
interaction maps and insulation profiles of the MYC locus before and after Notch inhibition
(Figure 2-1H). Measurements of Notch transcription complex binding events in HCC1599
TNBC cells also showed that while Notch transcription complexes bound to many
HCC1599 contact domain boundaries (Figures S2-1I and S2-1J), alterations in Notch
activity did not impact contact domain integrity (Figures S2-1K and S2-1L). Moreover, the
comparison of A/B compartments between Notch-on and -off conditions revealed that
Notch inhibition did not reposition compartments from A-to-B or from B-to-A in MB157 and
HCC1599 (Figures S2-1M and S2-1N). Together, these data suggest that contact
domains and compartments are predominantly unaffected by Notch transcription complex
binding.
Chromatin state of contact domains in Notch-mutated tumors is lineage-specific
Contact domains generally restrict propagation of chromatin states along chromosomes
(Boettiger et al., 2016; Dixon et al., 2012; Dowen et al., 2014). In line with this prediction,
contact domains in MB157 and HCC1599 cells were either enriched for active (H3K27ac
and/or H3K4me1 -marked) or repressed (H3K27me3-marked) chromatin (Figures 2-2A,
2-2B, and S2-2A to D), with active contact domains containing, on average, twice the
number of expressed genes as repressed domains. Repressed contact domains with
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higher H3K27me3 level were on average 1.37 Mb and larger than active contact domains
whose average size was 0.92 Mb (Figures 2-2B and S2-2C). Overall, the chromatin states
of 79% of contact domains were identical in MB157 and HCC1599 TNBC cells (Fisher’s
exact p-value < 1E-15, Figure S2-2E). Analysis of active and repressed contact domains
in Notch-mutated MCL cells (Figures S2-2F to H) and comparison with TNBC cells
showed that on average 37% of contact domain chromatin states were lineage-specific
(Fisher’s exact p-value < 1E-06, Figure 2-2C). Together, our data indicate that while
contact domains are largely invariant in Notch-mutated MCL and TNBC, the chromatin
signature within contact domains shows significant lineage specificity.
Interactions within active enhancer-marked contact domains are Notch sensitive in
TNBC
Intradomain interactions linking regulatory DNA elements, such as enhancers and
promoters, are implicated in gene control (Dowen et al., 2013; Dowen et al., 2014; Kagey
et al., 2010; Lupianez et al., 2015). To determine whether Notch signaling activity impacts
intradomain interactions in TNBC, we first used 286 million unique read pairs of MB157
cohesin HiChIP to identify high-resolution (~5 Kb) significant interactions. We relied on a
statistical model that controls for both the protein occupancy level and linear genomic
distance between the connected DNA loop anchors (Phanstiel et al., 2015). This approach
identified 265,216 significant cohesin-associated DNA interactions in MB157 cells
supported by at least 4 read pairs. Unless stated otherwise, the high-confidence set of
interacting loci (also referred to as significant interactions) was used for further quantitative
analysis. We quantified significant interactions within contact domains in MB157 and
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observed that after Notch inhibition 236 contact domains showed at least a 4-fold
decrease in overall intradomain interaction (Figure 2-2D). These Notch-sensitive contact
domains were enriched within domains with an active chromatin state (proportion test pvalue < 1E-09, Figure 2-2E). To independently confirm this observation, we studied
HCC1599 cells, in which 472,073 significant cohesin-associated DNA interactions were
identified. We again detected Notch-sensitivity of intradomain interactions connecting loci
within contact domains with high loads of active enhancer histone marks (proportion test
p-value < 1E-15, Figures 2-2F and 2-2G). Together, these results show that in contrast
to invariant contact domain boundaries, long-range intradomain chromatin loops with
potential regulatory functions are Notch-sensitive in TNBC.
Notch activates TNBC distal enhancers
We next quantitated the direct effect of Notch on active enhancers in TNBC MB157 and
HCC1599 cells. On average, Notch binding events were 19 Kb away from the closest
transcription start site (Figure S2-3A). H3K27ac, a histone mark of active enhancers, was
deposited at nearly 85% of the Notch transcription complex-bound chromatin (proportion
test p-value < 1E-15). Notch inhibition markedly decreased the H3K27ac levels of Notchresponsive elements in TNBC cells (Figure S2-3B). Importantly, this effect of Notch
inhibition was not abrogated by ectopic expression of MYC (Figures S2-3C to E), a global
amplifier of active gene expression and a known direct Notch target in T-ALL and MCL
(Lin et al., 2012; Nie et al., 2012; Ryan et al., 2017; Wang et al., 2014). Moreover, the level
of H3K4me1 histone marks (Figure S2-3B) and chromatin accessibility (Figure S2-3F) of
Notch-responsive elements in TNBC cells were largely insensitive to changes in Notch
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activity. Together, these data suggest that Notch transcription complexes preferentially
bind and activate primed TNBC distal enhancers independent of MYC.
Notch-instructed and preformed enhancer-promoter contacts regulate direct Notch
target genes in TNBC
Regulatory DNA loops between promoters and distal enhancers are crucial for proper
gene control (Deng et al., 2012; Ghavi-Helm et al., 2014). We thus asked whether distal
Notch-responsive elements (Figures S2-3A and S2-3B) that are likely to directly regulate
TNBC transcriptional outputs also participate in Notch-sensitive intradomain long-range
interactions (Figures 2-2E and 2-2G). To this end, we first identified TNBC Notchsensitive genes (i.e. Notch-upregulated genes) using RNA-seq in MB157 and HCC1599
cells. Notch activation concordantly increased the transcription level of 2,038 genes in
these two cell lines. To assess the lineage-specificity of Notch-sensitive genes, we also
performed differential gene expression analysis in T-ALL DND41 and MCL Rec-1 cells.
We found that 504 genes, including the well-characterized Notch target genes MYC,
HES1, and CR2 (Ryan et al., 2017; Stoeck et al., 2014; Yatim et al., 2012), were positively
regulated by Notch in all three Notch-mutated cancer types (Figure S2-3G). Lineageindependent Notch-sensitive genes were enriched for known MYC targets and MYCregulated biological processes (Figure S2-3H), suggesting that these genes
predominantly belong to a MYC-driven expression program and are a secondary effect of
Notch activation in these three Notch-mutated cancers. Overall, 204 Notch sensitive
genes were specific to TNBC (Figure S2-3G), including CCND1, KIT and SAT1, all of
which have been implicated in TNBC (Abravanel et al., 2015; Choy et al., 2017; Cohen et
33

al., 2010; Kashiwagi et al., 2013; Regan et al., 2012). Furthermore, gene set enrichment
analysis showed the TNBC-specific Notch target genes were enriched for genes
associated with breast cancer and mammary epithelium biology (Figures S2-3G and S23I). These data indicate the existence of a TNBC-specific Notch-driven transcription
program, in line with the lineage-specificity of the TNBC contact domain chromatin state
(Figure 2-2C).
We next assessed how Notch-dependent gene expression relates to TNBC 3D genome
organization. After aligning the Notch-sensitive genes to the TNBC 3D genome landscape,
we observed that these genes were preferentially associated with active contact domains
with Notch-sensitive intradomain interactions (Fisher’s exact p-value < 1E-04, Figure 23A). Integrative analysis of Notch-binding events, Notch-dependent enhancers and
transcripts, and high confidence chromatin loops distinguished direct from indirect Notch
targets and identified 215 and 386 direct Notch-upregulated genes (i.e. Notch-activated
genes) in MB157 and HCC1599, respectively. In both TNBC lines, inhibition of Notch
signaling markedly decreased H3K27ac levels at Notch-bound enhancer elements linked
to Notch-activated genes (Wilcoxon rank sum p-value < 1E-15, Figure 2-3B). We also
observed a significant reduction in the frequency of long-range interactions between the
Notch-bound DNA elements and their target promoters upon Notch inhibition (Wilcoxon
rank sum p-value < 1E-03, Figure 2-3C).
We defined Notch-instructed loops as Notch-sensitive interactions connected to distal
Notch transcription complex-bound elements. To further dissect the mechanisms of direct
gene activation by Notch transcription complexes, we considered four possible regulatory
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modes: (a) Notch-instructed loops (DL) linking Notch-activated enhancers (DE) to
promoters; (b) Notch-instructed loops (DL) linking Notch-insensitive enhancers (ÆE) to
promoters; (c) Notch-insensitive (preformed) loops (ÆL) linking Notch-activated
enhancers (DE) to promoters; and (d) Notch-insensitive (preformed) loops (ÆL) linking
Notch-insensitive active enhancers (ÆE) to promoters (Figure 2-3D). Integrating the
Notch-dependent regulatory loops, enhancers, and Notch-binding events from MB157
cells showed that the greatest increase in transcription between the Notch-off and -on
states occurred in genes in which Notch both activated and repositioned the enhancers
(mode a, Wilcoxon rank sum p-value < 2E-03, Figure 2-3E). Similar observations were
made in HCC1599 cells (mode a, Wilcoxon rank sum p-value < 3E-02, Figure 2-3F).
Although “mode a” was associated with a more pronounced effect on expression of direct
Notch target genes, our analysis also identified a group of Notch-activated genes in which
only loops (mode b) or enhancers (mode c) were Notch-dependent (Figure 2-3D). Finally,
transcriptional outputs of another group of genes linked to Notch-insensitive enhancers
through preformed loops were shown to only depend on distal Notch binding, suggesting
that Notch functions as the final transcriptional trigger at these loci (mode d, Figures 23D to F and S2-3J).
We next closely scrutinized Notch-repositioned enhancer-promoters (Figure 2-3D modes
a and b), a previously unrecognized mode of Notch-dependent gene regulation. The protooncogene MYC, a known direct Notch target in B- and T-lymphoid malignancies (Fabbri
et al., 2017; Herranz et al., 2014; Ryan et al., 2017; Yashiro-Ohtani et al., 2014),
exemplifies genes with Notch-repositioned enhancer-promoter in TNBC (Figure 2-3G,
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also see Figure 2-5). To independently evaluate the Notch-dependency of enhancerpromoter contacts involving this critical proto-oncogene, we performed 3D DNAfluorescence in situ hybridization (FISH) to study the spatial localization of three elements
in MB157: 1) the MYC promoter; 2) a MYC enhancer located 451 Kb 5’ of the promoter
that interacted with the promoter through a Notch-sensitive long-range interaction; and 3)
a T-ALL-specific Notch-dependent MYC enhancer located 3' of the promoter which was
inactive and H3K27me3-marked in TNBC (Figure 2-3G). In concordance with the
decrease in MYC promoter-enhancer interaction frequency detected by HiChIP (Figure
2-3G), DNA-FISH analysis showed that the MYC promoter and the MYC 5' enhancer
probes became significantly separated upon Notch inhibition (Figure 2-3H). Interestingly,
we observed that the MYC promoter and the 3' MYC probes became markedly closer after
Notch inhibition (Figure 2-3H), a change that was also observed globally in TNBC
genomes (Figures 2-2E and 2-2G). Critically, in both cases the DNA-FISH data agreed
with changes seen in the HiChIP-measured contact frequencies (Figures 2-3G and 23H). Together, these data support the observation of Notch-instructed long-range
interactions in TNBC as measured by cohesin HiChIP.
We next examined genes which were activated by Notch-instructed interactions to Notchinsensitive enhancers (Figure 2-3D mode b), to further analyze this previously
unappreciated mode of Notch-dependent gene regulation. Virtual 4C (v4C) analysis of the
TNBC-specific long noncoding RNA (lncRNA) LINC00511 (Xu et al., 2017) showed gain
of contacts between the promoter and Notch-insensitive 3’ enhancers E3 (Figure 2-3I).
Normalized contact tracks showed that in addition to LINC00511, Notch binding
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significantly increased the frequency of contacts between anchors linking Notch-bound
Notch-insensitive enhancers and the Notch-sensitive gene SOX9 (mode b, paired t-test
p-value < 1E-03, Figure 2-3I). The same mode of Notch regulation of LINC00511 and
SOX9 also operated in HCC1599 cells (mode b, paired t-test p-value = 2E-03, Figure S23K). Together, these data are consistent with the ability of Notch to facilitate repositioning
of certain enhancer-promoters to activate direct Notch target genes, independent of
changes in enhancer H3K27ac level.
In some instances, a common enhancer spatially co-regulates multiple genes through
looping interactions with the promoters of each target gene (Fanucchi et al., 2013; Fukaya
et al., 2016; Ghavi-Helm et al., 2014; Sanborn et al., 2015; Schoenfelder et al., 2010;
Zhang et al., 2013). In MB157 and HCC1599 TNBC cells, Notch activation promotes
looping interactions involved in spatial co-regulation of the kinase RIPK4 and the serine
protease TMPRSS2 (Figures 2-3J and S2-3L), both of which are implicated in breast
cancer pathogenesis (Huang et al., 2013; Liu et al., 2015; Luostari et al., 2014; Partanen
et al., 2012; Xing et al., 2011). Based on normalized contact tracks (Figures 2-3J and S23L), Notch activation significantly increased transcript abundance and contact frequency
of RIPK4 and TMPRSS2 promoters to common Notch-bound and -activated enhancers,
located 155 and 150 Kb away, respectively. Taken together, these results suggest that in
addition to activating enhancers already in contact with promoters, Notch signaling can
promote and strengthen interactions between subset of promoters and enhancers in
TNBC.
Notch preferentially targets hyperconnected 3D regulatory cliques in TNBC
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In addition to long-range enhancer-promoter loops, enhancer-enhancer and promoterpromoter interactions are implicated in gene control (Hah et al., 2013; Kim et al., 2010; Li
et al., 2012; Melo et al., 2013; Mifsud et al., 2015; Mumbach et al., 2017; Wang et al.,
2011a). To examine the higher-order structure of regulatory interactions in Notch-mutated
TNBC, we integrated our high-resolution connectivity maps and epigenomic data to
annotate the regulatory loop anchors connecting enhancer or promoter elements. We
observed that a multiplicity of enhancer and promoter interactions were common in the
Notch-mutated TNBC genomes, with each element on average connecting to 6 other
regulatory elements (Figure S2-4A), as reported in other cell types (Marinic et al., 2013;
Pope et al., 2014). Enhancer-promoter interactions accounted for only 30% of the longrange connections between regulatory elements in Notch-mutated TNBC genomes
(Figure 2-4A), also consistent with frequencies reported in other studies of mammalian
cells (Weintraub et al., 2017). Notably, only 30% of Notch-sensitive loops connected an
enhancer to a promoter, while the majority linked pairs of enhancers (64%) (Figure 2-4A).
In addition, 18% of interactions were between promoter pairs, in line with other reports
suggesting the existence of regulatory promoter-promoter interactions (Li et al., 2012;
Mifsud et al., 2015).
To globally model the higher-order structure of interactions involving Notch-sensitive
regulatory interactions in TNBC cells, we used undirected graph mathematical abstraction
(Diestel, 1997), and algorithmically (Blondel et al., 2008) searched for groups of densely
connected enhancers and promoters with high intra-group and sparse inter-group
interactions. We called these groups of highly interconnected elements “3D cliques”. We
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observed a significant asymmetry in the 3D clique connectivity distributions (Figures 24B and 2-4C), which was distinct from the accumulation of H3K27ac within large stretches
of enhancers on the linear genome, i.e. super-enhancers (Figure 2-S4B). Although 90%
of 3D cliques contained less than 20 interactions, nearly 140 cliques were categorized as
hyperconnected 3D cliques and had more than 100 interactions in either MB157 or
HCC1599 (Figure 2-4B). The clique containing MYC was identified as a hyperconnected
3D clique, ranking among the top 11 most connected 3D cliques in both HCC1599 and
MB157 cells (Figure 2-4B). Inspection of the MYC cliques in MB157 and HCC1599 cells
showed that Notch significantly promoted up to 46% of its constituent enhancers and more
than 30% of interactions among and between its promoters and enhancers (Figures 2-4D
and S2-4C).
This observation led us to ask whether Notch preferentially targets highly connected
cliques in TNBC. We observed that the Notch-bound cliques exhibited significantly more
connectivity than cliques lacking Notch binding (Wilcoxon rank sum p-value < 1E-15,
Figures 2-4E and S2-4D). More connected cliques also contained significantly more
Notch-sensitive loops (Wilcoxon rank sum p-value < 1E-15, Figure 2-4F). Furthermore,
promoters connecting to Notch-activated enhancers through Notch-instructed loops
interacted with more enhancers on average (Wilcoxon rank sum p-value < 1E-15, Figure
S2-4E) and fell within cliques with higher connectivity (Wilcoxon rank sum p-value < 1E02, Figures 2-4G and 2-4H). More importantly, the top 25% of the most connected cliques
were enriched for direct Notch target genes relative to other cliques after correcting for
clique connectivity (Wilcoxon rank sum p-value < 1E-03, Figures 2-4I and 2-4J). Direct
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Notch-activated genes within hyperconnected 3D cliques, such as MYC (Figure 2-4D and
S2-4C), were associated with processes and pathways that have important functions in
TNBC pathobiology (Figure S2-4F). Overall, these results suggest that oncogenic Notch
activates not only large stretches of enhancers as reported (Wang et al., 2014; YashiroOhtani et al., 2014), but also promotes regulatory DNA loops linking multiple distally
located enhancers to their target genes.
Perturbation of Notch-bound interacting enhancers reveals cooperativity in the
MYC clique
Multiple enhancers are found in the several megabase region flanking the MYC gene
body, but which transcription factors regulate MYC via these enhancers is not completely
understood (Ahmadiyeh et al., 2010; Fabbri et al., 2017; Herranz et al., 2014; Lin et al.,
2016; Ryan et al., 2017; Schuijers et al., 2018; Shi et al., 2013; Sur et al., 2012;
Wasserman et al., 2010; Yashiro-Ohtani et al., 2014). We observed that the MYC
enhancers identified in Notch-mutated TNBC were also active in other TNBC lines but not
non-TNBC cell lines (Figure S2-5A). Based on our observations that MYC enhancers in
TNBC cells are organized into a hyperconnected 3D clique with frequent inter-enhancer
interactions (Figures 2-4B, 2-4D, and S2-4C), and that several distinct Notch-bound
super-enhancers lie 5’ of the MYC promoter (Figures 2-4D and 2-5A), we next asked
whether MYC enhancers cooperatively regulate MYC expression. Our data showed that
among all MYC enhancer pairs (labeled E1 to E5 in Figure 2-5A), the strongest
RBPJ/NICD1 ChIP-seq signals and the largest Notch-dependent changes in H3K27ac
were observed in E1 and E5 enhancers (Figure 2-5A), located 451 and 65 Kb 5’ of the
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MYC promoter. Based on the HiChIP signal, Notch inhibition reduced the interaction
frequency between the highly interacting E1 and E5 enhancer pair by ~4-fold (Figure S27E), which was comparable to the average reduction in the contact frequencies between
the MYC promoter and its distal enhancers (Figure 2-5A).
To test the functional role of the E1 and E5 enhancers in MYC regulation, we used
CRISPR/Cas9 genome editing (Figure S2-5C) to mutate the consensus RBPJ binding
motifs in E1 and E5 (Figures 2-4D, 2-5A and S2-5C). Mutation of RBPJ binding sites at
E1 or E5 resulted in a 15% or 25% decrease in MYC expression, respectively; while
simultaneous targeting yielded more than a 50% reduction in MYC transcript abundance
(Figure 2-5B) and greatly reduced MYC protein amount (Figure 2-5C). Dual targeting of
these enhancers also suppressed cell proliferation as assessed by cell-trace violet
staining (t-test p-value < 1E-03, Figure 2-5D) and cell counts (t-test p-value < 1E-03,
Figure 2-5E). Overall, these data suggest that Notch transcription complexes increase
MYC expression by promoting cooperative higher order interactions involving the E1 and
E5 enhancers and the MYC promoter.
Notch-bound

non-interacting

enhancers

independently

regulate

CCND1

transcription
Our data showed that Notch directly upregulates CCND1 transcripts in TNBC, as reported
(Choy et al., 2017; Ronchini and Capobianco, 2001), but not in Notch-mutated MCL and
T-ALL (Figure S2-3G). In MB157, the CCND1 promoter and associated enhancers were
organized into a 3D clique of moderate connectivity (46 interactions), which was
41

substantially smaller than the MYC clique (682 interactions) (Figure S2-5D). Analysis of
the CCND1 locus in MB157 demonstrated a 1.4-fold or greater reduction in contact
frequency between the CCND1 promoter and Notch-responsive enhancers after Notch
inhibition (paired t-test p-value < 1E-09, Figures 2-5F and S2-5D). However, the
enhancer-enhancer interaction frequency between the two strongest Notch-bound
CCND1 enhancers, E1 and E2, was 12-fold lower than the interactions between the MYC
E1 and E5 enhancers (Figures 2-5A and 2-5F). To test for cooperativity between the
CCND1 E1 and E2 enhancers, we again used CRISPR/Cas9 targeting (Figures 2-5F, S25E, and S2-5F). Single targeting of RBPJ motifs in the E1 and E2 enhancers led to 55%
and 35% decreases in CCND1 expression, respectively (Figure 2-5G). However,
simultaneous targeting of E1 and E2 did not show significant additive or cooperative
effects on CCND1 transcript abundance (Figure 2-5G). Nevertheless, we did observe
significant effects of E1 and E2 dual targeting on Cyclin D1 protein amount (Figure 2-5H),
cell proliferation and cell cycle progression, as assessed by cell-trace violet staining (t-test
p-value < 1E-03, Figure 2-5I) and EdU incorporation (t-test p-value < 1E-02, Figure 25J), respectively. Thus, like MYC, CCND1 is another proto-oncogene that is dysregulated
in TNBC by Notch through Notch-sensitive looping interactions involving lineage-specific
distal enhancers. Furthermore, our data hint that enhancer-enhancer interactions may
influence the cooperativity between some distal enhancers in transcriptional regulation.
TNBC Notch regulatory modes are generalizable to Notch-mutated MCL
The observation that Notch preferentially promoted or strengthened regulatory loops in
highly connected 3D cliques of Notch-mutated TNBC led us to investigate whether the
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same relationships hold in other Notch-dependent malignancies, such as MCL. Using
cohesin HiChIP, we first measured long-range interactions between two previously
characterized Notch-activated enhancers located 525 Kb and 433 Kb 5’ of the MYC
promoter in MCL Rec-1 cells (Ryan et al., 2017). Analysis of Rec-1 cohesin HiChIP
showed that these two Notch-activated MYC enhancers (Figure S2-6A) interacted
frequently (116.2 normalized reads) and that Notch inhibition significantly reduced this
interaction (t-test p-value < 1E-15, Figure 2-6A). In line with these chromatin looping data
and our analysis of Notch-activated MYC enhancers in TNBC, we conjectured that the two
MCL-restricted Notch-activated enhancers cooperatively control MYC expression. This
hypothesis was confirmed in our published work where use of CRISPR-Cas9-KRAB
repressors showed that these two enhancers cooperate to regulate MYC in MCL Rec-1
cells (Ryan et al., 2017).
To extend this analysis genome-wide, we first assessed the Notch sensitivity of
intradomain interactions and their relationship to active and repressed chromatin in Rec1 cells. As in Notch-mutated TNBC cells (Figures 2-2D to 2-2G), Notch inhibition
decreased the intradomain interaction frequencies of more than 130 contact domains by
more than 4-fold (Figure 2-6B), and this reduction preferentially occurred in active
chromatin domains (Wilcoxon rank sum p-value < 1E-15, Figures 2-6B and 2-6C). In
Notch-mutated MCL Rec-1 cells, the integration of chromatin conformation, epigenomic,
and transcriptomic data sets again showed that direct Notch target genes with the greatest
increase in transcription were those with both Notch-activated and Notch-repositioned
enhancers (Wilcoxon rank sum p-value < 0.03, Figure 2-6D and Figure 2-3D mode a). In
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addition to MYC, LYN, a direct Notch target gene that is essential for B-cell receptor
activity (Gauld and Cambier, 2004; Ryan et al., 2017), also showed Notch-repositioned
enhancer-promoters (paired t-test p-value < 1E-15, Figure S2-6B and Figure 2-3D mode
a). SH2B2, a gene coding for an adaptor protein with an important role in B-cell
development and activation (Iseki et al., 2005; Naudin et al., 2016), was regulated by
Notch-instructed interactions between Notch-insensitive enhancers and the SH2B2
promoter (paired t-test p-value < 1E-15, Figure S2-6C and Figure 2-3D mode b).
Inspection of HiChIP data from Rec-1 cells also identified Notch-instructed loops that
permit spatial co-regulation of two genes from a shared Notch-activated enhancer (Figure
S2-6D). Together, these data confirm that distinct Notch regulatory modes identified in
TNBC also apply to Notch-mutated MCL.
Analysis of HiChIP data revealed that the Rec-1 genome is also organized into 3D cliques
consisting of densely interconnected enhancers and promoters. A significant asymmetry
was also observed in the Rec-1 clique connectivity distribution, which was distinct from
the super-enhancers in the Rec-1 linear genome (Figures S2-6E and S2-6F). Cliques with
higher connectivity were enriched for direct Notch target genes, including MYC and genes
involved in the B-cell signaling response and regulation (e.g. IL10RA, PAX5) (Figures 26E, S2-6E, and S2-6G). Further assessment of Rec-1 cliques showed significant
enrichment for direct Notch target genes in highly connected 3D cliques with Notchsensitive enhancers and looping interactions (Wilcoxon rank sum p-value < 1E-06,
Figures 2-6E and 2-6F). These direct Notch-activated genes were associated with
processes and pathways with known roles in B cell biology and lymphomagenesis (Figure
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S2-6H). Overall, these results suggest that Notch signaling controls not only MCL
transcriptional enhancers, as reported (Ryan et al., 2017), but also facilitates enhancerpromoter repositioning in MCL cliques to regulate critical B cell pathways.
Activation of ncRNA associates with Notch-instructed loop anchors
To further elucidate how Notch binding events instruct enhancer-promoter repositioning,
we assessed the impact of Notch signaling on accessibility and cohesin content of the
Notch-responsive elements in MB157. Comparison of SMC1a ChIP-seq signals at Notchresponsive elements showed no significant difference in cohesin loading in the Notch-on
and -off conditions (Figure S2-6I). While Notch inhibition had only a marginal impact on
accessibility of Notch-responsive elements (Figure S2-3F), this effect was even more
limited for Notch target genes linked by Notch-instructed loops to Notch-insensitive
enhancers (Figure S2-6J and Figure 2-3D mode b), providing further evidence that the
Notch-instructed enhancer repositioning facilitates the expression of this class of genes.
We next leveraged differential motif analysis to identify potential transcription factors
present at loop anchors of Notch-repositioned enhancers in TNBC and MCL. Compared
to the other enhancers, the 500 base pair flanking sequences of the Notch binding sites
at the Notch-repositioned enhancers were strongly enriched for the zinc-finger
transcription factors SP1 and ZNF263 binding motifs (Figure S2-6K). Specifically, multiple
SP1 and ZNF263 recognition sites were found in 90% of the sequences flanking Notch
binding sites at the Notch-repositioned enhancers, compared to only 15% of Notchunbound enhancers.
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Given the proposed regulatory role of non-coding RNA transcripts (ncRNA) in enhancerpromoter interactions (Isoda et al., 2017), we next tested whether Notch-dependent
activation of ncRNA increases the frequency of ncRNA-interacting loops. In both TNBC
and MCL Notch-instructed loops, Notch inhibition markedly reduced the frequency of
ncRNA-interacting loops compared to long-range interactions not spatially associated with
ncRNAs (Figure S2-6L). Furthermore, the ratio of hyperconnected 3D cliques with at least
one Notch-sensitive ncRNA was ~22-fold and ~10-fold higher than non-hyperconnected
3D cliques in TNBC HCC1599 and MB157 cells, respectively (proportion test p-value <
1E-15). Similarly in MCL Rec-1, we observed 21-fold more hyperconnected 3D cliques
with at least one Notch-sensitive ncRNA compared to non-hyperconnected 3D cliques.
Overall, on average more than 70% of Notch-sensitive ncRNA were located in
hyperconnected 3D cliques in MCL and TNBC. Taken together, these results suggest that
other transcription factors such as SP1 and ZNF263 and Notch-sensitive ncRNAs
participate in mechanisms that underline element-specific Notch-instructed enhancerpromoter repositioning.
Notch reactivation restores regulatory looping interactions
Our data revealed that Notch inhibition “decommissions” regulatory loops, leading to
down-regulation of Notch target genes. If Notch-mediated regulatory loops are
dynamically regulated by Notch, these loops should be restored following Notch
reactivation by GSI washout (Figure 2-7A). Analysis of cohesin HiChIP following GSIwashout (Figure S2-7A), as expected, showed no change in contact domain boundaries
with Notch reactivation (Figures S2-7B and S2-7C). However, long-range regulatory
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interactions, including enhancer-enhancer, enhancer-promoter and promoter-promoter
interactions, were restored after Notch reactivation (paired t-test p-value < 1E-15, Figure
2-7B). By contrast, ectopic expression of MYC, a protein which was implicated in
chromatin decompaction (Kieffer-Kwon et al., 2017) and was identified as a direct Notch
target gene (Figure 2-5), failed to protect Notch-instructed regulatory interactions from
Notch inhibition in MB157 cells (Figures S2-7D). Specifically, Notch reactivation by GSIwashout recovered more than 75% of these interactions (paired t-test p-value < 1E-15,
Figure 2-7C), including looping interactions involving MYC and CCND1 (Figures 2-7D,
S2-7E and S2-7F). Furthermore, Notch reactivation recovered 74% of the Notchdependent chromatin loops in the MYC clique (Figure 2-7E). Together, these results
support a model in which loading of Notch transcription complexes onto regulatory
elements has widespread effects on looping interactions involving the genomes of Notchmutated cancer cells.
2.4 Discussion
Chromatin architecture dynamics in response to oncogenic transcription factors is not well
understood. Here, we used the response to oncogenic subversion of the developmental
transcription factor Notch in TNBC and MCL, two cancers with frequent Notch-activating
mutations, to examine the impact of aberrant transcription factor activity on long-range
regulatory loops. Our data corroborate earlier studies showing that Notch binding events
often associate with increased histone acetylation, not necessarily in proximity to
transcribed genes (Ryan et al., 2017; Wang et al., 2014). We analyzed the impact of Notch
on chromatin state and conformation and the consequence of such changes on
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transcriptional outputs. Our high-resolution chromatin conformation maps of Notchmutated tumors revealed that oncogenic Notch signaling differentially affects the 3D
genome organization hierarchy. While chromatin contact domains are largely Notchinsensitive and conserved across different types of Notch-mutated cancer cells, we
strikingly find that in addition to activating enhancers already in contact with genes,
oncogenic Notch leads to a gain in contact frequency between activated genes and distal
Notch-bound enhancers. Based on our data, we propose that Notch relies on four distinct
regulatory modes, defined by different combinations of enhancer activation and/or
repositioning, to control its direct target genes. Importantly, concomitant Notch-mediated
enhancer activation and repositioning results in a larger increase in the expression of
direct Notch target genes. Together, our data suggest that in addition to activating
enhancers already in contact with transcriptional targets, oncogenic transcription factors
may promote or stabilize regulatory interactions between promoters and enhancers to
activate transcription.
Past study of long-range regulation of gene expression by signal-dependent transcription
factors has produced conflicting results as to whether transcription factors rely on preexisting loops or remodel loops to activate gene expression (Jin et al., 2013; Kuznetsova
et al., 2015; Qiao et al., 2015; Rickman et al., 2012; Stavreva et al., 2015). These
discrepancies may be due to differences in resolution, methodology, or biological
differences among various transcription factors. Recent studies showed that lineagespecific chromatin structures are established in tissue progenitor cells and are further
remodeled during terminal differentiation (Rubin et al., 2017; Stadhouders et al., 2018).
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Here, we demonstrate that oncogenic subversion of developmental transcription factor
Notch controls gene expression by reorganizing long-range regulatory interactions in
cancer cells. Although it remains unclear whether Notch regulates differentiation through
similar mechanisms, our observation has implications for targeting “undruggable” protooncogenes such as MYC that are controlled by Notch-mediated long-range regulatory
loops in Notch-addicted tumors.
Notch transcription complexes recruit other regulatory factors, such as chromatin enzymes
(Oswald et al., 2001) and transcriptional coactivators (Fryer et al., 2004). Our results
suggest that Notch-binding is selectively required for enhancer activation and
repositioning, and is insufficient to determine regulatory loops and chromatin state
dynamics. Since chromatin accessibility and cohesin loading at Notch-responsive
elements are insensitive to Notch signals, it appears that factors including zinc-finger
proteins and ncRNA activities could contribute to mechanisms underpinning various Notch
regulatory modes and the specificity requirements of Notch-instructed regulatory DNA
loops.
Chromatin organization is a major determinant of regulatory interactions. By definition,
interactions between regulatory DNA elements are more likely to occur within contact
domains than across them (Dowen et al., 2013; Dowen et al., 2014; Kagey et al., 2010;
Lupianez et al., 2015). Nevertheless, sequences in different domains of a chromosome
interact, albeit at a much lower frequency, and may be important for proper gene control
(Furlong and Levine, 2018). Our high-resolution regulatory connectivity maps identified
complexities of localized and long-range enhancer and promoter sharing. We identified
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spatially interacting communities of regulatory elements, termed 3D cliques, that are
organized independent of contact domains. By systematically delineating clusters of
enhancers and promoters that converge through space in the regulatory interaction graph
(i.e. 3D regulome) of Notch-mutated cancer cells, we defined 3D clique structures that are
distinct from super-enhancers, which were defined as large clusters of enhancers on a
linear display of the genome. Our work expands on previous observations of pairwise
contacts between super-enhancers, frequent interactions among constitutive elements of
super-enhancers, and promiscuous locally interacting regions (Beagrie et al., 2017; IngSimmons et al., 2015; Schmitt et al., 2016). Here, we show that long-range regulatory
loops of Notch-mutated cancer cells coalesce enhancers and promoters to form regulatory
3D cliques. We also find that oncogenic Notch preferentially promotes enhancers and
DNA loops in hyperconnected 3D cliques. To this end, oncogenic Notch not only activates
large stretches of enhancers (or super-enhancers) in the 1D genome as reported in Notchdependent T cell leukemia (Herranz et al., 2014; Wang et al., 2014), it also promotes longrange regulatory interactions among multiple distal enhancers, including distinct superenhancers, to induce MYC expression (Figures 2-4D and S2-4C). These findings suggest
that the entire regulatory interaction map should be taken into consideration for enhancer
editing, as cooperativity between enhancers to control gene expression may not solely
depend on individual promoter interaction, but could depend on other factors such as
connectivity among enhancers.
Our data also suggest that by targeting hyperconnected 3D cliques of key oncogenes such
as MYC, Notch potentially uses a multiplicity of distal enhancers and enhancer-enhancer
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interactions to maximize Notch-driven pathogenic transcriptional outputs. These
observations suggest that while the genomic loci with a high frequency of chromatin
interactions are highly enriched for super-enhancers (Beagrie et al., 2017; Schmitt et al.,
2016), several super-enhancers might distally interact to control key oncogenes. Notch
activation of hyperconnected 3D cliques formed by pre-existing and gained DNA loops is
reminiscent of “active chromatin hub” formation at the beta-globin locus in which multiple
distal sites loop to the active beta-globin genes during specific stages of erythrocyte
development (Dekker and Misteli, 2015; Denker and de Laat, 2016; Krivega and Dean,
2016). Aggregation of enhancers distally located on a linear genome into Notch-sensitive
3D cliques raises the possibility that the formation of larger aggregates of regulatory
elements in space might serve to raise the concentration of oncogenic Notch binding
events to mobilize transcription apparatus and promote their aberrant aggregation and
phase-separated nucleation (Boija et al., 2018; Fukaya et al., 2016; Hnisz et al., 2017;
Sabari et al., 2018). Hence, the observation of exceptionally large interacting Notchsensitive 3D cliques of regulatory elements advocates in favor of testing the applicability
of the nuclear condensate model for the Notch-mediated activation of key protooncogenes in the future. Together, our results implicate reorganization of regulatory loops
as an instructive factor for implementing oncogenic transcription factor-driven
transcriptional programs.
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2.5 Main Figure Titles and Legends

Figure 2-1 Contact domains of Notch-mutated tumors are lineage and Notch
signaling insensitive.
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(A) Contact matrices showing MB157 SMC1 HiChIP, lower half, and HCC1599 SMC1
HiChIP, upper half, share contact domain boundaries at chromosome 8. Left: the whole
chromosome, at 500 Kb resolution; right: 127.5 - 131.5 Mb MYC locus shown at 5 Kb
resolution. Red square on the bottom right of each panel indicates maximum intensity.
Gray arrows: boundaries demarcated by local minimum detection of insulation score.
(B) Contact matrices showing MB157 SMC1 HiChIP, lower half, and Rec-1 SMC1 HiChIP,
upper half, share contact domain boundaries on chr8: 127.5 - 131.5 Mb MYC locus shown
at 5 Kb resolution. Gray arrows: boundaries demarcated by local minimum detection of
insulation score.
(C) Venn diagram comparing the contact domain boundaries of Rec-1, HCC1599 and
MB157 depicts that a significant number of boundaries are shared (Fisher’s exact p-value
< 1E-15).
(D) Heatmap displaying RBPJ, SMC1 and CTCF occupancy on left and right boundaries
of 920 MB157 contact domains.
(E) Contact map (bottom) and genome-browser tracks of RBPJ, CTCF and SMC1 ChIPseq at GRHL2 locus showing contact domain boundaries are enriched for RBPJ, CTCF
and SMC1 binding. The intensity of each pixel on the 25 Kb-binned contact map
represents the Z-score transformed interaction frequency between two loci. Gray box:
RBPJ, CTCF and SMC1 binding events on contact domain boundaries.
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(F) Heatmap of NICD1 and RBPJ occupancy showing 3,216 reproducible Notchresponsive elements determined with IDR pipeline in MB157 with a significant decrease
(enrichR FDR < 0.05) in Notch-off (GSI) versus Notch-on (GSI-washout).
(G) Metagene analyses (top) showing Notch occupancy, and pile-up plots (bottom)
depicting aggregated Z-score interaction on MB157 domain boundaries in Notch-on
(DMSO) and Notch-off (GSI) conditions where the overall differential boundary insulation
scores are insignificant (Wilcoxon rank sum test p-value > 0.15). Left: centered around
1,003 Notch-bound domain boundaries. Right: matching number of Notch-unbound
boundaries.
(H) Contact map (top) and insulation profile (bottom) at MYC locus showing contact
domain boundaries are unaltered in Notch-on (DMSO) and Notch-off (GSI) conditions.
Gray arrows: boundaries demarcated by local minimum detection of insulation score.
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Figure 2-2. Notch sensitivity of chromatin interactions within TNBC active
enhancer-marked contact domains.
(A) Heatmap displaying normalized H3K27ac, H3K4me1 and H3K27me3 levels within
1,621 contact domains with significant intradomain contacts in MB157. Each domain is
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categorized into active or repressed based on the differential H3K27ac and H3K27me3
total level and sorted in descending order.
(B) Contact map (bottom) and genome browser tracks (top) in MB157 showing that
H3K27ac and H3K27me3 marks are insulated within contact domain boundaries
demarcated by CTCF and SMC1 at CCNE1 locus. Red/blue dashed-line boxes:
active/repressed domains. Gray boxes: CTCF and SMC1 binding events on the
boundaries.
(C) Heatmap showing chromatin state of contact domains shared between TNBC
(HCC1599 and MB157) and MCL (Rec-1).
(D) Heatmap of normalized significant interactions at scaled and flanked contact domains
of MB157 in Notch-on (DMSO) and Notch-off (GSI) conditions. Contact domains are
ranked by change (log2 fold change) of total intradomain interactions with the chromatin
states indicated on the left. The overall differential intradomain contact frequency is
significant (paired t-test p-value < 1E-15).
(E) Barplots depicting the number of active/repressed contact domains per quartile of total
intradomain interaction frequency change in MB157 (proportion test p-value < 1E-09).
(F) Heatmap as (D) in HCC1599 (paired t-test p-value < 1E-15).
(G) Barplots as (E) in HCC1599 (proportion test p-value < 1E-15).
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Figure 2-3. Activation of direct Notch target genes by Notch-instructed and
preformed enhancer-promoter interactions in TNBC.
(A) Barplots showing the proportion of contact domains encompassing any Notchsensitive gene conditioned on whether intradomain interactions were Notch-sensitive or
Notch-insensitive in MB157 (Fisher’s exact test p-value < 1E-04) (left) and HCC1599
(Fisher’s exact p-value < 1E-05) (right).
(B) Box and violin plots of differential (log2 fold change) H3K27ac level at Notch-bound or
-unbound distal enhancers of Notch-sensitive genes in MB157 (left) and HCC1599 (right)
(Wilcoxon rank sum p-value < 1E-15).
(C) Violin plots of differential (-log10 FDR) frequency of interactions between Notch-bound
or unbound distal enhancers and Notch-sensitive gene promoters in MB157 (left, Wilcoxon
rank sum p-value < 1E-03) and HCC1599 (right, Wilcoxon rank sum p-value < 1E-07).
(D) Model depicting four possible Notch regulatory modes controlling Notch direct target
genes by combinations of Notch-bound and -instructed loops (ΔL), Notch-bound and activated enhancers (ΔE), Notch-bound but Notch-insensitive loops (ØL), and Notchbound but Notch-insensitive enhancers (ØE).
(E) Boxplots showing differential (log2 fold change) gene expression of direct Notchactivated genes in MB157 categorized by Notch-dependency of interacting Notch-bound
enhancers and loops per mode in (D). Notch-bound and -instructed loops (ΔL), Notchbound and -activated enhancers (ΔE), Notch-bound but Notch-insensitive loops (ØL), and
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Notch-bound but Notch-insensitive enhancers (ØE). Number of genes in each mode is
listed in parenthesis.
(F) Boxplots as in (E) for HCC1599.
(G) Frequency of interactions between MYC promoter and enhancer significantly
decreased after Notch inhibition. Top: ChIP-seq tracks showing H3K27ac and H3K27me3
load at MYC locus marked with matching colors for the position of probes against MYC
promoter (cyan), MYC enhancer (yellow), and H3K27me3-marked MYC 3’ (magenta)
sequences for a 3-color DNA-FISH. Bottom: The quantification of HiChIP-measured
interaction frequency between MYC promoter and MYC enhancer probes (left), and MYC
promoter and MYC 3’ probes (right) in Notch-on (DMSO) and Notch-off (GSI) conditions
in MB157 cells are compared.
(H) Distances between MYC promoter and enhancer significantly increased after Notch
inhibition in MB157 cells. Left: examples of cells and magnified images for 3-color, cyanyellow, and cyan-magenta, from left to right, in Notch-on (DMSO) and Notch-off (GSI) in
MB157 cells are shown. Blue: Hoechst. Scale bars: Left: 5 µm; Right: 1 µm. Center:
Cumulative density functions of distances between MYC promoter and the closest MYC
enhancer probe in the same cells are compared between Notch-on cells (red, N = 4,314)
and Notch-off cells (blue, N = 5,271). Mean (+/- S.D.) distance of Notch-on and Notch-off
are 0.71 +/- 0.30 µm, and 0.83 +/- 0.32 µm, respectively (Kolmogorov-Smirnov test pvalue = 1E-29). Right: Cumulative density functions of distances between MYC promoter
and the closest MYC 3’ probe in the same cells are compared between Notch-on and
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Notch-off cells. Mean (+/- S.D.) distance of Notch-on and Notch-off were 1.0 +/- 0.32 µm,
and 0.88 +/- 0.31 µm, respectively (Kolmogorov-Smirnov p-value = 1E-29).
(I) Notch-instructed loops (ΔL) linking Notch-insensitive active enhancers (ØE) E1 and E2
to SOX9 promoter and E3 to LINC00511 promoter in MB157. Top panel: virtual 4C plot
depicting the normalized interaction frequency from LINC00511 promoter viewpoint. ChIPseq tracks showing Notch-sensitive NICD1 and RBPJ occupancy, and Notch-insensitive
H3K27ac load marked with gray boxes. HiChIP arcs displaying normalized significant
interactions of SOX9 and LINC00511 promoters to distal enhancers in Notch-on (top,
DMSO) and Notch-off (bottom, GSI) (paired t-test p-value < 1E-03). Bottom track
indicating SOX9 and LINC00511 Ensembl gene positions and their expression fold
change and FDR.
(J) Notch-instructed loops (ΔL) enabling spatial co-regulation of TMPRSS2 and RIPK4
genes in MB157 cells through shared Notch-activated enhancers (ΔE). ChIP-seq tracks
showing Notch-sensitive NICD1 and RBPJ occupancy and H3K27ac load marked with
gray box. HiChIP arcs displaying normalized significant interactions between enhancers
and promoters in Notch-on (top, DMSO) and Notch-off (bottom, GSI) in MB157 (paired ttest p-value < 0.05). Bottom track indicating Ensembl gene positions and their expression
fold change and FDR.
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Figure 2-4. Notch targets hyperconnected 3D regulatory cliques in TNBC cells.
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(A) Barplots showing the number of Notch-sensitive and -insensitive enhancer-enhancer
(EE), enhancer-promoter (EP), promoter-promoter (PP) interactions in MB157 (left) and
HCC1599 (right).
(B) Distribution of 3D cliques connectivity revealing two classes of interacting enhancers
and promoters. Cliques are plotted in an ascending order of their total connectivity for
MB157 (left) and HCC1599 (right). Hyperconnected cliques are defined as the ones above
the elbow of 3D clique total connectivity distribution. Example 3D cliques are marked and
named with their representative Notch-sensitive genes.
(C) Five randomly selected cliques from either below (left) or above (right) the elbow point
of the curve in (B) demonstrating the asymmetric distribution of clique total connectivity in
MB157. (D) Circos plot showing the clique associated with MYC in MB157. Red-marked
circle (square) and line depicting Notch-sensitive enhancer (promoter) and interactions,
respectively. E1 to E5 mark groups of enhancers in descending linear genomic distance
to MYC promoter located within the MYC 5’ contact domain. (E) Cumulative density
function of clique total connectivity with or without Notch-bound enhancers in MB157 (left)
and HCC1599 (right) (Wilcoxon rank sum p-value < 1E-15). (F) Barplots depicting the
average ± SEM corrected percentage of Notch-sensitive loops per quartile of clique total
connectivity distribution in MB157 (left) and HCC1599 (right) (Wilcoxon rank sum p-value
< 1E-15). (G) Boxplots showing the total connectivity of cliques containing promoters
associated with combination of Notch-bound and -instructed loops (ΔL), Notch-bound and
-activated enhancers (ΔE), Notch-bound but Notch-insensitive loops (ØL), and Notchbound but Notch-insensitive enhancers (ØE) in MB157 (left) and HCC1599 (right). (H)
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Three randomly selected cliques in MB157 associated with either Notch-insensitive
enhancers and loops (ØE+ØL, left) or Notch-activated enhancers and Notch-instructed
loops (ΔE+ΔL, right) emphasizing on the difference in clique total connectivity. (I) Barplots
depicting the average ± SEM corrected percentage of direct Notch-activated genes per
quartile of clique total connectivity distribution in MB157 (left, Wilcoxon rank sum p-value
< 1E-03) and HCC1599 (right, Wilcoxon rank sum p-value < 1E-07). (J) Three randomly
selected cliques in either the first (left) or fourth (right) quartile of clique total connectivity
distribution highlighting the difference in the number of direct Notch-activated genes.

63

64

Figure 2-5. MYC but not CCND1 Notch-activated distal enhancers cooperate to
increase gene expression.
(A) Notch-instructed loops (ΔL) linking Notch-activated enhancers (ΔE) to MYC in MB157.
Top panel: virtual 4C plot depicting the normalized interaction frequency from MYC
promoter viewpoint. ChIP-seq tracks showing Notch-sensitive NICD1 and RBPJ
occupancy, and Notch-sensitive H3K27ac level marked with gray box. HiChIP arcs
displaying normalized significant interactions between MYC promoter and distal
enhancers in Notch-on (top, DMSO) and Notch-off (bottom, GSI) (paired t-test p-value <
1E-15). Bottom track indicating MYC Ensembl gene position.
(B) Barplots showing qRT-PCR measurements of MYC mRNA after transduction of Cas9expressing MB157 with control sgRNAs, sgRNAs targeting the E1, E5 or both reveal
cooperativity of Notch-sensitive E1 and E5 MYC enhancers. TFRC: negative control. Data
represent mean ± SEM of n=3-7 independent experiments. t-test p-value: *p < 0.05, ***p
< 1E-03.
(C) Western blotting of MYC in Cas9-expressing MB157 cells transduced with control
sgRNAs or sgRNAs simultaneously targeting MYC E1 and E5 enhancers as in (B). bACTIN is loading control.
(D) Representative histograms of CellTrace Violet (CTV) dilution in Cas9-expressing
MB157 after transduction with control sgRNAs or sgRNAs simultaneously targeting MYC
E1 and E5 enhancers as in (B). Unstained cells and freshly stained CTV cells are negative
and positive controls, respectively. Barplots showing the average geometric mean
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fluorescent intensity ± SD, n=3 biological replicates, representative of 3 independent
experiments. t-test p-value: ***p < 1E-03.
(E) Relative cell growth rates in Cas9-expressing MB157 after transduction with control
sgRNAs or sgRNAs simultaneously targeting MYC E1 and E5 enhancers as in (B). Data
represent mean ± SEM of n=8-10 biological replicates from 2 independent experiments.
Day 9 data t-test p-value: ***p < 1E-03.
(F) Notch-instructed loops (ΔL) linking Notch-activated enhancers (ΔE) to CCND1 in
MB157. Top panel: virtual 4C plot depicting the normalized interaction frequency from
CCND1 promoter viewpoint. ChIP-seq tracks showing Notch-sensitive NICD1 and RBPJ
occupancy, and Notch-sensitive H3K27ac load marked with gray box. HiChIP arcs
displaying normalized significant interactions between CCND1 promoter and distal
enhancers in Notch-on (top, DMSO) and Notch-off (bottom, GSI) (paired t-test p-value <
1E-09). Bottom track indicating CCND1 Ensembl gene position.
(G) Barplots showing qRT-PCR measurements of CCND1 mRNA after transduction of
Cas9-expressing MB157 cells with control sgRNAs, sgRNAs targeting the E1, E2 or both
reveal lack of cooperativity of Notch-sensitive E1 and E2 CCND1 enhancers. Data
represent mean ± SEM of n=3-5 independent experiments. t-test p-value: **p < 0.01, ***p
< 1E-03.
(H) Western blotting of Cyclin D1 in Cas9-expressing MB157 transduced with control
sgRNAs or sgRNAs simultaneously targeting CCND1 E1 and E2 enhancers as in (G).
TUBULIN is loading control.
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(I) Representative histograms of CellTrace Violet (CTV) dilution in Cas9-expressing
MB157 after transduction with control sgRNAs or sgRNAs simultaneously targeting
CCND1 E1 and E2 enhancers as in (G). Unstained cells and freshly stained CTV cells are
negative and positive controls, respectively. Barplots showing the average geometric
mean fluorescent intensity ± SD, n=3 biological replicates, representative of 3 independent
experiments. t-test p-value: ***p < 1E-03.
(J) Representative flow plots of EdU incorporation in unstained cells, Cas9-expressing
MB157 transduced with control sgRNAs or sgRNAs simultaneously targeting CCND1 E1
and E2 enhancers as in (G). Barplots showing the average geometric mean fluorescent
intensity (MFI) ± SD, n=3 biological replicates, representative of 2 independent
experiments. t-test p-value: **p < 0.01.
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Figure 2-6. Activation of direct Notch target genes in MCL by Notch-instructed and
preformed enhancer-promoter interactions.
(A) Notch-instructed loops (ΔL) linking Notch-activated enhancers (ΔE) to MYC in MCL
Rec-1 cells. Top panel: virtual 4C plot depicting the normalized interaction frequency from
MYC promoter viewpoint. ChIP-seq tracks showing Notch-sensitive NICD1 and RBPJ
occupancy, and Notch-sensitive H3K27ac load marked with gray box. HiChIP arcs
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displaying normalized significant interactions among MYC promoter and distal enhancers
in Notch-on (top, DMSO) and Notch-off (bottom, GSI) (paired t-test p-value < 1E-15).
Bottom track indicating MYC Ensembl gene position and its expression fold change and
FDR.
(B) Heatmap of normalized significant interactions at scaled and flanked contact domains
of Rec-1 in Notch-on (DMSO) and Notch-off (GSI) conditions. Contact domains are ranked
by change (log2 fold change) of total intradomain interactions with the chromatin states
indicated on the left. The overall differential intradomain interaction frequency is significant
(paired t-test p-value < 1E-15).
(C) Barplots depicting the number of active/repressed contact domains per quartile of total
intradomain interaction frequency change in Rec-1 (proportion test p-value < 1E-15).
(D) Boxplots showing differential (log2 fold change) gene expression of direct Notchactivated genes in Rec-1 categorized by Notch-dependency of interacting Notch-bound
enhancers and loops. Notch-bound and -instructed loops (ΔL), Notch-bound and activated enhancers (ΔE), Notch-bound but Notch-insensitive loops (ØL), and Notchbound but Notch-insensitive enhancers (ØE).
(E) Circos plot showing the clique associated with MYC in Rec-1. Red-marked circle
(square) and line depicting Notch-sensitive enhancer (promoter) and interactions,
respectively.
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(F) Barplots depicting the average ± SEM corrected percentage of direct Notch-activated
genes per quartile of clique total connectivity distribution in Rec-1 (Wilcoxon rank sum pvalue < 1E-06).
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Figure 2-7. Notch reactivation restores regulatory interactions.
(A) Scheme showing reduced transcriptional activities as a result of loop and enhancer
deactivation upon Notch-inhibition by GSI and restoration after Notch recovery by GSIwashout.
(B) Boxplots displaying the normalized interaction frequency of Notch-instructed
enhancer-enhancer, enhancer-promoter, and promoter-promoter interactions in Notch-on
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(DMSO), Notch-off (GSI) and Notch-recovery (GSI-washout) conditions in MB157 (paired
t-test p-value < 1E-15).
(C) Heatmap showing the normalized enhancer-promoter interactions of direct Notch
targets with Notch-instructed loops (ΔL) in Notch-on (DMSO), Notch-off (GSI) and Notchrecovery (GSI-washout) conditions. Each row is a pair of enhancer-promoter interaction
sorted in descending order of Notch differential effect (log2 fold change). The overall
differences between enhancer-promoter interactions in Notch-on versus Notch-off and
Notch-recovery versus Notch-off are significant (paired t-test p-value < 1E-15).
(D) Notch recovery rescues interactions at MYC locus in MB157. Top panel: virtual 4C
plot depicting the normalized interaction frequency from MYC promoter viewpoint. ChIPseq tracks showing H3K27ac load. MYC enhancers are marked with gray box as in Figure
5. HiChIP arcs displaying normalized significant interactions between MYC promoter and
distal enhancers in Notch-on (top, DMSO), Notch-off (middle, GSI), and Notch-recovery
(bottom, GSI-washout).
(E) Interactions of the MYC clique in MB157 were recovered upon Notch reactivation. Red
lines represent interactions significantly decreased in Notch inhibition and restored in
Notch-recovery (log2 fold change > 0.5, enrichR FDR < 0.05).
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2.6 Supplemental Figure Titles and Legends

73

Figure S2-1. TNBC contact domain boundaries and A/B compartments are mostly
Notch-invariant. Related to Figure 2-1.
(A) Contact matrices depicting Rec-1 SMC1 HiChIP, upper half, and GM12878 in situ HiC, lower half, share contact domains at chromosome 8. Left: the whole chromosome,
shown at 500 Kb resolution; middle: 120-140 Mb shown at 25 Kb resolution; right: 127.5 131.5 Mb MYC locus shown at 5 Kb resolution. The intensity of each pixel represents the
normalized interaction frequency between two loci. Red square on the bottom right of each
panel indicates maximum intensity. Gray arrows: boundaries demarcated by local
minimum detection of insulation score.
(B,C) Venn diagrams comparing contact domain boundaries in (B) Rec-1 SMC1 HiChIP
versus GM12878 in situ Hi-C (Fisher’s exact p-value < 1E-15) (C) GM12878 in situ Hi-C
versus SMC1 HiChIP (Fisher’s exact p-value < 1E-04).
(D) Heatmap (left) showing GM12878 in situ Hi-C, upper half, and SMC1 HiChIP, lower
half, share Pearson correlation matrices of 1-Mb resolution contact matrices at
chromosome 8. Scatter plot (right) depicting the concordance of the first principal
component (PC1) of the Pearson correlation matrices of GM12878 in situ Hi-C and SMC1
HiChIP. Range from -1 (blue) to +1 (red). MYC locus is marked by a dash box.
(E) Heatmap indicating the presence of CTCF and SMC1 on the boundaries of 2,317
MB157 contact domains.
(F) Pie chart showing the frequency of the four possible orientations of CTCF motif on
contact domain boundary pairs depicts that the majority are in convergent (+/-) orientation.
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(G) Venn diagram comparing contact domain boundaries in HCC1599 SMC1 HiChIP
versus MB157 SMC1 HiChIP (Fisher’s exact p-value < 1E-15).
(H) Histogram showing the distance between each Notch occupied site and its closest
contact domain boundary in MB157. Orange mark: Notch binding within 3 x 25 Kb bins of
a boundary.
(I) Heatmap of NICD1 and RBPJ occupancy shows 9,302 reproducible Notch binding
events determined with IDR pipeline in HCC1599 with significant decrease in Notch-off
(GSI) condition (enrichR FDR < 0.05).
(J) Contact map (bottom) and genome-browser track of RBPJ ChIP-seq at GRHL2 locus
showing domain boundaries are enriched for Notch transcription complexes binding in
HCC1599 similar to MB157.
(K) Metagene analyses (top) showing Notch occupancy, and pile-up plots (bottom)
depicting aggregated Z-score interaction on HCC1599 domain boundaries in Notch-on
(DMSO) and Notch-off (GSI) conditions where the overall differential boundary insulation
scores are insignificant (Wilcoxon rank sum p-value > 0.11). Left: centered around 1,431
Notch-bound domain boundaries. Right: matching number of Notch-unbound boundaries.
(L) Contact map (top) and insulation profile (bottom) at MYC locus of HCC1599 in Notchon (DMSO) and Notch-off (GSI) conditions showing intact domain boundaries. Gray
arrows: boundaries demarcated by local minimum detection of insulation score.
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(M,N) Distribution of PC1 sign change (top) between Notch-on (DMSO) and Notch-off
(GSI) conditions in MB157 (M) and HCC1599 (N) showing that genome-wide and at the
MYC locus (dashed line) compartmentalization is Notch-invariant. Heatmap (bottom)
comparing the Pearson correlation metrices of 1-Mb resolution contact matrices at
chromosome 8 in Notch-off (upper half) and Notch-on (lower half) conditions in MB157
(M) and HCC1599 (N). MYC locus is marked by a dash box.
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Figure S2-2. Chromatin state aligns with contact domains in Notch-mutated
cancers. Related to Figure 2-2.
(A) Contact map (bottom) and genome browser tracks (top) in MB157 showing H3K27ac
and H3K27me3 histone marks separated by contact domain boundaries with CTCF and
SMC1 occupancy at CCND1 locus. Red dashed-line box: active domain. Gray boxes:
marking CTCF and SMC1 binding events on the boundaries.
(B) Heatmap displaying normalized H3K27ac, H3K4me1 and H3K27me3 load within
1,709 contact domains with significant intradomain interactions in HCC1599. Each contact
domain is categorized into active or repressed based on the differential H3K27ac and
H3K27me3 total level and sorted in descending order.
(C) Contact map (bottom) and genome browser tracks of H3K27ac and H3K27me3 (top)
in HCC1599 showing contact domain boundaries and chromatin state shared between
MB157 and HCC1599 at CCNE1 locus. Red/blue boxes: active/repressed domains.
(D) Contact map (bottom) and genome browser tracks (top) in HCC1599 showing
H3K27ac and H3K27me3 histone marks separated by contact domain boundaries at
CCND1 locus.
(E) Heatmap showing chromatin state of 686 contact domains shared between MB157
and HCC1599 cells (Fisher’s exact p-value < 1E-15).
(F) Same heatmap as in (B) showing 1,523 contact domains in Rec-1.
(G, H) CCNE1 locus as (C) in Rec-1 and CCND1 locus as (D) in Rec-1.
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Figure S2-3. Notch activates TNBC distal enhancers. Related to Figure 2-3.
(A) Boxplots showing the linear genomic distance between Notch binding sites and their
closest Ensembl annotated transcription start site (TSS) in log10 scale.
(B) Heatmap showing H3K27ac and H3K4me1 level at Notch-activated enhancers
centered around Notch-responsive elements +/- 3 kb flanking regions in MB157 (left) and
HCC1599 (right). Rows were sorted by log2 fold change of H3K27ac level in Notch-on
(GSI-washout) versus Notch-off (GSI).
(C,D) Barplots of qRT-PCR measurements (C) and western blot (D) validating recovery of
MYC in GSI-treated pINDUCER-20-MYC transduced MB157 cells (MB157-pIND-MYC)
upon doxycycline treatment. b-ACTIN is loading control. dox: doxycycline. Data represent
mean ± SD. NS: t-test p > 0.05.
(E) Heatmap showing H3K27ac level at Notch-activated enhancers centered around
Notch-responsive elements +/- 3 kb flanking regions in GSI-treated MB157-pIND-MYC
with and without doxycycline treatment. Rows are ordered as in Figure S3B.
(F) Volcano plot showing ATAC-seq signal fold enrichment (x-axis) versus false discovery
rate (FDR) (y-axis) in Notch-on and Notch-off conditions in MB157 cells. Each point
depicts a Notch-responsive element. Eight Notch-responsive elements with FDR < 0.01
and log2 fold change => 1 in Notch-on versus Notch-off are marked in red.
(G) Heatmap displaying common and unique Notch-sensitive genes in TNBC (HCC1599
and MB157), MCL (Rec-1) and T-ALL (DND41). Each row is a gene grouped by K-means
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clustering on differential expression (log2 fold change) of Notch-on (GSI-washout) vs
Notch-off (GSI).
(H) GSEA analyses showing the enrichment of genes in the MSigDB Hallmark MYC
targets in Notch-on (GSI-washout) vs Notch-off (GSI) in MB157, Rec-1 and DND41
(permutation FDR < 1E-05).
(I) Selected GO terms and pathways enriched with direct Notch target genes in TNBC.
MSigDB was used for analysis of functional gene annotation.
(J) Notch as a final transcriptional trigger (example of mode d). Notch-bound but Notchinsensitive loops (ØL) linking Notch-bound but Notch-insensitive enhancers (ØE) to
RPS6KA5 in MB157. ChIP-seq tracks showing Notch-sensitive NICD1 and RBPJ
occupancy and Notch-insensitive H3K27ac level marked with gray box. HiChIP arcs
displaying Notch-insensitive normalized significant interactions between enhancers and
promoters in Notch-on (DMSO, top) and Notch-off (GSI, bottom) in MB157 (paired t-test
p-value > 0.05). Bottom track indicating Ensembl gene position of RPS6KA5 and its
expression fold change and FDR.
(K) Same locus as in Figure 2-3I in HCC1599.
(L) Same locus as Figure 2-3J in HCC1599.
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Figure S2-4. Notch target genes within hyperconnected cliques associate with key
pathways in TNBC. Related to Figure 2-4.
(A) Density plots showing the number of connections to each enhancer or promoter in
MB157 (left) and HCC1599 (right).
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(B) Ranked order of H3K27ac-loaded enhancers identifies super-enhancers associated
with MYC and SOX9 as the 84th and 11th strongest, respectively. MB157 (left) and
HCC1599 (right).
(C) Circos plot showing the clique associated with MYC in HCC1599. Red-marked circle
(square) and line depicting Notch-sensitive enhancer (promoter) and interactions,
respectively. E1 to E5 mark groups of enhancers in descending linear genomic distance
to MYC promoter located within the MYC 5’ contact domain.
(D) Three randomly selected cliques with or without Notch-bound enhancers in MB157
(up) and HCC1599 (down) from Figure 2-4E emphasizing on differences in their
connectivity.
(E) Barplots depicting the average ± SEM number of enhancers connecting each Notchsensitive gene with combination of Notch-bound and -instructed loops (ΔL), Notch-bound
and -activated enhancers (ΔE), Notch-bound but Notch-insensitive loops (ØL), and Notchbound but Notch-insensitive enhancers (ØE) in MB157 (left) and HCC1599 (right)
(Wilcoxon rank sum p-value < 1E-15).
(F) Selected GO terms and pathways enriched with direct Notch target genes within
hyperconnected cliques in TNBC. MSigDB was used for analysis of functional gene
annotation.
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Figure S2-5: Targeting MYC and CCND1 Notch-dependent enhancers in TNBC.
Related to Figure 2-5.
(A) Genome-browser tracks showing difference between the H3K27ac level of TNBC and
non-TNBC breast cancer lines at MYC locus.
(B) Same locus as in Figure 2-5A in HCC1599.
(C) NICD1 binding and H3K27ac level at MYC E1 and E5 enhancers in MB157 cells.
Consensus RBPJ logos are aligned with CRISPR-targeted RBPJ motifs determined by
FIMO (p-value < 1E-03) in each enhancer. The sgRNAs sequences are italicized and their
positions are boxed.
(D) The clique associated with CCND1 in MB157.
(E) Same locus as in Figure 2-5F in HCC1599.
(F) NICD1 binding and H3K27ac level at CCND1 E1 and E2 enhancers in MB157 cells.
Consensus RBPJ logos are aligned with CRISPR-targeted RBPJ motifs determined by
FIMO (p-value < 1E-03) in each enhancer. The sgRNAs sequences are italicized and their
positions are boxed.
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Figure S2-6. ncRNA activation and putative ZNF263 bindings associate with Notchinstructed loop anchors. Related to Figure 2-6.
(A) H3K27ac ChIP-seq tracks showing MCL-specific (Rec-1) and TNBC-specific (MB157)
MYC enhancers. Gray box: MCL-specific enhancers.
(B) Notch-instructed loops (ΔL) linking Notch-activated enhancers (ΔE) to LYN in Rec-1.
ChIP-seq tracks showing Notch-sensitive NICD1 occupancy, and Notch-sensitive
H3K27ac level. HiChIP arcs displaying normalized significant interactions of LYN promoter
to distal enhancers, and enhancer-enhancer interactions in Notch-on (DMSO, top) and
Notch-off (GSI, bottom) (paired t-test p-value < 1E-15). Bottom track indicating LYN
Ensembl gene position and its expression fold change and FDR as determined by
DESeq2.
(C) Notch-instructed loops (ΔL) linking Notch-bound but Notch-insensitive enhancers (ØE)
to SH2B2 promoter in Rec-1. Tracks’ descriptions as in panel (B).
(D) Notch-instructed loops (ΔL) enabling spatial co-regulation of FAM210A and LDLRAD4
genes in MCL through shared Notch-activated enhancers (ΔE). Tracks’ descriptions as in
panel (B).
(E) Distribution of 3D cliques connectivity in Rec-1 plotted in an ascending order. Example
cliques are marked and named with their representative Notch-activated genes.
(F) Ranked order of H3K27ac-loaded enhancers does not identify any MYC-associated
super-enhancer in Rec-1.
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(G) Circos plot showing the clique associated with IL10RA, one of the known Notch target
genes in Rec-1. Red-marked circle (square) and line depicting Notch-sensitive enhancer
(promoter) and interactions, respectively.
(H) Selected GO terms and pathways enriched with direct Notch target genes within
hyperconnected cliques in Rec-1. MSigDB was used for analysis of functional gene
annotation.
(I) Heatmap showing SMC1 level at Notch-activated enhancers centered around Notchresponsive elements +/- 2 kb flanking regions in Notch-off and Notch-on conditions. Rows
are ordered as in Figure S2-3B.
(J) Box and violin plots showing differential (log2 fold change) chromatin accessibility at
Notch-responsive elements of direct Notch-activated genes in MB157 categorized by
Notch-dependency of interacting Notch-bound enhancers and loops. Notch-bound and instructed loops (ΔL), Notch-bound and -activated enhancers (ΔE), Notch-bound but
Notch-insensitive loops (ØL), and Notch-bound but Notch-insensitive enhancers (ØE).
(K) Scatterplots depicting the percentage of anchors with transcription factor motifs and
rank of the enrichment score for each transcription factor. The top 20 ranked transcription
factor motifs that are found in more than 90% of Notch-repositioned enhancers are marked
in red. Transcription factors with bHLH and zinc-finger domains are shown.
(L) Box and violin plots showing the difference between the frequency of interactions in
Notch-on (DMSO) and Notch-off (GSI) conditions for Notch-instructed loops (ΔL)
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depending on whether loop is spatially associated with ncRNA or not in MB157 (left),
HCC1599 (center) and Rec-1 (right); p-values determined with Wilcoxon rank sum tests.
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Figure S2-7. Contact domains are invariant in Notch recovery. Related to Figure 27.
(A) Western blot validating recovery of NICD1 in GSI-washout. b-ACTIN is loading control.
(B) Metagene analyses (top) showing Notch occupancy, and pile-up plots (bottom) in
MB157 contact domain boundaries in Notch-on (DMSO), Notch-off (GSI), and Notchrecovery (GSI-washout) (Wilcoxon rank sum p-value > 0.15). Left: centered around 1,003
Notch-bound domain boundaries. Right: matching number of Notch-unbound boundaries.
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(C) Contact map (top) and insulation profile (bottom) at MYC locus showing contact
domain boundaries are similar in Notch-on (DMSO), Notch-off (GSI) and Notch-recovery
(GSI-washout) conditions. Gray arrows: boundaries identified by local minimum detection
of insulation score.
(D) Box and violin plots showing difference between the restoration of Notch-instructed
regulatory interaction frequencies upon Notch-recovery (MB157 GSI-washout vs GSI) or
ectopic MYC expression in Notch-inhibited MB157 cells (GSI-treated MB157-pIND-MYC
with vs without doxycycline).
(E) Barplots displaying the normalized interaction frequency of E1 and E5 MYC enhancers
in Notch-on (DMSO), Notch-off (GSI) and Notch-recovery (GSI-washout) conditions in
MB157.
(F) Notch recovery rescues interactions at CCND1 locus in MB157. Top panel: virtual 4C
plot depicting the normalized interaction frequency from CCND1 promoter viewpoint.
ChIP-seq tracks showing H3K27ac level. HiChIP arcs displaying normalized significant
interactions between CCND1 promoter and distal enhancers in Notch-on (top, DMSO),
Notch-off (middle, GSI), and Notch-recovery (bottom, GSI-washout).
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3.1 Abstract
Chromatin misfolding has been implicated in cancer pathogenesis, yet its role in therapy
resistance remains unclear. Here, we systematically integrated sequencing and imaging
data to examine the spatial and linear chromatin structures in targeted therapy sensitive
and resistant human T cell acute lymphoblastic leukemia (T-ALL). We found widespread
alterations in successive layers of chromatin organization including spatial compartments,
contact domain boundaries and enhancer positioning upon the emergence of targeted
therapy resistance. Reorganization of genome folding structures closely coincides with
restructuring of chromatin activity and redistribution of architectural proteins.
Mechanistically, derepression and repositioning of the B-lineage-determining transcription
factor EBF1 from the heterochromatic nuclear envelope to the euchromatic interior
instructs widespread genome refolding, and promotes therapy resistance in leukemic T
cells. Together, our findings suggest that lineage-determining transcription factors can
instruct changes in genome topology as a driving force for epigenetic adaptations in
targeted therapy resistance.
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3.2 Introduction
Epigenetic adaptations are emerging as important contributors to anticancer therapy
resistance (Marine et al., 2020). Epigenetic reprogramming in response to cancer therapy
can result from multiple mechanisms, including activation of alternative enhancer
elements and/or their repositioning within the nuclear space. Accumulating body of
evidence supports the role of licensing alternative enhancers in anticancer therapy
evasion (Bell et al., 2019; Iniguez et al., 2018; Marine et al., 2020; Zawistowski et al.,
2017). Nevertheless, the contribution of chromatin folding reorganization to treatment
resistance remains largely unknown.
Compaction of chromatin into the nuclear space is possible through the assembly of
structures at successive length scales (Dekker and Misteli, 2015; Furlong and Levine,
2018). At the megabase scale, the genome is partitioned into transcriptionally permissive
A and repressive B compartments, within which preferentially interacting regions form
topologically associating domains (TADs) and sub-TADs (Dixon et al., 2012; LiebermanAiden et al., 2009; Nora et al., 2012). TAD boundaries generally restrain the contacts
among distal regulatory elements and gene promoters, thus achieving accurate
spatiotemporal regulation of gene expression (Stadhouders et al., 2019). Architectural
proteins including the cohesin complex, the insulator protein CCCTC-binding factor
(CTCF), and the zinc finger transcription factor YY1 are crucial for connecting higher-order
chromatin structures, including regulatory enhancer-promoter and structural CTCF-CTCF
loops (Kagey et al., 2010; Narendra et al., 2015; Schmidt et al., 2010; Sofueva et al., 2013;
Splinter et al., 2006; Weintraub et al., 2017; Wendt et al., 2008). We and others explored
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regulatory roles of chromatin misfolding in oncogenesis, and revealed that in addition to
dysregulation of architectural proteins, genomic rearrangements and oncogenic
subversion of non-architectural proteins can lead to genome topology changes in
treatment-naive cancer cells (Corces and Corces, 2016; Flavahan et al., 2016; Hnisz et
al., 2016b; Johnstone et al., 2020; Kloetgen et al., 2020; Petrovic et al., 2019; Valton and
Dekker, 2016; Viny et al., 2019). Nevertheless, few studies have investigated potential
regulatory roles of chromatin folding in therapy-resistant phenotype. To investigate the
role of genome refolding in targeted therapy resistance, we elucidated chromatin folding
changes and identified their underpinning molecular mechanisms in Notch-mutated TALL.
Notch gain-of-function mutations are observed in nearly 60% of T-ALL patients, and
correlate with poor prognosis (Belver et al., 2019; Litzow and Ferrando, 2015). These
observations provide a compelling rationale for developing Notch signaling antagonists,
such as gamma-secretase inhibitors (GSIs), as a targeted therapy for Notch-mutated TALL. Activating Notch mutations often disrupt the Notch negative regulatory region (NRR)
that allow ligand-independent release of the intracellular Notch (ICN) domain from the cell
membrane by gamma-secretase (Weng et al., 2004). Excessive ICNs in the nucleus form
oncogenic Notch transcription complexes (NTCs) with the DNA-binding factor RBPJ,
mastermind-like factors (MAML), and other cofactors, resulting in aberrant expression of
Notch target genes, such as the proto-oncogene MYC. Besides the role of Notch in
activating distal MYC enhancers (Herranz et al., 2014; Yashiro-Ohtani et al., 2014), we
and others recently showed that GSI-mediated short-term Notch inhibition alters lineage95

restricted long-range interactions among enhancer and promoter elements at and beyond
the MYC locus, but does not impact chromatin compartment and TAD structures (Kloetgen
et al., 2020; Petrovic et al., 2019). However, it remains unknown whether and how
chromatin refolding contributes to GSI-resistance in Notch-mutated T-ALL.
To investigate the impact of genome topology changes and reveal the molecular
underpinnings of chromatin refolding in GSI-resistant T-ALL, we used multi-pronged
sequencing, imaging and functional genomic approaches to identify precise changes in
gene expression, chromatin activity, and genome folding in GSI-resistant T-ALL. Our
studies of three-dimensional (3D) genome organization in GSI-resistant T-ALL revealed
widespread alterations in tandem layers of genome topology, including compartment
shifting, TAD boundary reorganization and enhancer repositioning. The alterations in
successive levels of genome folding structures coincide with chromatin activity and
transcriptional changes, promoting the GSI-resistant phenotype. Our studies further
elucidated the mechanisms underpinning genome refolding and showed that GSIresistant T-ALL cells repress the early T cell developmental transcription factors TCF1
and LEF1, and instead activate the B cell lineage-determining transcription factor EBF1 to
connect higher-order chromatin structures and overcome addiction to oncogenic Notch
signals. Together, these observations provide additional support for the role of chromatin
refolding as an epigenetic mechanism capable of conferring resistance to targeted
therapy, and implicate the differential activity of lineage-determining transcription factors
as a driver of chromatin folding reorganization underlying cancer treatment response.
3.3 Results
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Generating a GSI-resistant NOTCH1-mutated T-ALL model
T-ALL DND41 cells harbor prototypical activating NOTCH1 mutations and are sensitive to
treatment by the Notch antagonist GSI. To gain insights into mechanisms of targeted
therapy resistance in T-ALL, we modeled GSI-resistance in DND41 cells and investigated
molecular characteristics of resistant cells. To this end, we derived GSI-resistant DND41
cells by prolonged treatment of “parental” DND41 cells with 125 nM GSI. Assessing cell
viability showed that 10 nM GSI was sufficient to kill 70% of parental DND41 in 6 days,
yet more than 90% of the GSI-resistant DND41 cells remained viable in 10 μM GSI (Figure
S3-1A). In contrast to parental cells, GSI treatment did not induce apoptosis in GSIresistant DND41 (Figures S3-1B and S3-1C). But similar to GSI-treated parental cells,
the active intracellular form of NOTCH1 (ICN1) was undetectable in the resistant cells
(Figure S3-1C), and expression levels of known NOTCH1 targets CD300A, CR2 and
DTX1 (Ryan et al., 2017; Wang et al., 2014), were significantly reduced in GSI-resistant
DND41 (Figure S3-1D). Notably, no additional mutation was observed at the sequences
of NOTCH1 transmembrane and gamma-secretase cleavage site in GSI-resistant cells.
Together, these data showed that GSI-resistance in DND41 is not due to reactivation of
Notch signals.
Chromatin compartmentalization is reorganized in GSI-resistant T-ALL
The absence of NOTCH1 reactivation and lack of new genetic mutations in cancerassociated genes led us to examine the possibility that epigenetic adaptation could confer
resistance to GSI in DND41. To investigate the potential role of chromatin restructuring in
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GSI-resistance, we mapped genome folding structures using in situ HiC and cohesin
subunit SMC1 HiChIP. Given that the cohesin complex is loaded at enhancer-promoter
loops and is involved in CTCF-mediated interactions, both assays accurately detect
chromatin compartments and TADs (Mumbach et al., 2016; Petrovic et al., 2019). In situ
HiC measures all possible interactions across the genome, yet sequencing depth severely
restricts its resolution to detect long-range regulatory contacts. Conversely, cohesincentric HiChIP provides an efficient method to accurately identify high-resolution longrange contacts with significantly lower sequencing depth than in situ Hi-C, but might be
confounded by the cohesin loading changes (Yu and Ren, 2017). Hence, we used the
complementary features of these two chromatin conformation capture assays to examine
reproducible changes in successive layers of chromatin folding structures in GSI-resistant
cells at a high resolution.
At the megabase length scale, chromosomes are organized into euchromatic A or
heterochromatic B compartments (Hildebrand and Dekker, 2020; Yu and Ren, 2017). To
investigate whether changes in chromatin compartments contribute to GSI-resistance, we
first delineated A and B compartments of parental and GSI-resistant genomes. Given the
high correlation of SMC1 HiChIP- and HiC-defined compartments (Figure S3-1E), we
marked differential compartments as the ones reproducibly identified by both assays.
Although most compartments remained invariant, 115 and 171 loci shifted from A to B or
from B to A compartment in GSI-resistant cells.
To examine how compartment changes align with alterations in chromatin activity, we
compared the abundance of active and repressive histone marks within each
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compartment. In the resistant cells, moving from the A to B compartment coincided with
repression of active chromatin, as measured by ChIP sequencing (ChIP-seq) or Cut&Run
analyses of H3K27ac, H3K4me1 and H3K27me3 histone marks (Figure 3-1A).
Conversely, parental B compartment loci that changed to A compartment in the resistant
cells gained active and lost repressive histone marks (Figure 3-1A). To further test the
functional impacts of the compartment changes, we compared expression of genes in
parental and GSI-resistant cells. Loci that moved to A compartment in the resistant cells
were enriched for upregulated genes (Figure 3-1A), including the T cell proliferation
regulator KLF7 (Flotho et al., 2007; Schuettpelz et al., 2012) and the T-ALL-associated
transcription factor ZEB2 (De Coninck et al., 2019) (Figures S3-1F and S3-1G). In
concordance with B to A compartment reorganization of KLF7 and ZEB2 loci, active
histone marks H3K27ac and H3K4me1 were notably increased, while repressive histone
mark H3K27me3 was decreased at these two loci. In contrast to moving from B to A
compartment, loci that shifted from A to B compartment predominantly held genes that
were downregulated in the GSI-resistant cells (Figure 3-1A), as exemplified by the T-cellrestricted Ikaros family member IKZF2 (Hahm et al., 1998). Concomitant with A to B
compartment reorganization, we observed visible changes in the contact frequency
Pearson correlation matrix, and its first principal component (PC1) at the IKZF2 locus
(Figures 3-1B and 3-1C). Repositioning of IKZF2 from the euchromatic A to the
heterochromatic B compartment was accompanied with significant loss of chromatin
activity as measured by H3K27ac, H3K4me1 and H3K27me3 histone marks (Figure 31C).
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A and B compartments are predominantly positioned at the nuclear interior and envelope,
respectively (Falk et al., 2019; Johnstone et al., 2020). To establish whether IKZF2
compartment change relates to its nuclear repositioning, we assessed 3D distance
between the IKZF2 locus and the nuclear envelope. To this end, we used high-resolution
Oligopaint DNA fluorescence in situ hybridization (FISH) technology together with LaminB1 immunofluorescence (IF) and 3D confocal imaging to visualize the compartment
switching of the IKZF2 locus at a single-cell resolution. As predicted by the HiC analysis
(Figures 3-1B and 3-1C), we found that IKZF2 was mainly sequestered at the nuclear
envelope in resistant (106/126 alleles) compared to parental cells (72/157 alleles,
Kolmogorov–Smirnov (K-S) test p = 5.56E-10) (Figure 3-1D). Together, our sequencing
and optical chromatin conformation mapping suggest that genomic loci are repositioned
in the nuclear space of GSI-resistant cells, and these repositioning events coincide with
large scale changes in chromatin and transcriptional activities.

GSI-resistance alters T-cell receptor alpha TAD boundaries
TADs and their boundaries comprise chromatin folding organization at the sub-megabase
length scale (Dixon et al., 2012; Jin et al., 2013; Nora et al., 2012). Given that TAD
boundaries are invariant to short-term Notch inhibition (Kloetgen et al., 2020; Petrovic et
al., 2019), we investigated whether developing resistance due to long-term Notch
inhibition alters TAD structures. Comparison of 4,102 TAD boundaries defined by both
HiC and SMC1 HiChIP identified 111 boundaries that significantly gained insulation
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potential in GSI-resistant cells (Figures 3-1E, S3-1H and S3-1I). Gain of boundary
insulation correlated with alterations in chromatin and transcriptional activities, as
exemplified by the immunoglobulin J chain-encoding gene IGJ and T cell-related receptor
CD69 loci (Figures 3-1F, S3-1J and S3-1K). Significant IGJ upregulation in resistant cells
coincided with the gain of a TAD boundary located 5’ of its promoter, which further
insulated the two sub-TADs at the IGJ locus (Figure 3-1F and S3-1J). While IGJ and a
number of active elements were isolated in one of the two sub-TADs, the other sub-TAD
was epigenetically repressed in resistant cells. As another example, gain of boundary
insulation and CD69 sequestration from nearby active elements were accompanied by a
significant transcriptional inhibition in resistant cells (Figure S3-1K).
In addition to increased TAD boundary insulation in GSI-resistance, our data also revealed
decreased insulation potential at 148 boundaries (Figures 3-1E, S3-1H and S3-1I). For
example, highly expressed T-cell receptor alpha (TCRA) gene segments were located in
a TAD spanning 0.5 Mbp of chromosome 14 in GSI-sensitive parental cells. Notably, the
boundaries of the TCRA TAD were disrupted in GSI-resistant cells (Figure 3-1G). In
concordance with the loss of TAD boundary insulation, the repressive chromatin mark
H3K27me3 spread across the boundaries and TCRA gene segments, which were
significantly inhibited in resistant cells (Figure 3-1H).
To visualize the disrupted TCRA TAD boundaries at a single-cell resolution, we designed
Oligopaint DNA FISH probes spanning three 100 Kbp regions at this locus (Figure 3-1H,
left panel). TCRA-1 probe visualized a region 5’ of the TCRA TAD, which was marked
with repressive histone mark H3K27me3 in both parental and resistant cells. TCRA-2 and
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TCRA-3 probes marked regions within the parental TCRA TAD flanking the disrupted
boundaries. Quantifications of SMC1 HiChIP and HiC showed increased contact
frequencies between TCRA-1 and both TCRA-2 and TCRA-3 probes, suggesting that
inter-TAD interactions increased across the disrupted boundaries (Figure 3-1H, right
panel). In concordance with the genomic data, measuring TCRA-1 and TCRA-2 3D
distances in 2,515 parental and 3,418 resistant cells using confocal microscopy showed
that loci marked by these probes were markedly closer in the resistant cells (Figure 3-1I)
(K-S test p = 4.15E-10). Furthermore, the measurement of the TCRA-1, TCRA-2, TCRA3 spatial perimeter suggested that the TCRA TAD was compacted in GSI-resistant cells
(Figure 3-1I), confirming HiC data (Figure 3-1H). Together, these analyses suggest that
a subset of TADs are reorganized in GSI-resistance, and TAD restructuring largely
corresponds to changes in chromatin activity and gene expression.
GSI-resistance reorganizes enhancer-promoter loops
Long-range chromatin interactions connecting regulatory elements are implicated in gene
control (Deng et al., 2014; Kagey et al., 2010). To determine whether changes in contact
frequency among regulatory elements, such as enhancers, promoters, and CTCF-bound
insulators, contribute to the GSI-resistant phenotype, we first used HiC and SMC1 HiChIP
to identify significant and reproducible high-resolution contacts (~5 Kbp) in the genomes
of parental and GSI-resistant DND41. While the majority of long-range contacts remained
unchanged, the interaction frequency between 484 and 441 loci pairs were significantly
reduced or enhanced in resistant cells, respectively (Figures 3-2A, S3-2A). We next
tested what regulatory elements were connected by these differential loops (Figure 3-2B).
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Our data showed that 39% of the significantly decreased long-range contacts connected
gene promoters to distal enhancers in the parental cells. On the other hand, 65% of
increased long-range contacts were among enhancers in the resistant cells. Notably, only
a small number of structural loops (5%), connecting two CTCF-bound elements, were
altered. Together, these data indicate that differential long-range contacts observed during
GSI-resistance development are mostly among enhancers and promoters.
Changes in enhancer activity and positioning coincide with transcriptional
deregulation in GSI-resistant T-ALL
Chromatin activity and looping are both crucial for proper gene control (Blackwood and
Kadonaga, 1998; Furlong and Levine, 2018; Heintzman et al., 2007; Strahl and Allis,
2000). To investigate how differential transcriptional outputs of GSI-resistant cells relate
to the alterations in chromatin activity and long-range DNA loops, we first correlated the
changes in enhancer activity with the frequency of distal interactions among gene
promoters and enhancers. Our data revealed that the increased alterations in enhancer
activity correlated with increased changes in enhancer-promoter contact frequency
(Figures 3-2C, S3-2B and S3-2C). Furthermore, hyperacetylation or gain of superenhancers in the GSI-resistant cells coincided with marked increases in long-range
contacts at these regions (Figure S3-2D) and within the super-enhancer loci (Figure 32D). Conversely, long-range contacts were significantly decreased at the loci with loss of
super-enhancer activity in the resistant cells (Figures 3-2D and S3-2D). Together, these
data suggest that there are concordant changes in the enhancer activity and DNA looping
in GSI-resistant T-ALL.
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We next asked whether changes in chromatin activity and looping relate to gene
expression associated with the GSI-resistant phenotype. We found that changes in the
frequency of contacts between genes and their interacting distal enhancers led to
significant and concordant gene expression changes (Figure 3-2E). Furthermore, gain
and loss of super-enhancer activity, respectively, led to upregulation and downregulation
of genes in the resistant compared to parental cells (Figure S3-2E). Notably, we observed
the most significant gene expression alteration when both enhancer activity and position
concomitantly changed in GSI-resistant cells (Figure 3-2F). Together, these results
indicate that changes in enhancer activity and positioning, in addition to reorganization of
TADs and compartments, coincide with differential transcriptional outputs of GSI-resistant
cells.

MYC super-enhancers are repositioned in GSI-resistant cells
Notch-dependent long-range control of MYC expression is critical for T-ALL pathogenesis
(Herranz et al., 2014; Yashiro-Ohtani et al., 2014). To elucidate the contribution of MYC
locus refolding to GSI-resistance, we captured promoter contact frequency and activity of
enhancers at the MYC locus in parental and resistant cells. The integrity of TAD
boundaries at ~4 Mbp sequences flanking the MYC promoter remained unchanged
(Figure S3-2F). Comparing the activity of enhancers contacting the MYC promoter
showed that Notch-bound super-enhancer (E1), located ~1.35 Mbp 3’ of the MYC
promoter in parental cells, was inactivated in the resistant cells (Figure 23-G), as reported
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(Yashiro-Ohtani et al., 2014). Conversely, the Notch-unbound super-enhancer (E2),
located further ~0.5 Mbp 3’ of E1, markedly gained activity in GSI-resistant cells (Figure
3-2G). Knowing that Notch relies on different combinations of enhancer activation and
positioning to control its transcriptional targets (Petrovic et al., 2019), we next asked
whether MYC enhancers are repositioned in GSI-resistant cells. Our sequencing data
revealed that the contact frequency between the Notch-bound super-enhancer E1 and the
MYC promoter decreased in the resistant cells (Figure 3-2G); in contrast, the contact
frequency between the Notch-unbound super-enhancer E2 and the MYC promoter
increased in the GSI-resistant T-ALL (Figure 3-2G).
We next sought to establish whether the observed changes in MYC promoter-enhancer
contact frequencies by HiC and SMC1 HiChIP relate to physical distances between the
interacting elements across individual T-ALL cells. We thus designed Oligopaint DNA
FISH probes spanning 50 Kbp regions at the MYC promoter, as well as both Notch-bound
and Notch-unbound super-enhancers E1 and E2 (Figure 3-2G). We imaged 1,652 DMSOtreated parental, 1,323 GSI-treated parental, and 1,694 GSI-resistant DND41 cells by
confocal microscopy and measured 3D distances between the MYC promoter and the
distal super-enhancers E1 and E2. In contrast to Notch-mutated triple-negative breast
cancer and small B cell lymphoma (Petrovic et al., 2019), short-term GSI treatment did not
reposition the MYC promoter and its two super-enhancers E1 and E2 in Notch-mutated TALL (Figure S3-2G). Unlike the effects of short-term GSI treatment, direct measurement
of the 3D distance between the MYC promoter and Notch-bound super-enhancer E1
showed that these two elements were significantly separated in the resistant cells (Figure
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3-2H). Conversely, Notch-unbound super-enhancer E2 became markedly closer to the
MYC promoter in GSI-resistant cells (Figure 3-2H). Together, our optical mapping of the
MYC locus 3D organization, concordant with sequencing assay (Figure 3-2G), showed
the repositioning of both MYC super-enhancers E1 and E2 in GSI-resistant cells at a
single-cell resolution.
To investigate the functional consequence of chromatin restructuring at the MYC locus,
we assessed MYC expression in parental and resistant cells. Interestingly, changes in the
activity and positioning of the MYC super-enhancers E1 and E2 coincided with the
restoration of MYC expression (Figure 3-2I), and its known targets (Figure S3-2H) in the
resistant cells to levels comparable to parental DND41. Importantly, MYC expression was
restored in GSI-resistant cells despite absence of any genomic alteration, and detectable
NOTCH1 activity (Figure 3-2I). Together, these data indicate that resistant cells bypass
their addiction to oncogenic Notch signals and re-express MYC, a key survival gene
required for both parental and GSI-resistant T-ALL (Figure S3-2I).
GSI withdrawal from resistant cells reverses MYC locus chromatin activity and
folding
Given our data showing Notch-independent MYC reactivation in GSI-resistant cells
(Figure 3-2I), we further postulated that epigenetic adaptation and not genetic alterations
leads to MYC recovery in the resistant cells. To directly examine this hypothesis, we
generated ‘reversed’ DND41 cells by drug withdrawal from GSI-resistant cells for 6 weeks.
While E2 super-enhancer activity did not change and remained GSI-insensitive, MYC
106

super-enhancer E1 regained activity and was sensitive to short-term GSI treatment in the
reversed cells (Figure 3-2J).
To investigate plasticity of the MYC locus folding, we next performed MYC promotercentric 4C-seq studies to examine the MYC locus conformation in parental, resistant and
reversed cells (Figure 3-2J). These data confirmed our 3D DNA FISH studies (Figure S32G) and showed that contact frequencies between the E1 and E2 super-enhancers and
the MYC promoter were invariant to short-term Notch inhibition (Figure 3-2J). Similar to
our HiC (Figure 3-2G) and 3D DNA FISH (Figure 3-2H) studies, the 4C-seq data further
showed significant repositioning of E1 and E2 super-enhancers in the resistant cells
(Figure 3-2J). More importantly, while E2 maintained its contact with the MYC promoter,
the super-enhancer E1 interaction with the MYC promoter was recovered in the reversed
cells (Figure 3-2J). In concordance with the reactivation and repositioning of the superenhancer E1, MYC expression increased in the reversed cells, and was sensitive to shortterm GSI treatment (Figure 3-2I). Together, these data suggest that the resistant cells can
be resensitized to GSI due to the highly dynamic chromatin structure of the MYC locus.
Differential loading of architectural proteins coincides with refolded loops in GSIresistant cells
Folding of chromatin into structural and regulatory loops are facilitated by architectural
proteins, including the ring-shape cohesin complex, the insulator protein CTCF, and the
ubiquitous transcription factor YY1 (Rowley and Corces, 2018). To elucidate the
underlying mechanisms of wide-spread chromatin refolding in GSI-resistance, we
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investigated whether differential chromatin binding of CTCF, YY1 and cohesin subunit
SMC1 relate to the chromatin looping changes that we observed in GSI-resistant cells.
Although the expression levels of these architectural proteins were unchanged (Figure
S3-3A), our differential ChIP-seq analyses in parental and resistant cells identified 4,143,
2,272 and 5,376 loci with marked changes in occupancy of SMC1, CTCF and YY1,
respectively. Among the 503 elements connected by the intensified DNA loops (Figure 32A), more than 80% (407/503) gained SMC1 loading in the resistant cells (Figures 3-3A
and S3-3B). Conversely, 64% (442/689) of the 689 elements connected to attenuated
DNA loops lost SMC1 loading in the resistant cells (Figures 3-3A and S3-3B). As
expected, chromatin loops remained invariant at the sites similarly bound to SMC1 in
parental and resistant cells (Figures 3-3A and S3-3B). Comparison of CTCF (Figure 33B and S3-3C) and YY1 binding events (Figure 3-3C and S3-3D) also showed that loss
and gain of their chromatin occupancy coincided with decreased and increased looping in
the resistant cells, respectively.
To further quantitate how changes in chromatin occupancy of architectural proteins relate
to genome looping reorganization, we evaluated the differential SMC1, CTCF and YY1
binding events at the sites of altered looping. Chromatin occupancy of SMC1, CTCF and
YY1 was significantly decreased at loci with reduced looping in resistant cells (Figure S33E). By contrast, chromatin binding of these proteins was markedly increased at the loci
with enhanced looping in resistant cells (Figure S3-3E). Concordant with these
observations, our data showed that higher changes in loading of SMC1, CTCF, and YY1
were associated with more differential contact frequencies between their bound loci
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(Figure S3-3F). Together, these data suggest that redistribution of CTCF, YY1 and SMC1
chromatin binding facilitates reorganization of long-range loops in GSI-resistant cells.
Observing the relation between redistribution of architectural proteins and changes in
contact frequencies led us to next investigate their differential propensity for altering
structural and regulatory loops in GSI-resistant cells. Our data revealed that concomitant
differential loading of SMC1, CTCF, and YY1 had the highest impact on differential looping
(Figure S3-3G). Moreover, we observed that differential CTCF and YY1 binding events
were mutually exclusive in the absence of differential SMC1 binding. Given that GSIresistance only altered a small number of structural loops (Figure 3-2B), we specifically
investigated the impact of differential SMC1, CTCF and YY1 chromatin binding on
enhancer-promoter loops. The occupancy of all three proteins was altered at loci
connected to differential enhancer-promoter loops (Figure 3-3D). However, CTCF, which
is not employed by most enhancer-promoter loops (Weintraub et al., 2017), showed the
least differential loading, while the cohesin subunit SMC1 exhibited the highest changes
at elements connected to differential enhancer-promoter loops (Figure 3-3D). Compared
to the promoters, YY1 was preferentially recruited to distal enhancers that gained
interactions in resistant cells (Figure 3-3D), as exemplified by the enhancers connected
to the early cortical thymocyte marker CD1B (Martin et al., 1987) and transcriptional
coregulator NRIP1 (Augereau et al., 2006) (Figures 3-3E and 3-3F). Concomitant with
the significant reduction in YY1, CTCF, and SMC1 loading levels, drug resistance
markedly decreased transcriptional abundance and contact frequency of CD1B to a distal
enhancer located 65 Kbp away (Figure 3-3E). Conversely, upregulation of NRIP1 in the
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resistant cells coincided with recruitment of YY1, CTCF, and SMC1, as well as
repositioning of resistant-cell-restricted enhancers located 400 Kbp 5’ of the NRIP1
promoter (Figure 3-3F). Together, these data suggest that changes in chromatin
recruitment of YY1, SMC1 and, to a lesser extent, CTCF contribute to repositioning of
enhancer and promoter elements in GSI-resistant T-ALL cells.
TCF1/LEF1 and EBF1 deregulation links to differentially accessible elements in GSIresistant cells
We found that chromatin occupancy of SMC1, YY1 and, to some extent, CTCF was
significantly altered at the repositioned elements in GSI-resistant cells. Yet, these
architectural proteins are ubiquitously expressed, and their levels were invariant between
the parental and resistant cells (Figure S3-3A). These observations led us to investigate
the molecular underpinnings of CTCF, YY1 or SMC1 differential recruitment and enhancer
repositioning in GSI-resistance. We first leveraged ATAC-seq to map differential
chromatin accessibility in parental and resistant cells. Although short-term Notch inhibition
had no significant effect on chromatin accessibility (Figure S3-4A), development of GSIresistance due to long-term Notch inhibition led to significant changes in the accessibility
of more than 7,000 genomic elements (Figure 3-4A). In concordance with significant
reduction in chromatin opening, we observed substantial depletion of active enhancer
marks H3K27ac and H3K4me1, and deposition of repressive mark H3K27me3 at ~3,000
parental-cell-restricted accessible elements (Figures 3-4B and S3-4B). Conversely,
concomitant with H3K27me3 loss, H3K27ac and H3K4me1 were deposited at nearly 4000
resistant-cell-restricted accessible elements (Figures 3-4B and S3-4B).
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To identify the transcription factors that contributed to the differential chromatin opening
of parental and resistant cells, we separately performed motif analysis in parental- and
resistant-cell-restricted accessible elements using the opposite phenotype as background.
Sequences of parental-cell-restricted accessible elements were most enriched with motifs
of TCF (Figure 3-4C), a high-mobility group (HMG) family of proteins (Giese et al., 1992;
van de Wetering et al., 1991; Verbeek et al., 1995). Notably, RNA-seq data showed
significant downregulation of LEF1 and TCF7, gene encoding the key early T-lineage
differentiation factor TCF1 (Weber et al., 2011; Yui and Rothenberg, 2014) in resistant
cells (Figure S3-4C). Immunoblotting further confirmed transcriptomic data and showed
nearly undetectable LEF1 and TCF1 expression in GSI-resistant cells (Figure 3-4C).
Conversely, recognition motifs of EBF transcription factors were the top enriched motifs in
the sequences of resistant-cell-restricted accessible elements (Figure 3-4C). Among EBF
protein family, EBF1, a transcription factor essential for B-lineage specification and
maintenance (Boller et al., 2016; Northrup and Allman, 2008; Nutt and Kee, 2007; Treiber
et al., 2010) was undetectable in parental cells and only expressed in resistant cells
(Figures 3-4C and S3-4C). Notably, EBF1 and TCF1 both are capable of creating de
novo chromatin accessibility during early B and T-lineage differentiation, respectively
(Boller et al., 2016; Johnson et al., 2018). Together, these data suggest that TCF1/LEF1
loss and EBF1 gain may restructure chromatin accessibility, conferring GSI-resistance.
To further substantiate the effect of TCF1, LEF1 and EBF1 on differential chromatin
accessibility observed in GSI-resistant cells, we measured their ability to bind chromatin
in GSI-sensitive and -resistant DND41 cells. As motif analysis predicted (Figure 3-4C),
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TCF1 and LEF1 bound to parental-cell-restricted accessible elements and were
undetectable in resistant cells (Figure 3-4D). Conversely, resistant-cell-restricted
accessible elements bound to EBF1 after its derepression in GSI-resistant cells (Figure
3-4D). Together, these data indicate that differential TCF1/LEF1 and EBF1 expression
and binding coincide with the chromatin accessibility differences between GSI-sensitive
and -resistant cells.
Differential TCF1/LEF1 and EBF1 binding directs SMC1, CTCF, or YY1 to GSIresistant repositioned elements
Our data revealed that differential recruitment of architectural proteins is closely
associated with enhancer repositioning in the GSI-resistant cells (Figure 3-3). We further
identified widespread changes in chromatin opening and activity at elements differentially
bound to TCF1/LEF1 and EBF1 in the parental and resistant cells, respectively (Figures
3-4B and 3-4D). As removal of nucleosomes might be a key step to allow recruitment of
architectural proteins, we considered the possibility that differential TCF1/LEF1 and EBF1
activities might serve a crucial role in differentially recruiting CTCF, SMC1 and YY1, and
repositioning enhancer elements in resistant cells. To examine the effect of TCF1/LEF1
loss and EBF1 gain on the recruitment of architectural proteins, we compared the binding
of these transcription factors and loading of SMC1, CTCF, and YY1 at the parental- and
resistant-cell-restricted accessible elements. Notably, we observed significant loss of
SMC1, YY1, and CTCF at 81%, 52% and 30% of TCF1-bound parental-cell-restricted
elements, respectively (Figures 3-B, 3-4D and 3-4E). On the other hand, 95%, 65% and
27% of the EBF1-bound resistant-cell-restricted accessible elements exhibited significant
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gain of SMC1, YY1, and CTCF, respectively (Figures 4B, 4D and 4E). Together, these
data raise the possibility that differential TCF1/LEF1 and EBF1 chromatin activity underlies
the redistribution of SMC1, YY1 and, to a lesser extent, CTCF in GSI-resistant cells.
To substantiate the role of TCF1/LEF1 and EBF1-mediated redistribution of architectural
proteins in reorganization of T-ALL genome folding, we assessed the effect of their
differential chromatin binding on DNA loops. Contact frequencies were greatly reduced
among the parental genomic elements that lost TCF1/LEF1 binding and accessibility
(Figures 3-4F and S3-4D). Conversely, contact frequencies were greatly enhanced
among the elements that bound EBF1 and gained accessibility in resistant cells (Figures
3-4F and S3-4D). Interestingly, genome-scale analysis of paired loci revealed that
concordant loss of TCF1/LEF1 on one anchor and SMC1, CTCF, or YY1 at the other
anchor similarly diminished contact frequencies (Figures 3-4G, S3-4E, S3-4F and S34G). Conversely, concordant gain of EBF1 and these architectural proteins at both loop
anchors greatly intensified contact frequencies in the resistant cells (Figures 3-4G, S34E, S3-4F and S3-4G). Together, these data further support the potential role of
TCF1/LEF1 and EBF1 in selective recruitment of architectural proteins and genome
folding reorganization that confers differential GSI response in Notch-mutated T-ALL.
Coordinated differential recruitment of TCF1/LEF1, EBF1, and architectural proteins
mediates GSI-resistant transcriptional program
To assess how changes in TCF1/LEF1- and EBF1-mediated chromatin accessibility and
DNA folding relate to the GSI-resistant transcriptional program, we first linked H3K27ac113

marked enhancers to gene promoters using our high resolution in situ HiC and SMC1
HiChIP, and then quantified the impact of chromatin opening changes on gene expression.
1,460 genes that were significantly downregulated in the resistant cells were generally
associated with T-cell-related pathways and more specifically involved in processes
differentiating T from B lymphocytes (Figure S3-4H). As expected, changes in
accessibility at gene promoters and distal enhancers greatly altered transcriptional outputs
of GSI-resistant compared to parental cells (Figure 3-4H). Notably, changes in opening
of both promoters and enhancers, compared to promoters alone, led to significantly higher
differential gene expression (Figure 3-4H), further supporting that changes in distal
regulatory elements contribute to GSI-resistance.
After observing the impact of chromatin opening changes on gene expression (Figure 34H) and association of TCF1/LEF1 and EBF1 with differentially accessible elements
(Figures 3-4B and 3-4D), we next assessed the contribution of differential TCF1/LEF1
and EBF1 chromatin binding on GSI-resistant transcriptional outputs. Genes markedly
upregulated in the resistant cells were preferentially connected to distal enhancers that
gained EBF1 (Figure 3-4I, proportion test p = 0.01). Furthermore, TCF1/LEF1 was
significantly depleted at distal enhancers connected to genes downregulated in resistant
cells (proportion test p < 1E-15). Notably, only 11% of differentially expressed genes did
not connect to enhancers with gain of EBF1 or loss of TCF1/LEF1 (Figure 3-4I). Together,
these data support the importance of differential activity and binding of TCF1 and EBF1 in
orchestrating GSI-resistant gene expression.
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Given the association between differential TCF1/LEF1 and EBF1 binding and
redistribution of architectural proteins (Figures 3-4D and 3-4E), we next investigated how
TCF1/LEF1- and EBF1-mediated recruitment of SMC1, YY1, and CTCF impacts GSIresistant transcriptional outputs. Notably, concordant loss of TCF1/LEF1, and SMC1,
CTCF, or YY1 led to markedly stronger gene repression (Figure 3-4J). Pathway and
gene-ontology analysis of 540 TCF1/LEF1 direct targets showed that loss of TCF1/LEF1
led to repression of genes encoding components of T cell activation, differentiation, and
associated signaling (Figure S3-4I), as exemplified by RAG2 V(D)J endonuclease, LEF1
itself, as well as T cell surface proteins CD6 and CD5 (Gimferrer et al., 2003) (Figures 34K, 3-4L, and S3-4I). Close scrutiny of these loci revealed that concomitant loss of
TCF1/LEF1, SMC1 and YY1 coincided with reduced looping frequency between parentalcell-specific regulatory elements and their connected gene targets. For example, loss of
TCF1/LEF1, SMC1 and YY1 in resistant cells diminished looping levels involved in spatial
co-regulation of CD6 and CD5 (Figure 3-4L).
Besides downregulating TCF1/LEF1 targets, GSI-resistance significantly upregulated
1,128 genes, among which 400 were direct EBF1 targets, defined as activated genes with
an EBF1-bound promoter and/or enhancer. Interestingly, concomitant gain of EBF1
binding and SMC1, CTCF, or YY1 recruitment led to significantly higher transcriptional
activation (Figure 3-4J). Gene set enrichment analysis of EBF1 direct targets revealed
that EBF1 binding led to upregulation of genes associated with B cell differentiation,
activation, and lineage choice (Figure S3-4K), as exemplified by the B cell receptor
component CD79A (Minegishi et al., 1999), plasma cell master regulator PRDM1 (Shaffer
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et al., 2002), and B-cell leukemia-associated antigen HB-encoding gene HMHB1 (Dolstra
et al., 1997) (Figures S3-4L, Figure 3-4M and Figure 3-4N). Close examination of these
loci revealed EBF1 binding led to de novo accessibility and recruitment of architectural
proteins to regulatory elements, which in turn increased long-range interactions to target
genes. Together, these results indicate that TCF1/LEF1 repression and EBF1
derepression impact chromatin activity and folding to shift the GSI-resistant T-ALL
transcription away from a T cell-associated towards a B cell-associated program.
In addition to directing architectural proteins to the regulatory elements connected to
differentially expressed genes, EBF1 derepression also guided SMC1, CTCF, or YY1 to
MYC-connected regulatory elements, whose reactivation was crucial for GSI-resistant cell
survival (Figures 3-2I and S3-2I). Interestingly, restoration of MYC expression in resistant
cells coincided with the replacement of TCF1/LEF1 with EBF1 at both distal superenhancers E1 and E2 (Figures 3-2J, S3-4M and S3-4N). Loss of TCF1/LEF1 in resistant
cells led to depletion of architectural proteins and closing of several accessible elements
within the Notch-dependent super-enhancer E1. Notably, the polycomb-associated
H3K27me3 histone mark was deposited at the Notch-bound element of the superenhancer E1 in resistant cells (Figures 3-2J and S3-4M). Conversely, our data showed
that resistant cells concomitantly gained EBF1, SMC1, and YY1 binding as well as
chromatin opening and activity at two elements within the Notch-independent superenhancer E2 (Figure S3-4N). Together, these data demonstrate the underlying
mechanisms of enhancer switching that maintain MYC expression in GSI-resistant cells.
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EBF1 and TCF1 but not LEF1 can create de novo chromatin accessibility and
looping in Notch-mutated TNBC
We observed the widespread association between differential binding of TCF1, LEF1 and
EBF1 and changes in accessibility and looping of GSI-resistant chromatin. However, it is
unclear whether these transcription factors are equally able to bind chromatin and induce
opening and folding. To investigate this question, we examined the ability of TCF1, LEF1
and EBF1 to create de novo open chromatin and instruct looping in nonhematopoietic
cancer gain-of-function models. We reasoned that Notch-mutated breast cancer cells
could serve as an ideal model since their chromatin is distinct from Notch-mutated
hematolymphoid cells, and they lack endogenous expression of lymphocyte lineagedetermining transcription factors, including TCF1, LEF1, and EBF1 (Figure S3-5A), which
allows an accurate assessment of their roles in chromatin opening and looping. We thus
transduced Notch-mutated triple-negative breast cancer (TNBC) MB157 cells with
doxycycline-inducible LEF1, TCF1 or EBF1 (Figure S3-5A), and assessed genome-scale
changes in chromatin opening, architectural protein loading, and DNA looping three days
post induction. Ectopic LEF1, TCF1, or EBF1 markedly increased accessibility of 411,
1,691, and 8,550 genomic regions, respectively (Figure 3-5A). Notably, the elements that
significantly gained accessibility after expression of TCF1 and EBF1, but not LEF1, were
enriched for TCF and EBF family recognition sequences (Figure 3-5A) and predominantly
bound TCF1 and EBF1 (Figure 3-5B), respectively. Concordant with increased opening,
H3K27ac was deposited at 23% of the EBF1-bound and 12% of the TCF1-bound elements
(Figure 3-5B). Together, these data suggest that EBF1 and TCF1, but not LEF1, can
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create de novo accessibility in the MB157 genome, in concordance with their pioneering
potential previously described during lymphocyte differentiation (Boller et al., 2016;
Johnson et al., 2018).
In addition to changes in chromatin opening, our data also showed concomitant differential
TCF1 and EBF1 binding, SMC1 and YY1 recruitment, and enhancer repositioning in GSIresistant T-ALL cells (Figures 3-4B to 3-4G). Concordantly, ectopic EBF1 and TCF1
chromatin binding in TNBC MB157 cells greatly intensified looping levels of 1,354 and 562
long-range contacts, respectively (Figures 3-5C and 3-5D). This result was illustrated by
HEY2 and IL15RA-connected loops (Figures S3-5B and S3-5C). Interestingly, EBF1- and
TCF1-instructed loops in TNBC mainly connected to enhancer and promoter elements
and only marginally affected structural CTCF-CTCF loops (Figure 3-5E). Furthermore,
SMC1 and/or YY1, but not CTCF, markedly increased at the loci connected to EBF1- or
TCF1-instructed loops (Figures S3-5D and S3-5E). Together, these data suggest that
similar to GSI-resistant and -sensitive T-ALL (Figures 3-4G and S3-4E to S3-G), EBF1
and, to a lesser extent, TCF1 can instruct DNA looping in MB157, potentially via
recruitment of architectural proteins.
Ectopic EBF1 induces GSI-resistant T-ALL-associated genes in TNBC cells
Our data revealed the ability of EBF1 and TCF1 to induce widespread chromatin opening
and looping in TNBC MB157 cells (Figures 3-5B, 3-5C and 3-5D). To evaluate how these
epigenetic changes control MB157 gene expression, we next measured transcriptional
changes three days post EBF1 or TCF1 induction. Ectopic EBF1 or TCF1 significantly
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increased expression of 1,463 and 898 genes, respectively (Figure S3-5F). Linking gene
promoters to H3K27ac-marked distal enhancers using our high-resolution chromatin
conformation data revealed that the concomitant EBF1- or TCF1-induced enhancer and
promoter opening led to significantly higher increases in gene expression compared to
opening only one of these elements (Figure S3-5G), supporting the finding that EBF1 and
TCF1 activate both proximal and distal regulatory elements. Notably, the EBF1- or TCF1bound enhancers that were both activated and repositioned induced higher gene
expression compared to the EBF1- or TCF1-bound enhancers that were only activated or
repositioned (Figure S3-5H), further supporting the role of these transcription factors in
enhancer positioning.
Examining EBF1-induced genes in TNBC MB157 revealed that EBF1 direct targets,
defined as upregulated genes with an EBF1-bound promoter and/or enhancer, were
overrepresented in genes involved in adaptive immunity and associated signaling (Figure
S3-5I), consistent with the role of EBF1 in promoting expression of key genes during early
B cell development (Nechanitzky et al., 2013; Treiber et al., 2010). More specifically,
known EBF1 targets in early B cell development (Nechanitzky et al., 2013; Treiber et al.,
2010) were upregulated following ectopic EBF1 expression in MB157 (Figure 3-5F).
Similarly, TCF1 targets in MB157 cells were overrepresented in the components of known
TCF-dependent pathways (Figure S3-5J). Together, these data suggest that the lineagedetermining transcription factors EBF1 and TCF1 can respectively activate B- and Trelated gene programs in transformed mammary epithelial cells.
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Intrigued by this observation, we next examined the extent to which ectopic EBF1 can
activate GSI-resistant T-ALL-related genes in TNBC cells. Remarkably, EBF1 directly
induced overlapping set of genes in epigenetically disparate TNBC and GSI-resistant TALL (Figures 53-G and S3-5K), as exemplified by the B cell receptor component CD79A,
the B-lineage transcription factor encoding gene TCF3 (Lin et al., 2010), and the cancer
therapy resistance-associated gene PHLDA1 (Fearon et al., 2018) (Figures 3-5H and S35L). Interestingly, EBF1 binding within the 13 Kbp region flanking PHLDA1 instructed DNA
looping in addition to increasing chromatin activity and gene expression in both GSIresistant T-ALL and EBF1-expressing TNBC cells (Figure 3-5H). Together, these data
suggest that EBF1 can create de novo chromatin opening and looping to control
transcription in unrelated hematopoietic and non-hematopoietic cancer cells.
TCF1 or LEF1, but not both, are dispensable for the maintenance of T-ALL
chromatin opening
TCF1/LEF1 loss coincided with reduced chromatin opening in GSI-sensitive T-ALL
(Figures 3-4B and 3-4D) and ectopic TCF1 (although less than EBF1) created de novo
chromatin opening in TNBC MB157 chromatin (Figures 3-5A and 3-5B). These
observations led us to test the requirement of TCF1 and LEF1 for viability and chromatin
opening in drug-naive T-ALL. LEF1 and TCF1 double knockout (Figure S3-6A) resulted
in a mild but statistically significant decrease in proliferation of Cas9-expressing parental
DND41 (Figure S3-6B). Interestingly, loss of TCF1 or LEF1 alone exhibited negligible
effects on DND41 chromatin opening (Figure 3-6A). Yet, our mapping of the chromatin
accessibility dynamics showed significantly reduced opening at 80, 158 and 263 sites
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three, six and nine days post co-transduction of TCF1 and LEF1 sgRNAs (Figure 3-6B).
TCF family recognition sites were the top enriched motifs and observed in 82% of
elements with a significant decrease in accessibility after TCF1 and LEF1 genetic deletion,
suggesting their direct dependency on TCF1/LEF1. By contrast, regions that gained
accessibility upon TCF1 and LEF1 loss were not enriched for TCF family motifs and were
potentially due to indirect effects of TCF1/LEF1. Similar to Notch-dependent DND41, loss
of TCF1 and LEF1 together, but not alone, significantly reduced chromatin opening at the
sites with TCF family consensus binding sequences in T-ALL Jurkat cells (Figures S3-6C
and S3-6D) that express NOTCH1 but their growth is Notch-independent (O'Neil et al.,
2007). Together, these data suggest that although TCF1 and LEF1 have highly similar
protein structures and consensus binding sequences (Cadigan and Waterman, 2012),
only TCF1 can induce de novo chromatin opening when ectopically expressed (Figure 35A); however, both TCF1 and LEF1 can maintain accessibility of T-ALL chromatin.
EBF1 is required for accessibility of GSI-resistant-cell-restricted elements
Our studies in TNBC MB157 cells showed that ectopic EBF1 can create de novo chromatin
opening and looping (Figures 3-5A, 3-5B and 53-C). Yet, it is unclear whether EBF1 is
directly required to maintain chromatin accessibility in GSI-resistant T-ALL cells. To
address this question, we used CRISPR-Cas9 to genetically ablate EBF1 expression in
GSI-resistant DND41 cells. Three days post transduction of Cas9-expressing resistant
DND41 cells (DND41-Res-Cas9) with EBF1-targeting sgRNA, EBF1 protein levels were
significantly reduced (Figure 3-6C). EBF1 loss induced apoptosis (Figure 3-6D) and
suppressed proliferation (Figure 3-6E), suggesting that GSI-resistant DND41 cells are
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addicted to EBF1 signals. Moreover, loss of EBF1 in two independent Cas9-expressing
resistant DND41 lines led to significant reduction in accessibility of at least 90, 600, and
900 genomic regions three, six, and nine days post EBF1 sgRNA transduction,
respectively (Figures 3-6F and S3-6E). Furthermore, EBF family recognition sequences
were the top enriched motifs, observed in more than 70% of all the elements with a marked
reduction in accessibility (Figures 3-6F and S3-6E), suggesting their direct dependency
on EBF1. More importantly, EBF1 loss preferentially reduced the opening of the sites that
bound EBF1 and/or gained accessibility in GSI-resistant cells (Figures 3-6G and 3-6H),
suggesting that EBF1 loss specifically alters accessibility of elements promoting drug
resistance.
To further substantiate the role of EBF1 in chromatin reorganization during GSI-resistance
development, we assessed accessibility four weeks after GSI treatment. Time-course
study of cell proliferation showed an intermediate level of GSI sensitivity at week 4 (Figure
S3-6F). More refined time-course studies revealed that while TCF1 and LEF1 rapidly
reduced upon persistent GSI treatment, EBF1 gradually increased and its kinetics
correlated with MYC expression (Figures S3-6G and S3-6H). Concomitant with
TCF1/LEF1 loss in four-week-GSI-treated cells, chromatin opening was significantly
reduced at sequences with TCF family consensus binding motif, suggesting their direct
dependency on TCF1/LEF1 (Figure S3-6I). Importantly, in line with a rapid TCF/LEF1
repression, the number of sites with reduced accessibility was comparable between
resistant and four-week-GSI-treated cells (Figures S3-6I and S3-6J). Conversely, twofold more elements gained accessibility in resistant compared to four-week-GSI-treated
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cells, where EBF1 expression was markedly lower (Figures S3-6I, S3-6J and S3-6G).
The MYC locus exemplified these dynamics, where opening of E1 and E2 superenhancers was halfway between the parental and GSI-resistant cells four weeks into
treatment (Figure S3-6K). Together, these data, which relate the dynamics of differential
chromatin opening with TCF1 and EBF1 expression during GSI-resistance development,
further support the role of these transcription factors in regulation of chromatin
accessibility.
Intrigued by DND41 data, we next examined EBF1 functions in other Notch-dependent
cells. Similar to GSI-resistant T-ALL DND41 cells, loss of EBF1 (Figure S3-6L)
significantly decreased growth (Figure S3-6M), viability (Figures S3-6N and S3-6O) and
chromatin opening (Figure S3-6P) in EBF1-expressing mantle cell lymphoma Granta-519.
Importantly, gain of EBF1 decreased GSI sensitivity in Notch-addicted HPB-ALL and
KOPTK1 T-ALL (Figures S3-6Q and S3-6R). Together, these data suggest that the
widespread effect of EBF1 on chromatin promotes survival of EBF1-expressing cells
including Notch-addicted T-ALL.
EBF1 is required for positioning of GSI-resistant-cell-restricted accessible elements
In addition to opening chromatin, we observed that EBF1 can recruit SMC1 and YY1, and
instruct DNA looping in TNBC cells (Figures 3-5B and 3-5C). Moreover, EBF1 binding
coincided with the repositioned genomic elements in the GSI-resistant T-ALL cells
(Figures 3-4G and S3-4E to S3-G). These observations led us to examine whether EBF1
chromatin binding is required for GSI-resistant genome folding. Thus, we focused on early
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EBF1 genomic targets to overcome the significant time-scale difference between the
emergence of GSI-resistance (> 12 weeks) and genetic deletion of EBF1 (6 days). We
reasoned that “early” EBF1 targets were the genomic elements that bound EBF1 and
gained accessibility in GSI-resistant cells, and concordantly lost opening six days post
EBF1 sgRNA transduction (EBF1-KO) (Figure 3-7A). Interestingly, early EBF1 target
elements mostly gained accessibility four weeks into treatment (Figure 3-7A).
Comparison of parental and resistant cells showed SMC1, YY1 and, to a lesser extent,
CTCF were most enhanced at the early EBF1 target elements in GSI-resistant cells
(Figure 3-7B). If looping levels to early EBF1 target elements are dynamically regulated
by EBF1 chromatin binding, then these loops should be attenuated following EBF1
knockout. Consistent with this hypothesis, differential in situ HiC analysis after EBF1
genetic deletion in two independent GSI-resistant DND41 lines showed significant
reduction in the frequency of long-range interactions connected to the early EBF1 target
elements (Figures 3-7C and S3-7A, p-value < 2.2E-16). Specifically, loss of EBF1
significantly decreased frequency of interactions connected to 83% of the early EBF1
target sites (Figures 3-7D and S3-7B). Importantly, EBF1 deletion in GSI-resistant cells
significantly reduced expression of MYC, as well as EBF1 target genes activated upon
GSI-resistance (Figures 3-7E and S3-7C). In addition to long-range DNA loops, timecourse in situ HiC analysis further supported the involvement of EBF1 in regulating the
integrity of TAD boundaries, as exemplified by TCRA and IGJ loci (Figures S3-7D and
S3-7E). In concordance with intermediate EBF1 expression (Figure S3-6E), a parentalcell-restricted TCRA TAD boundary was partially disrupted four weeks into treatment
(Figure S3-7D). Conversely, the insulation of a GSI-resistant-cell-restricted IGJ TAD
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boundary gradually increased and was midway between the parental and resistant in fourweek-GSI-treated cells (Figure S3-7E). The time-course chromatin conformation data
further supported the EBF1 role in controlling A/B compartmentalization. This result was
illustrated by the IKZF2 locus, where PC1 and gene expression were partially attenuated
four weeks after GSI treatment; however, the reduction was much greater in the resistant
cells with markedly higher EBF1 expression (Figures S3-7F and S3-6G).
Although our data established a strong link between differential chromatin activity, looping
and gene expression in GSI-resistant cells (Figure 3-4H, 3-J, S3-4I and S3-4J), it was
still unclear whether transcription precedes or follows chromatin restructuring
(Stadhouders et al., 2018). We thus interrogated GSI-resistant-cell-repositioned loci to
identify genes for which changes in the chromatin structures preceded transcriptional
activation. Our data showed that hematopoietic stem cell marker KIT was inactive in
parental, four-week-GSI-treated, EBF1-wildtype GSI-resistant, and EBF1-KO GSIresistant DND41 cells (Figure 3-7F). Interestingly, EBF1 bound to three silent sites that
had been inaccessible in the parental cells and gradually opened chromatin. Concomitant
with activation of EBF1-bound elements, we observed restructuring of the KIT locus
topology. Notably, contact frequencies to the EBF1-bound elements were markedly
increased, as they moved from the repressive B to the permissive A compartment during
GSI-resistant development. Importantly, EBF1 genetic deletion in the resistant cells
significantly reduced opening and looping levels of the three EBF1-induced de novo
accessible elements. Together, these data revealed that the EBF1 requirement for
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activation and positioning of genomic elements can occur independent of transcriptional
activation during GSI-resistance acquisition.
EBF1 derepression confers GSI-resistance in T-ALL
We next sought to elucidate the mechanism of EBF1 derepression in GSI-resistant T-ALL
(Figures 3-4C and S3-4C). In addition to loss of the active form of NOTCH1 in GSIresistant cells (Figure S3-1C), we observed concurrent, but gradual, downregulation of
GATA3, a known EBF1 repressor (Banerjee et al., 2013) (Figure S3-7G). Concomitant
with EBF1 derepression, the E2A-encoding gene TCF3, a known EBF1 activator
(Rothenberg, 2010), was also significantly upregulated in the resistant cells (Figure S37G). Moreover, GATA3 and TCF3 remained unchanged after EBF1 deletion in Cas9expressing resistant cells (Figure S3-7G), consistent with their roles upstream of EBF1.
Intrigued by the data showing coordinated differential activity of EBF1 and its known
regulators (Figures S3-7G and 3-4C), we next examined whether EBF1 repositioning to
the euchromatic nuclear compartment activates its expression. We thus mapped the EBF1
nuclear localization using genomic and optical approaches. Notably, sequencing data
revealed that EBF1 and its 1Mbp flanking region, which was located in the
heterochromatic B compartment and marked by the polycomb-associated H3K27me3
histone mark in GSI-sensitive cells, moved to the euchromatic A compartment and
concomitantly gained substantial chromatin activity and opening in the GSI-resistant cells
(Figures 3-7G and 3-7H). Consistent with sequencing data, time-course optical mapping
of 3D distances between the EBF1 and the Lamin-B1-marked nuclear envelope visualized
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gradual relocalization of EBF1 locus away from the nuclear periphery to the interior
(Figures 3-7I and S3-7H), and further confirmed EBF1 repositioning from B to A
compartment in GSI-resistant cells. Notably, EBF1 genetic deletion did not revert EBF1
locus back to the nuclear envelope in six days (Figure S3-7I). Together, these data
suggest that loss of EBF1 repressors and gain of EBF1 activators repositioned EBF1 from
the nuclear envelope to the interior, thus resulted in its activation that is required for
chromatin reorganization and promotes GSI-resistance (Figures 3-7J).
3.4 Discussion
The role of chromatin folding adaptation in cancer therapy resistance, and its underlying
molecular mechanisms are not well understood (Achinger-Kawecka et al., 2020; Debruyne
et al., 2019). Here, we studied chromatin folding changes in GSI-resistant Notch-mutated
T-ALL to identify underpinning mechanisms of genome topology reorganization in targeted
therapy resistance. Our high-resolution sequencing and optical mapping of genome
topology revealed that the emergence of GSI-resistance affects chromatin folding
structures at various length scales. We found that GSI-resistance selectively repositions
enhancer and promoter elements. Restructuring and repositioning of enhancer elements
allows GSI-resistant NOTCH1-mutated T-ALL cells to repress T-lineage signature
programs, and instead activate genes associated with B cell lineage. Our gain and loss of
function studies elucidated molecular mechanisms of genome refolding. Our data showed
that repression of the T-lineage specific transcription factors TCF1 and LEF1, and
derepression of the B-lineage determining transcription factor EBF1 instructs restructuring
and repositioning of enhancer elements, enabling NOTCH1-mutated T-ALL cells to
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bypass their addiction to oncogenic signals from NOTCH1, a key driver of T cell fate choice
(Taghon et al., 2005). These findings reveal that chromatin misfolding engendered by
lineage-determining transcription factors can result in lineage plasticity and epigenetic
adaptation conferring anticancer therapy evasion in T-ALL (Figure 7J), an observation
which may extend to other cancers.
We and others have demonstrated that chromatin compartments are insensitive to shortterm Notch inhibition (Kloetgen et al., 2020; Petrovic et al., 2019). Here, we identified
widespread reorganization of compartments in T-ALL resistant cells generated by GSImediated long-term Notch inhibition. This observation resembles the role of compartment
switching during T and B lymphocyte differentiation (Hu et al., 2018; Isoda et al., 2017; Lin
et al., 2012; Lin et al., 2010; Stadhouders et al., 2019; Stadhouders et al., 2018). Absence
of Notch signaling promotes B-lineage specification, where Ebf1 nuclear positioning and
activation orchestrates B cell fate choice (Lin et al., 2012; Lin et al., 2010; Taghon et al.,
2005; Treiber et al., 2010). During the pre-B to pro-B cell transition, the Ebf1 locus moves
from the nuclear envelope to the euchromatic interior (Lin et al., 2012). In terminal
differentiation to plasma B cells, Ebf1 nuclear positioning reverses and the Ebf1 locus
moves to heterochromatic-region-associated gamma-satellite DNA and nucleoli (Bortnick
et al., 2020). Analogous studies reported a similar role for compartment switching in T cell
development (Hu et al., 2018; Isoda et al., 2017). During the progression of multipotent
progenitors to double-negative stage 2 (DN2) T cells, the Bcl11b intergenic region
repositions from the nuclear lamina to the interior and thus activates Bcl11b expression
(Isoda et al., 2017). Here, we demonstrated the role of spatial chromatin
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compartmentalization in anticancer therapy resistance (Figures 7J). Our detailed studies
of T-lineage-specific IKZF2 and B-lineage-specific EBF1 loci exemplified widespread
compartment repositioning that promotes transcriptional reprogramming to confer GSIresistance. The capability of Notch1-mutated DND41 leukemic cells to repress T-lineage
transcription factors and programs, while derepressing B-lineage factors and pathways
suggest their distinct developmentally plastic state. In line with these observations, we
found elevated EBF1 and reduced TCF1 expression in primary T-ALL samples classified
as immature compared to the mature subtypes (Homminga et al., 2011; Zhang et al.,
2012) (Figure S3-7J). Although further studies are needed, our findings suggest that
examining higher-order chromatin structures may identify additional nuclear features that
can serve as topological prognostic and diagnostic markers relevant to staging and
treating T-ALL.
Genetic mutations are the most studied cause of drug resistance in T-ALL (Delgado-Martin
et al., 2017; Dieck et al., 2018; O'Neil et al., 2007; Oshima et al., 2020; Palomero et al.,
2007; Sentis et al., 2020). We and others previously described that transcription programs
of a rare population of drug-naive T-ALL cells resemble that of GSI-resistant cells
(Schwartz et al., 2020; Stoeck et al., 2014). However, our genomic sequencing and
detailed epigenetic analyses of the MYC locus revealed that neither activity nor positioning
of MYC enhancers in resistant cells is predetermined. In the absence of oncogenic MYC
mutations, restructuring of the MYC locus enables Notch-addicted T-ALL to switch from a
TCF1/LEF1/NOTCH1-driven regulatory program to an EBF1-driven one to maintain MYC
expression and evade GSI effects (Figure 3-7J). Our observations suggest that when
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facing the long-term challenge of therapies targeting oncogenic-subversion of a cell fate
driving factor, in our case Notch, reactivating alternative pathways through mutation and/or
selection of a drug-tolerant subpopulation are not the only possible mechanisms of
resistance. Instead, intrinsically plastic cancer cells can utilize lineage-determining factors,
normally activated along their cell fate decision trajectory, to adapt their epigenetic
programs. These dynamic epigenetic events, including switching enhancer repertoires
and repacking DNA fiber within the nuclear space, are for the purpose of sustaining critical
survival signals such as MYC; yet, they closely mimic the efforts of normal cells to achieve
accurate spatiotemporal regulation of lineage-specific gene expression. Therefore, our
observations of 1D and 3D genome reorganization driven by T/B-lineage defining factors
in leukemic cells can in turn provide insights into their roles during normal hematopoietic
differentiation, and potentially can be generalized to other non-hematolymphoid normal
and malignant cells driven by other lineage-determining factors. Given that cell-fate choice
involves substantial chromatin reorganization, further work will establish whether lineagedetermining transcription factor-mediated restructuring of chromatin looping is a general
mechanism by which tumor cells co-opt developmental networks to sustain alternative cell
states in response to targeted therapies.
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3.5 Main Figure Titles and Legends
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Figure 3-1: Chromatin compartments and TADs are reorganized in GSI-resistant TALL.
(A) From left to right: cumulative distribution plots showing loss (gain) of active histone
marks H3K27ac and H3K4me1, gain (loss) of repressive histone mark H3K27me3 and
decreased (increased) gene expression in loci switched from A to B (B to A) compartment.
(B) Contact frequency Pearson correlation matrices in parental (top) and GSI-resistant
(bottom) cells at the T-cell-restricted Ikaros family member IKZF2 (Hahm et al., 1998)
locus. Notice that the IKZF2 locus changes from negatively correlated to positively
correlated with its neighboring regions in GSI-resistant cells.
(C) ChIP-seq and Cut&Run (CnR) tracks showing loss of active histone marks H3K27ac
and H3K4me1 and gain of repressive histone mark H3K27me3 at the IKZF2 locus. The
gray box marks Oligopaint DNA FISH probes labeling a 75 Kbp region flanking the IKZF2
promoter. The first principal component (PC1) values of HiC contact Pearson correlation
matrices in parental and GSI-resistant cells show compartment switching from A (>0) to B
(<0). Bottom track indicating IKZF2 gene position, expression fold change and FDR as
determined by DESeq2.
(D) Distances between the IKZF2 promoter and Lamin-B1-marked nuclear envelope
significantly decrease in the GSI-resistant compared to parental cells. Left: cumulative
distribution plots of the closest distance between the IKZF2 promoter and nuclear lamina
in the same cell comparing 126 and 157 alleles in parental and GSI-resistant cells,
respectively. Mean (+/- S.D.) distance in parental and GSI-resistant cells is 0.36 (+/- 0.64)
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µm, and 0.087 (+/- 0.27) µm, respectively (Kolmogorov-Smirnov p-value = 5.56E-10).
Right top: representative parental cell showing IKZF2 located away from the nuclear
envelope from top and side angle views. Right bottom: representative GSI-resistant cell
with IKZF2 on the nuclear envelope from top and zoomed views. Paired images are the
original image and modeled by Imaris.
(E) Pileup plots depicting normalized HiC contact frequencies at TAD boundaries in
parental (top) and GSI-resistant (bottom) cells where the boundary insulation potentials
are decreased (left), increased (middle) or invariant (right) in the GSI-resistant cells. Each
boundary was padded with 250 Kbp flanking regions on both sides. Resolution: 5 Kbp. (F,
G) Normalized HiC contact matrices in parental (top) and GSI-resistant cells (middle) and
insulation profile (bottom) at Immunoglobulin J chain (IGJ) locus (F) and T-cell receptor
alpha (TCRA) locus (G). A TAD boundary is gained at the IGJ locus in GSI-resistant cells
(F). Two TAD boundaries at the TCRA locus lose insulation potential in GSI-resistant cells
(G). Gray arrows: differential boundaries.
(H) Left: ChIP-seq and Cut&Run tracks showing loss of active histone marks H3K27ac
and H3K4me1 and gain of repressive histone mark H3K27me3 at the TCRA locus in GSIresistant cells. SMC1 HiChIP arcs displaying normalized significant interactions among
promoters and enhancers in parental (top) and GSI-resistant (bottom) cells (paired t-test
p-value = 4.11E-8). Bottom track indicating TCRA gene segments, range of expression
fold change and FDR as determined by DESeq2. Oligopaint DNA FISH probes are marked
with gray boxes and labeled above the tracks. Right: Barplots showing normalized HiC
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contacts between probes TCRA-1 and TCRA-2 or TCRA-3 increase (top), while contacts
between TCRA-2 and TCRA-3 decrease (bottom) in GSI-resistant cells.
(I) Distances between TCRA-1, TCRA-2 and TCRA-3 probes significantly decrease in
GSI-resistant cells. Left: representatives of cells and magnified images for 3-color, TCRA1 (yellow)-TCRA-2 (cyan), and TCRA-1 (yellow)-TCRA-3 (magenta), from left to right, in
parental (top) and GSI-resistant (bottom) cells are shown. Locations of three 100 Kbp
Oligopaint probes TCRA-1 (yellow), TCRA-2 (cyan) and TCRA-3 (magenta) are marked
in (H). Right top: cumulative distribution plots of the closest distance between TCRA-1 and
TCRA-2 probes in the same cell are compared between 2,515 parental and 3,418 GSIresistant cells. Mean (+/- S.D.) distance in parental and GSI-resistant cells is 0.92 (+/0.57) µm, and 0.81 (+/- 0.53) µm, respectively (Kolmogorov-Smirnov p-value = 4.15E-10).
Right bottom: cumulative distribution plots of spatial perimeter formed by TCRA-1, TCRA2 and TCRA-3 probes. Mean (+/- S.D.) in parental and GSI-resistant cells is 2.46 (+/- 1.40)
µm, and 2.20 (+/- 1.25) µm, respectively (Kolmogorov-Smirnov p-value = 7.21E-8). Left
bottom: Models representing the relative spatial perimeter formed by the three probes in
parental and GSI-resistant cells based on the cumulative distributions at the TCRA locus.
Blue: DAPI.
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Figure 3-2: GSI-resistance restructures enhancer-promoter loops.
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(A) Pileup plots of normalized HiC contact maps in parental (top) and GSI-resistant
(bottom) cells centered around the long-range contacts with decreased (left), increased
(middle) or invariant (right) interaction frequencies in GSI-resistant compared to parental
cells. Each contact was padded with equal length flanking regions on both sides and
rescaled to 100 bins. Resolution: 5 Kbp.
(B) Barplots depicting the fraction of contacts among enhancers (Enh), promoters (Pro),
CTCF-bound and unannotated elements with decreased (left), invariant (middle) or
increased (right) interaction frequencies in GSI-resistant compared to parental cells.
(C) Cumulative distribution plots showing differential HiC contact frequencies in GSIresistant compared to parental cells as a function of differential H3K27ac load (log2
resistant/parental) on connected enhancers subdivided as quartiles (Q1-4).
(D) Pileup plots of normalized HiC contact maps in parental (top) and GSI-resistant
(bottom) cells centered around the super-enhancers with decreased (left), increased
(middle) or invariant (right) H3K27ac loads in GSI-resistant compared to parental cells.
Each super-enhancer was padded with flanking regions half of its length on both sides
and rescaled to 100 bins. Resolution: 5 Kbp.
(E) Cumulative distribution plots showing differential gene expression as a function of
connected enhancer-promoter (EP) loops with decreased (blue), increased (red) or
invariant (black) contact frequencies in GSI-resistant compared to parental cells. (F)
Boxplot showing differential expression of genes with decreased (left), invariant (middle),
and increased (right) enhancer activity and enhancer-promoter contact in GSI-resistant
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compared to parental cells. p-values: Wilcox rank sum test. (G) Frequency of interactions
between the MYC promoter and Notch-bound super-enhancer E1 significantly decreases
in GSI-resistant cells. Left top: ChIP-seq tracks showing Notch transcription complex
component MAML1 and H3K27ac at the MYC locus marked with matching colors for
position of the probes against the MYC promoter (yellow), Notch-bound super-enhancer
E1 (magenta), and Notch-unbound super-enhancer E2 (cyan) sequences for a 3-color
DNA FISH in Figures 2H and S2G. Bottom track indicating MYC gene, E1 and E2
positions. Left bottom: HiC arcs displaying normalized significant interactions among the
MYC promoter, Notch-bound super-enhancer E1 and Notch-unbound super-enhancer E2.
Right: The quantification of HiC-measured contact frequencies between the MYC
promoter and Notch-bound super-enhancer E1 (top), and the MYC promoter and Notchunbound super-enhancer E2 (bottom) in parental and GSI-resistant cells.
(H) Distances between the MYC promoter and super-enhancers E1 and E2 significantly
increase and decrease in GSI-resistant cells, respectively. Top: representative cells and
magnified images for 3-color, MYC promoter (yellow)-super-enhancer E1 (magenta), and
MYC promoter (yellow)-super-enhancer E2 (cyan), from left to right, in parental and GSIresistant cells are shown. Location of three 50 Kbp MYC promoter (yellow), superenhancer E1 (magenta) and super-enhancer E2 (cyan) for which Oligopaint probes were
designed are marked in 2G. Bottom: Boxplots of distances between the MYC promoter
and the closest MYC enhancer probes in the same cell are compared between parental
(blue, N = 1,652) and GSI-resistant (red, N = 1,694) cells. Mean (+/- S.D.) distance of
MYC promoter-super-enhancer E1 in parental and GSI-resistant cells is 0.399 (+/- 0.176)
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µm, and 0.407 (+/- 0.176) µm, respectively (Wilcox rank sum test p-value = 0.031). Mean
(+/- S.D.) distance of MYC promoter-super-enhancer E2 in parental and GSI-resistant
cells is 0.401 (+/- 0.173) µm, and 0.389 (+/- 0.177) µm, respectively (Wilcox rank sum test
p-value = 8.39E-4). Blue: DAPI.
(I) MYC and NOTCH1 activities are recovered in GSI-resistant cells and GSI-resistant
cells released from GSI (reversed), respectively. Top: Barplots of normalized RNA-seq
reads showing MYC mRNA levels in DMSO-treated parental, 24-hour GSI-treated
parental, GSI-resistant, DMSO-treated reversed, and 24-hour GSI-treated reversed
DND41 cells. Bottom: Immunoblot showing intracellular NOTCH1 (ICN1) and MYC levels
in the same conditions as above. b-Actin is a loading control.

(J) Super-enhancers E1 and E2 are dynamically activated and repositioned during
emergence of GSI-resistance. Left, top five panels from top to bottom: normalized UMI
4C-seq interactions from the MYC promoter viewpoint in DMSO-treated parental, 24-hour
GSI-treated parental, GSI-resistant, DMSO-treated reversed, and 24-hour GSI-treated
reversed DND41 cells. Left, bottom five panels from top to bottom: H3K27ac tracks in the
same conditions as above. Right: quantification of normalized UMI 4C-seq interactions
between the MYC promoter and super-enhancer E1 (top) or the MYC promoter and superenhancer E2 (bottom). Data represent mean ± S.D. of 3 replicates. Student's t-test pvalue: *p < 0.05, **p < 0.01, ****p < 1E-4, *****p < 1E-5, NS p > 0.05.
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Figure 3-3: Differential loading of SMC1, CTCF, or YY1 coincides with refolded
loops.
(A), (B), (C) Pileup plots of normalized HiC contact maps in parental (top) and GSIresistant (bottom) cells centered around the SMC1 (A), CTCF (B) and YY1 (C) peaks with
decreased (left), increased (middle) or invariant (right) protein loading in GSI-resistant
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compared to parental cells. Numbers in parentheses indicate count of differential binding
events for each protein. Each heatmap showing +/- 100 Kbp flanking the center with 5
Kbp resolution.
(D) Boxplots of SMC1 (top), CTCF (middle) and YY1 (bottom) loading at the promoters
(left) and enhancers (right) connected by long-range DNA loops (EP contact) with
decreased, increased or invariant contact frequencies in GSI-resistant compared to
parental cells. p-values: Wilcox rank sum test.
(E) Concordant decrease of architectural protein loading, enhancer activity and DNA loops
associating with downregulation of early cortical thymocyte marker CD1B (Martin et al.,
1987) and CD1E. ChIP-seq tracks showing SMC1, CTCF1, YY1 and H3K27ac decrease
at both the enhancer and promoters of CD1B and CD1E. SMC1 HiChIP arcs displaying
normalized significant enhancer-promoter interactions (paired t-test p-value = 0.039).
Bottom track indicating CD1B and CD1E Ensembl gene positions, expression fold
changes and FDRs as determined by DESeq2.
(F) Concordant increase of architectural protein loading, enhancer activity and DNA loops
associating with upregulation of transcriptional coregulator NRIP1 (Augereau et al., 2006).
ChIP-seq tracks showing SMC1, CTCF1, YY1 and H3K27ac increase at both the
enhancers and promoter of NRIP1. HiC arcs displaying normalized significant interactions
among enhancers and the promoter (paired t-test p-value = 3.06E-6). Bottom track
indicating NRIP1 Ensembl gene position, expression fold change and FDR as determined
by DESeq2.
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Figure 3-4: TCF1/LEF1 and EBF1 differential activity underlies GSI-resistant T-ALL
enhancer positioning.
(A) Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery
rate (FDR) (y axis) in GSI-resistant and parental cells. Each point depicts an accessible
element. 3,107 and 4,109 elements with decreased and increased accessibility in GSIresistant cells are marked in blue and red, respectively. Significance cutoff: DESeq2 FDR
< 1E-5 and log2(fold change) => 1.
(B) Heatmaps displaying normalized ATAC-seq and H3K27ac for each of the 3,107 and
4,109 elements with significantly decreased (top) or increased (bottom) accessibility in
GSI-resistant compared to parental cells, respectively. Each column was centered on
differentially accessible sites per panel A +/- 2 Kbp flanking sequences. Bin size: 50 bp.
(C) Left: HOMER motif enrichment at the sequences with significantly decreased (top) or
increased (bottom) accessibility in GSI-resistant compared to parental cells. Right:
Immunoblot showing that LEF1/TCF1 protein levels in parental DND41 are insensitive to
short-term GSI treatment but decrease in GSI-resistant cells. EBF1 protein is undetectable
in parental cells but is abundant in GSI-resistant cells.
(D), (E) Heatmaps displaying normalized LEF1, TCF1, EBF1 (D), SMC1, CTCF, YY1 (E)
levels at each of the 3,107 and 4,109 elements with significantly decreased (top) or
increased (bottom) accessibility in GSI-resistant compared to parental cells, respectively.
Each column was centered on differentially accessible sites per panel (A) +/- 2 Kbp
flanking sequences with 50 bp resolution.
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(F) Pileup plots of normalized HiC contact maps in parental (top) and GSI-resistant
(bottom) cells centered around the accessible elements with significantly decreased (left),
significantly increased (middle) or invariant (right) accessibility in GSI-resistant compared
to parental cells. Each heatmap showing +/- 100 Kbp flanking the center with 5 Kbp
resolution.
(G) Pileup plots of normalized HiC contact maps in parental (top) and GSI-resistant
(bottom) cells depicting pairwise contact between accessible elements with loss of TCF1
and SMC1 (left); gain of EBF1 and SMC1 (middle); loss of TCF1 and gain of EBF1 and
invariant SMC1 (right) in GSI-resistant cells. Each heatmap showing +/- 100 Kbp flanking
the center with 5 Kbp resolution.
(H) Boxplots of log2 resistant/parental gene expression as a function of combinatorial
decreased (-), invariant (Æ) or increased (+) accessibility of promoters and connected
enhancers. Numbers in parentheses indicate gene counts with each combination of
enhancer and promoter differential accessibility. p-values: Wilcox rank sum test. (I)
Barplots showing the fraction of enhancers only bind EBF1 in GSI-resistant cells, only bind
TCF1 in parental cells, do not bind EBF1 or TCF1 (Neither), or bind TCF1 in parental and
EBF1 in GSI-resistant cells (Either) as a function of connected genes’ differential
expression. Numbers in parentheses indicate gene count per differential expression
condition.
(J) Boxplots of log2 resistant/parental gene expression with differential binding of SMC1
(left), CTCF (middle) and YY1 (right) on the promoter, as a function of TCF1 and EBF1
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levels on connected enhancers. Numbers in parentheses indicate gene counts. p-values:
Wilcox rank sum test.
(K), (L): Diminished long-range interactions connect less accessible enhancers and
downregulated genes during emergence of GSI resistance. ATAC-seq, ChIP-seq and
Cut&Run tracks showing decreased chromatin accessibility, LEF1 and/or TCF1, SMC1,
YY1, H3K27ac and H3K4me1 and increased H3K27me3 levels at distal enhancers of
RAG2 (K) and CD5/CD6 (L), which are significantly downregulated in GSI-resistant cells.
HiC arcs displaying normalized significant contacts among enhancers and promoters in
parental and GSI-resistant cells (paired t-test p-value: RAG2 = 1.57E-6; CD5/CD6 =
4.99E-4). Bottom track indicating Ensembl gene position, log2 resistant/parental
expression fold change and FDR as determined by DESeq2.
(M), (N) Intensified long-range interactions connect more accessible enhancers and
upregulated genes during emergence of GSI resistance. ATAC-seq, ChIP-seq and
Cut&Run tracks showing increased accessibility and EBF1, SMC1, CTCF, YY1, H3K27ac
and H3K4me1 at distal enhancers of HMHB1 (M) and PRDM1 (N), which are significantly
upregulated in GSI-resistant cells. HiC arcs displaying normalized significant contacts
among enhancers and promoters in parental and GSI-resistant cells (paired t-test p-value:
HMHB1 = 4.37E-16; PRDM1 = 1.06E-7). Bottom track indicating Ensembl gene position,
log2 resistant/parental expression fold change and FDR as determined by DESeq2.
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Figure 3-5: EBF1 and TCF1 can instruct looping in Notch-mutated TNBC genome.
(A) Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery
rate (FDR) (y axis) in transduced MB157 cells three days post doxycycline induction
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compared with MB157. From left to right: pINDUCER20-LEF1 (MB157-pInd-LEF1),
pINDUCER20-TCF1 (MB157-pInd-TCF1), and pINDUCER20-EBF1 (MB157-pInd-EBF1).
Each point depicts an accessible element. Elements with significantly decreased or
increased accessibility in ectopic LEF1, TCF1, or EBF1 are marked in blue and red,
respectively. Significance cutoff: DESeq2 FDR < 0.05 and log2(fold change) => 0.5.
Bottom track indicates p-values of HOMER motif enrichment.
(B) Top: Heatmaps displaying normalized ATAC-seq, EBF1, H3K27ac, SMC1, YY1 and
CTCF levels at each of the 8,550 elements with significantly increased chromatin
accessibility in MB157-pInd-EBF1 compared to MB157. Bottom: Heatmaps displaying
normalized ATAC-seq, TCF1, H3K27ac, SMC1, YY1 and CTCF levels at each of the 1,691
elements with significantly increased chromatin accessibility in MB157-pInd-TCF1
compared to MB157. Each column was centered on differentially accessible sites per
panel (A) +/- 2 Kbp flanking sequences with 50 bp resolution.
(C) Pileup plots of normalized SMC1 HiChIP contact maps in MB157 (top) and MB157pInd-EBF1 (bottom) centered around the accessible elements with significantly decreased
(left) or invariant (right) accessibility in MB157-pInd-EBF1 compared to MB157 cells. Each
heatmap showing +/- 100 Kbp flanking the center with 5 Kbp resolution.
(D) Same as C in MB157-pInd-TCF1.
(E) Barplots depicting the fraction of contacts among enhancers (Enh), promoters (Pro),
CTCF-bound and unannotated elements with significant increase in contact frequency in
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MB157-pInd-EBF1 (left) and MB157-pInd-TCF1 (right) or invariant (middle) compared to
MB157 cells.
(F) GSEA analysis showing upregulation of known EBF1 target genes (Nechanitzky et al.,
2013; Treiber et al., 2010) in MB157-pInd-EBF1 compared to MB157 (permutation FDR =
5E-4).
(G) GSEA analysis showing upregulation of MB157-pInd-EBF1 EBF1 targets in GSIresistant compared to parental DND41 (permutation FDR < 1E-5).
(H) EBF1 activates and connects genomic elements at the PHLDA1 locus in two distinct
cell lineages. ATAC-seq and ChIP-seq tracks showing increased accessibility, EBF1,
SMC1 and H3K27ac levels at the PHLDA1 locus in GSI-resistant DND41 T-ALL (left) and
MB157-pInd-EBF1 TNBC (right). SMC1 HiChIP arcs displaying normalized significant
contacts between distal enhancers and PHLDA1. Bottom track indicating Ensembl gene
position, log2 expression fold change and FDR as determined by DESeq2.
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Figure 3-6: EBF1, but not TCF1 or LEF1 alone, is required for the maintenance of
chromatin opening.
(A) Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery
rate (FDR) (y axis) in Cas9-expressing parental DND41 (DND41-Cas9) six days post
transduction with LEF1-targeting (LEF1-KO, left) or TCF1-targeting (TCF1-KO, right)
sgRNAs compared to control sgRNA (Ctrl). Each point depicts an accessible element.
Elements with significantly decreased or increased accessibility in LEF1-KO (left) or
TCF1-KO (right) cells are marked in blue and red, respectively. Significance cutoff:
DESeq2 FDR < 1E-3 and log2(fold change) => 1.
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(B) Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery
rate (FDR) (y axis) in DND41-Cas9 cells three (left), six (middle) or nine (right) days post
simultaneous transduction with LEF1 and TCF1-targeting sgRNAs (LEF1+TCF1-KO)
compared to control sgRNA (Ctrl). Each point depicts an accessible element. Elements
with significantly decreased or increased accessibility in LEF1+TCF1-KO cells are marked
in blue and red, respectively. Significance cutoff: DESeq2 FDR < 1E-3 and log2(fold
change) => 1. Right table showing HOMER motif enrichment at the sequences with
significantly decreased accessibility in LEF1+TCF1-KO compared to Ctrl.
(C) Immunoblot showing EBF1 protein levels decrease in Cas9-expressing GSI-resistant
DND41 (DND41-Res-Cas9) three, six and nine days post transduction with EBF1targeting sgRNA (EBF1-KO) compared to control sgRNA (Ctrl). Calnexin is a loading
control.
(D) Flow cytometry plots (left) and quantification (right) of cell apoptosis and death
measured by Annexin V and ToPro-3 staining. Ctrl and EBF1-KO DND41-Res-Cas9 cells
were sorted three days post lentiviral transduction and cultured for three days.
Representative experiment of 3 biological replicates with 5 technical replicates. Student’s
t-test p-values: ** p < 5E-3; *** p < 1E-4.
(E) Relative cell growth (CellTiter-Glo) in Cas9-expressing GSI-resistant DND41 (DND41Res-Cas9) after transduction with control sgRNA (Ctrl) or EBF1-targeting sgRNA (EBF1KO). Representative data of 3 independent experiments showing mean ± S.D. of 5
biological replicates. Student's t-test p-value = 1.56E-9.
149

(F) Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery
rate (FDR) (y axis) in EBF1-KO versus Ctrl GSI-resistant DND41 cells three (left), six
(middle) or nine (right) days post sgRNA transduction. Each point depicts an accessible
element. Elements with significantly decreased or increased accessibility in EBF1-KO
cells are marked in blue and red, respectively. Significance cutoff: DESeq2 FDR < 1E-3
and log2(fold change) => 1. Right table showing HOMER motif enrichment at the
sequences with significantly decreased accessibility in EBF1-KO compared to Ctrl.
(G) Boxplots showing significant loss of ATAC-seq signal in EBF1-KO versus Ctrl GSIresistant DND41 cells at elements with gain of accessibility in GSI-resistant compared to
parental DND41 cells.
(H) Boxplots showing significant loss of ATAC-seq signal upon EBF1-KO at elements
bound to EBF1 in GSI-resistant DND41.
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Figure 3-7: EBF1 derepression confers GSI-resistance in T-ALL.
(A) Heatmaps displaying normalized ATAC-seq signal in parental, four-week-GSI-treated
and resistant DND41 (left, middle, right), EBF1 signal in parental and resistant DND41,
and ATAC-seq signal in Cas9-expressing GSI-resistant DND41 (DND41-Res-Cas9)
transduced with control sgRNA (Ctrl) or EBF1-targeting sgRNA (EBF1-KO) for each of the
542 EBF1 “early” target elements. Each column was centered on EBF1 early target
elements +/- 2 Kbp flanking sequences. Bin size: 50 bp.
(B) Architectural proteins increase the most at the EBF1 early target elements. Boxplots
showing the log2 fold change of SMC1 (left), YY1 (middle), and CTCF (right) in GSIresistant versus parental DND41 cells as a function of EBF1-dependent accessibility.
EBF1-unbound: EBF1-unbound accessible elements in GSI-resistant DND41; EBF1bound: GSI-resistant EBF1-bound elements without change of accessibility in EBF1-KO;
EBF1 early targets from panel (A). p-values: Wilcox rank sum test.
(C) Boxplots showing the log2 fold change of normalized HiC contact frequencies in GSIresistant versus parental DND41 (left) and EBF1-KO versus Ctrl DND41-Res-Cas9 (right)
as a function of whether GSI-resistant accessible elements are EBF1 early targets. pvalues: Wilcox rank sum t-test.
(D) Heatmaps showing normalized HiC interactions, from top to bottom, in Ctrl or EBF1KO DND41-Res-Cas9; and parental or GSI-resistant DND41. Each column is a loop
connected to EBF1 early targets with decreased contact frequency in EBF1-KO versus
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Ctrl DND41-Res-Cas9 (log2 fold change < -0.5). Rows are sorted in descending order of
contact frequencies in Ctrl DND41-Res-Cas9. p-values: paired t-test.
(E) GSEA analysis showing downregulation of EBF1 targets in GSI-resistant DND41 cells
(Figure S4K) in EBF1-KO compared Ctrl DND41-Res-Cas9.
(F) Chromatin restructuring precedes KIT expression. From top to bottom: the PC1 values
of HiC contact matrices in parental and GSI-resistant cells showing shift from B (<0) to A
(>0) compartment. ChIP-seq and Cut&Run tracks showing gain of active histone marks
H3K27ac and H3K4me1 and loss of repressive mark H3K27me3. Gray boxes mark three
EBF1-bound elements with gradual increase in accessibility in four-week-GSI-treated and
GSI-resistant compared to parental cells, which decreased in EBF1-KO compared to Ctrl
DND41-Res-Cas9 cells. HiC arcs showing normalized contacts among accessible
elements, highlighting gradual increase in HiC contact frequencies in four-week-GSItreated and GSI-resistant compared to parental cells (paired t-test p-value = 2.48E-4),
which decreased in EBF1-KO compared to Ctrl DND41-Res-Cas9 cells (paired t-test pvalue = 0.03). Bottom track indicating KIT gene body location, whose expression was
undetectable in parental, four-week-GSI-treated, GSI-resistant, and DND41-Res-Cas9
cells. ATAC-seq, HiC and RNA-seq of EBF1-KO were conducted 6 days post transduction
of control or EBF1-targeting sgRNAs.
(G) Top: contact frequency Pearson correlation matrices of parental (top triangle) and GSIresistant (bottom triangle) cells at 4 Mbp region flanking EBF1. Notice that the EBF1 locus
changes from negatively correlated to positively correlated with its neighboring regions in
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GSI-resistant cells. Bottom: Zoomed-in normalized HiC contact matrices of parental (top
triangle) and GSI-resistant (bottom triangle) cells at 2 Mbp region flanking EBF1 showing
intensified intra-TAD interactions in GSI-resistant cells.
(H) EBF1 acquired active chromatin state and compartmentalization in GSI-resistant cells.
ATAC-seq, ChIP-seq and Cut&Run tracks showing gain of accessibility and active histone
marks H3K27ac and H3K4me1 and loss of repressive mark H3K27me3 at the EBF1 locus
in GSI-resistant cells. The PC1 values of HiC contact frequency Pearson correlation
matrices in parental and GSI-resistant cells showing shift of EBF1 from B (<0) to A (>0)
compartment. Gray box marking the EBF1-containing TAD boundary and location of
Oligopaint DNA FISH probe set labeled above the tracks.
(I) Distances between EBF1 and Lamin-B1-marked nuclear envelope gradually increase
during GSI-resistance acquisition. Left top: immunoblot showing gradual EBF1 activation
two weeks into GSI treatment. Left bottom: boxplots depicting the closest distance
between EBF1 probe and nuclear lamina in the same cell comparing 98, 98, 97 and 99
cells in parental, two-week-, five-week- and nine-week-GSI-treated conditions. Mean (+/S.D.) distances are: 0.74 (+/- 1.19) µm, 0.72 (+/- 1.20) µm, 1.18 (+/- 1.35) µm and 1.67
(+/- 1.44) µm, respectively. Right, top to bottom: representative two-week-, five-week- and
nine-week-GSI-treated cells showing EBF1 gradually repositions from nuclear envelope
to nuclear interior. Paired images are the original image and modeled by Imaris. b-Actin
is a loading control.
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(J) EBF1 nuclear repositioning instructs chromatin refolding in GSI-resistant T-ALL.
Schematic depicts that repressed B-lineage determining transcription factor EBF1 is
located at the nuclear lamina in parental DND41. Its dissociation from the nuclear envelop
allows for its activation in GSI-resistant cells. This in turn instructs large-scale and
concerted changes in all levels of genome topology organization, and enables GSIresistant cells to switch from a TCF1/LEF1/NOTCH1-driven to an EBF1-driven regulatory
program, which sets epigenetic regulatory networks of key genes including MYC.
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3.6 Supplemental Figure Titles and Legends

Figure S3-1: GSI-resistant T-ALL sustains high GSI dosage and reorganizes its
chromatin. Related to Figure 3-1.
(A) Relative cell growth (CellTiter-glo) of parental and GSI-resistant DND41 cells treated
with the indicated doses of GSI for 6 days. Representative experiment of 3 independent
biological replicates with 5 technical replicates per dose.
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(B) Flow cytometry plots (left) and quantification (right) of cell apoptosis and death
measured by Annexin V and ToPro-3 staining. Parental and GSI-resistant DND41 cells
were treated with 125nM GSI for 6 days. Representative experiment of 3 independent
biological replicates with 3 technical replicates. Student's t-test p-values: *** p < 1E-7.
(C) Immunoblot showing that inhibition of intracellular NOTCH1 (ICN1) for 6 days induces
apoptosis in parental DND41 cells measured by cleaved Caspase-3. GSI-resistant cells
are not apoptotic in the absence of ICN1. b-Actin is a loading control.
(D) qRT-PCR showing repression of known Notch target genes in GSI-treated parental
and GSI-resistant DND41. Treatment same as B. Student's t-test p-values: *** p = 0.
(E) Pairwise Pearson correlation between the PC1 values calculated in parental and GSIresistant HiC and SMC1 HiChIP of contact correlation matrices.
(F), (G) ChIP-seq and Cut&Run tracks showing gain of active histone marks H3K27ac and
H3K4me1, and loss of repressive chromatin mark H3K27me3 at the T cell proliferation
regulator KLF7 (Flotho et al., 2007; Schuettpelz et al., 2012) (F) and the T-ALL-associated
transcription factor ZEB2 (De Coninck et al., 2019) (G) loci. The PC1 values of HiC contact
correlation matrices in parental and GSI-resistant cells show compartment switching from
B (<0) to A (>0). Bottom track indicating gene positions, expression fold changes and
FDRs as determined by DESeq2.
(H) Scatter plots showing highly correlated insulation scores calculated with SMC1 HiChIP
and HiC contact matrices in parental (left) and GSI-resistant (right) DND41.
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(I) Pileup plots depicting normalized SMC1 HiChIP contact frequencies at DND41 TAD
boundaries in parental (top) and GSI-resistant (bottom) cells where the boundary
insulation potentials are decreased (left), increased (middle) or invariant (right) in the GSIresistant cells. Each boundary was padded with 1 Mbp flanking regions on both sides.
Resolution: 5 Kbp.
(J) ChIP-seq and Cut&Run tracks showing segregation of active and repressive histone
marks at the gained TAD boundary, marked by the gray box, near IGJ in GSI-resistant
cells.
(K) Top: ChIP-seq and Cut&Run tracks showing loss of active histone marks H3K27ac
and H3K4me1 and gain of repressive histone mark H3K27me3 at the CD69 locus. Bottom:
Normalized contact matrices in parental and GSI-resistant cells showing two TAD
boundaries (grey arrows and boxes) are strengthened in the GSI-resistant cells
encompassing the gained H3K27me3.
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Figure S3-2: Differential enhancer activities correlate with differential loops in GSIresistant T-ALL. Related to Figure 3-2.
(A) Pileup plots of normalized SMC1 HiChIP contact maps in parental (top) and GSIresistant (bottom) cells centered around the long-range contacts with decreased (left),
increased (middle) or invariant (right) interaction frequencies in GSI-resistant compared
to parental cells. Each contact was padded with equal length flanking regions on both
sides and rescaled to 100 bins. Resolution: 5 Kbp.
(B), (C) Pileup plots of normalized HiC (B) and SMC1 HiChIP (C) contact maps in parental
(top) and GSI-resistant (bottom) cells centered around the H3K27ac ChIP-seq peaks with
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decreased (left), increased (middle) or invariant (right) H3K27ac levels in GSI-resistant
compared to parental cells. Each heatmap showing +/- 100 Kbp flanking the center with 5
Kbp resolution.
(D), (E) Cumulative distribution plots showing differential HiC contact frequency (D) and
differential gene expression (E) in GSI-resistant compared to parental cells as a function
of whether the connected enhancer changes from super-enhancer (SE) to typical
enhancer (TE), remains unchanged, or changes from TE to SE in GSI-resistant compared
to parental cells.
(F) Normalized HiC contact matrices in parental (top) and GSI-resistant cells (middle), and
insulation profile (bottom) at the MYC locus (F) showing invariant TAD boundaries.
(G) Distances between the MYC promoter and super-enhancers E1 and E2 remain
unchanged in short-term GSI-treated parental DND41. Left: representative of cells and
magnified images for 3-color, MYC promoter (yellow)-super-enhancer E1 (magenta), and
MYC promoter (yellow)-super-enhancer E2 (cyan), from left to right, in parental DND41
treated with DMSO or 125 nM GSI for 24 hours are shown. Location of three 50 Kbp MYC
promoter (yellow), super-enhancer E1 (magenta) and super-enhancer E2 (cyan) for which
Oligopaint probes were designed are marked in Figure 2G. Right: Boxplots of distances
between the MYC promoter and the closest MYC enhancers E1 and E2 probes in the
same cell are compared between DMSO (blue, N = 1,652) and GSI-treated (grey, N =
1,323) cells. Mean (+/- S.D.) distance of MYC promoter-E1 in DMSO and GSI-treated cells
are 0.399 (+/- 0.176) µm, and 0.392 (+/- 0.175) µm, respectively (Student’s t-test p-value
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= 0.1). Mean (+/- S.D.) distance of MYC promoter-E2 in DMSO and GSI-treated cells are
0.401 (+/- 0.173) µm, and 0.399 (+/- 0.171) µm, respectively (Student’s t-test p-value =
0.6). Blue: DAPI.
(H) Selected pathways enriched with genes downregulated in GSI-treated parental cells
and re-expressed in GSI-resistant DND41. MSigDB was used for analysis of functional
gene annotation.
(I) Relative cell growth (CellTiter-Glo) in Cas9-expressing parental (left, DND41-Cas9) and
Cas9-expressing GSI-resistant (right, DND41-Res-Cas9) DND41 cells after transduction
with control sgRNA (Ctrl) or MYC-targeting sgRNA (MYC-KO). Representative data of 3
independent experiments showing mean ± S.D. of 5 technical replicates. p-values:
Student’s t-test.
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Figure S3-3: SMC1, CTCF and YY1 chromatin binding redistribution coincides with
differential loops in GSI-resistant cells. Related to Figure 3-3.
(A) Immunoblot showing invariant SMC1, CTCF and YY1 protein levels in DMSO-treated
parental, 24-hour GSI-treated parental, GSI-resistant, DMSO-treated reversed, and 24hour GSI-treated reversed DND41 cells. Calnexin is a loading control.
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(B), (C), (D): Pileup plots of normalized SMC1 HiChIP contact maps in parental (top) and
GSI-resistant (bottom) cells centered around the SMC1 (B), CTCF (C) and YY1 (D) peaks
with decreased (left), increased (middle) or invariant (right) protein loading in GSI-resistant
compared to parental cells. Numbers in parentheses indicate count of differential binding
events for each protein. Each heatmap showing +/- 100 Kbp flanking the center with 5
Kbp resolution.
(E) Boxplots of SMC1 (left), CTCF (middle) and YY1 (right) loading at the anchors of longrange DNA loops with decreased, increased or invariant interaction frequencies in GSIresistant compared to parental cells. p-values: Wilcox rank sum test.
(F) Cumulative distribution plots showing differential HiC contact frequencies in GSIresistant compared to parental cells as a function of differential SMC1 (left), CTCF
(middle) and YY1 (right) levels (log2 resistant/parental) at loop anchors subdivided as
quartiles (Q1-4).
(G) Boxplots of differential HiC contact frequencies in GSI-resistant compared to parental
cells as a function of combinatorial decreased (-), invariant (Æ) or increased (+) levels of
SMC1, CTCF and YY1. Numbers in parentheses indicate count of binding events for each
combination of proteins. p-values: Wilcox rank sum test.
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Figure S3-4: Differential activity of LEF1/TCF1 and EBF1 orchestrates epigenetic
and transcriptomic changes in GSI-resistance. Related to Figure 3-4.
(A) Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery
rate (FDR) (y axis) in parental DND41 cells treated with DMSO or 125 nM GSI for 24
hours. Each point depicts an accessible element, color coded by blue, red, and black
based on whether it significantly decreases, increases, or does not change accessibility
in GSI-treated parental cells. Significance cutoff: FDR < 1E-5 and log2(fold change) => 1.
(B) Heatmaps displaying normalized H3K4me1 (left) and H3K27me3 (right) levels at each
of the 3,107 and 4,109 elements with significant decrease (top) or increase (bottom) of
accessibility in GSI-resistant compared to parental cells, respectively. Each column of
H3K4me1 (H3K27me3) was centered on differentially accessible sites per Figure 4A +/12.5 (25) Kbp flanking sequences with 250 bp resolution.
(C) Expression of TCF and EBF family members in parental and GSI-resistant cells
measured by RNA-seq. FDR was calculated by DESeq2.
(D) Pileup plots of normalized SMC1 HiChIP contact maps in parental (top) and GSIresistant (bottom) cells centered around the accessible elements with significantly
decreased (left), increased (middle) or invariant (right) accessibility in GSI-resistant
compared to parental cells. Each heatmap showing +/- 100 Kbp flanking the center with 5
Kbp resolution.
(E) Pileup plots of normalized SMC1 HiChIP contact maps in parental (top) and GSIresistant (bottom) cells depicting pairwise contact between accessible elements with loss
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of TCF1 and SMC1 (left); gain of EBF1 and SMC1 (middle); loss of TCF1 and gain of
EBF1 and invariant SMC1 (right) in GSI-resistant cell. Each heatmap showing +/- 100 Kbp
flanking the center with 5 Kbp resolution.
(F), (G) Same as E for CTCF (F) and YY1 (G) on normalized HiC (top) and SMC1 HiChIP
(bottom) contact maps.
(H) GSEA analysis showing the enrichment of T-cell-related genes versus B-cell-related
genes in parental versus GSI-resistant DND41 cells.
(I) Selected gene-ontology terms and pathways enriched for TCF1 target genes, which
are defined as downregulated genes with loss of TCF1 binding at their promoters or
connected distal enhancers during GSI-resistance development. MSigDB was used for
analysis of functional gene annotation.
(J) ATAC-seq, ChIP-seq and Cut&Run tracks showing decreased chromatin accessibility,
LEF1, TCF1, SMC1, CTCF, YY1, H3K27ac and H3K4me1 levels and increased
H3K27me3 level at the LEF1 promoter in parental compared to GSI-resistant cells. Bottom
track indicating Ensembl gene position.
(K) Selected gene-ontology terms and pathways enriched for EBF1 target genes, defined
as upregulated genes with gain of EBF1 binding at their promoters or connected distal
enhancers in GSI-resistant cells. MSigDB was used for analysis of functional gene
annotation.
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(L) ATAC-seq, ChIP-seq and Cut&Run tracks showing increased chromatin accessibility,
EBF1, SMC1, YY1, H3K27ac and H3K4me1 levels at the CD79A promoter. Bottom track
indicating Ensembl gene position.
(M) MYC super-enhancer E1 loses LEF1, TCF1 and active chromatin marks in GSIresistant cells. Gray boxes marking elements with differential TCF1/LEF1 and EBF1 levels
in parental and GSI-resistant cells. Orange arrows marking differentially accessible
elements. Notably, the most 5’ element at the super-enhancer E1 region binds EBF1
instead of TCF1 and remains open in GSI-resistant cells.
(N) MYC super-enhancer E2 gains EBF1 and active chromatin marks in GSI-resistant
cells. Gray boxes marking elements with differential TCF1/LEF1 and EBF1 levels in
parental and GSI-resistant cells. Orange arrows marking differentially accessible
elements.
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Figure S3-5: Ectopic TCF1 and EBF1 instruct DNA loops and respectively induce Tand B- cell-specific transcriptional programs in TNBC. Related to Figure 3-5.
(A) Immunoblot showing ectopic expression of LEF1, TCF1 and EBF1 and invariant SMC1
and YY1 levels in MB157 cells transduced with pInducer20 plasmids carrying the
corresponding genes three days after adding 10 μg/ml doxycycline. Endogenously,
MB157 cells do not express these proteins. Calnexin is a loading control.
(B), (C): EBF1 induces chromatin accessibility and DNA loops in MB157 TNBC. ATACseq and ChIP-seq tracks showing increased accessibility, EBF1, SMC1 and H3K27ac
levels at distal enhancers connect to HEY2 (B) or IL15RA (C), which are significantly
upregulated in MB157-pInd-EBF1. SMC1 HiChIP arcs displaying normalized significant
contacts among enhancers and promoters in MB157 and MB157-pInd-EBF1 (paired t-test
p-value 7.05E-8). Bottom track indicating Ensembl gene position, log2 MB157-pIndEBF1/MB157 expression fold change and FDR as determined by DESeq2.
(D), (E): Boxplots showing the log2 fold change of SMC1 (left), YY1 (middle) and CTCF
(right) levels at elements with significant gain of DNA looping, EBF1 (D) or TCF1 (E)
binding, and accessibility in MB157-pInd-EBF1 (D) or MB157-pInd-TCF1 (E) compared to
MB157 cells. p-values: Wilcox rank sum test.
(F) Boxplots showing the log2 fold expression change in genes connected to elements
with significant gain of accessibility and EBF1 in MB157-pInd-EBF1 (left) or TCF1 in
MB157-pInd-TCF1 (right) compared to MB157 cells. p-values: Wilcox rank sum test.
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(G) Boxplots of log2 gene expression in MB157-pInd-EBF1 (left) or MB157-pInd-TCF1
(right) versus MB157 as a function of combinatorial increased (+) or invariant (Æ)
accessibility of promoters and connected enhancers. p-values: Wilcox rank sum test.
(H) Boxplots of log2 gene expression in MB157-pInd-EBF1 (left) or MB157-pInd-TCF1
(right) versus MB157 as a function of connected enhancers’ combinatorial increased (+)
or invariant (Æ) activity and interaction frequency. p-values: Wilcox rank sum test.

(I), (J) Selected gene-ontology terms and pathways enriched for EBF1 (I) or TCF1 (J)
target genes, which are defined as upregulated genes with gain of EBF1 (I) or TCF1 (J)
binding at their promoters or connected distal enhancers in MB157-pInd-EBF1 (I) or
MB157-pInd-TCF1 (J) compared to MB157 cells. MSigDB was used for analysis of
functional gene annotation.
(K) GSEA analysis showing upregulation of EBF1 targets in GSI-resistant DND41 cells
(Figure S4K) in MB157-pInd-EBF1 compared to MB157.
(L) EBF1 ChIP-seq tracks in GSI-resistant DND41 and MB157-pInd-EBF1 at CD79A (left)
and E2A-encoding gene TCF3 (right) promoters showing binding of EBF1 to the same loci
in GSI-resistant DND41 T-ALL and MB157-pInd-EBF1 TNBC cells. Bottom track indicating
Ensembl gene positions, log2 expression fold changes and FDRs as determined by
DESeq2.
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Figure S3-6: Loss of EBF1 and LEF1/TCF1 reduces chromatin accessibility in
transformed B and T cells. Related to Figure 3-6.
(A) Immunoblot showing reduction of TCF1 and LEF1 protein levels in Cas9-expressing
parental DND41 (DND41-Cas9) cells three days post transduction with LEF1-targeting
(LEF1-KO), TCF1-targeting (TCF1-KO) or both LEF1- and TCF1-targeting (LEF1+TCF1KO) sgRNAs compared to control sgRNA (Ctrl). Calnexin is a loading control.
(B) Relative cell growth of (CellTiter-Glo) Ctrl and LEF1+TCF1-KO DND41-Cas9.
Representative data of 3 independent experiments showing mean ± S.D. of 5 biological
replicates. Student’s t-test p-value: 1.44E-6.
(C) Immunoblot showing reduction of TCF1 and LEF1 protein levels in Cas9-expressing
Jurkat E6-1 (Jurkat-Cas9) cells three days post transduction with LEF1-targeting (LEF1KO), TCF1-targeting (TCF1-KO) or both LEF1- and TCF1-targeting (LEF1+TCF1-KO)
sgRNAs compared to control sgRNA (Ctrl). Calnexin is a loading control.
(D) Volcano plots showing ATAC-seq signal fold enrichment (x axis) versus false
discovery rate (FDR) (y axis) in Jurkat-Cas9 TCF1-KO (left) and LEF1+TCF1-KO (right)
compared to Ctrl. Each point depicts an accessible element. Elements with significantly
decreased or increased accessibility in TCF1-KO or LEF1+TCF1-KO cells are marked in
blue and red, respectively. Significance cutoff: DESeq2 FDR < 1E-3 and log2(fold change)
=> 1. Right table showing HOMER motif enrichment at the sequences with significantly
decreased accessibility in LEF1+TCF1-KO compared to Ctrl.
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(E) Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery
rate (FDR) (y axis) in the second biological replicate of EBF1-KO versus Ctrl GSI-resistant
DND41 cells three (left), six (middle) or nine (right) days post sgRNA transduction. Each
point depicts an accessible element. Elements with significantly decreased or increased
accessibility in EBF1-KO cells are marked in blue and red, respectively. Significance
cutoff: DESeq2 FDR < 1E-3 and log2(fold change) => 1. Right table showing HOMER
motif enrichment at the sequences with significantly decreased accessibility in EBF1-KO
compared to Ctrl.
(F) Relative cell growth (CellTiter-glo) of parental, four-week-GSI-treated, eight-week-GSItreated and GSI-resistant ( > 12 weeks) DND41 cells plated with the indicated doses of
GSI for 6 days. Live cells among four-week- and eight-week-GSI-treated cells were FACSsorted prior to plating. Representative experiment of 2 independent biological replicates
with 5 technical replicates per dose. (G) Time-course immunoblot showing ICN1 inhibition,
rapid TCF1 decrease, and gradual EBF1 increase in the FACS-sorted live cells during 10
weeks of GSI treatment. Calnexin is a loading control.
(H) Time-course qRT-PCR showing MYC expression dynamics and DTX1, LEF1 and
TCF7 repression in the FACS-sorted live cells during GSI-resistance acquisition. Student's
t-test p-value: **p < 5E-3, ***p < 5E-4, ****p < 1E-4, NS p > 0.05.
(I) Left: volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false
discovery rate (FDR) (y axis) in four-week-GSI-treated versus parental DND41 cells. Each
point depicts an accessible element. Elements with significantly decreased or increased
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accessibility in four-week-GSI-treated cells are marked in blue and red, respectively.
Significance cutoff: DESeq2 FDR < 1E-5 and log2(fold change) => 1. Right: table showing
HOMER motif enrichment at the sequences with significantly increased or decreased
accessibility in four-week-GSI-treated compared to parental cells.
(J) heatmaps displaying normalized ATAC-seq signal in parental, four-week-GSI-treated
and resistant cells at each of the 3,107 and 4,109 elements with significantly decreased
(top) or increased (bottom) accessibility in GSI-resistant compared to parental cells,
respectively. Each column was centered on differentially accessible sites per Figure 4A
+/- 2 Kbp flanking sequences. Bin size: 50 bp.
(K) MYC super-enhancer E1 and E2 (grey boxes) partially loses and gains chromatin
accessibility in four-week-GSI-treated cells, respectively.
(L) Immunoblot showing EBF1 and MYC proteins in Cas9-expressing mantle cell
lymphoma Granta519 (Granta519-Cas9) cells three, six and nine days post transduction
with control (Ctrl) or EBF1-targeting (EBF1-KO) sgRNA. Calnexin is a loading control.
(M) Relative cell growth (CellTiter-Glo) in Ctrl and EBF1-KO Granta519-Cas9.
Representative data of 3 independent experiments showing mean ± S.D. of 5 technical
replicates. Student’s t-test p-value: 1.67E-6.
(N) Flow cytometry plots (left) and quantification (right) of cell apoptosis and death
measured by Annexin V and ToPro-3 staining. Ctrl and EBF1-KO Granta519-Cas9 were
sorted three days post lentiviral transduction and cultured for three days. Representative
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experiment of 3 biological replicates with 5 technical replicates. Student’s t-test p-value:
***** p < 1E-5.
(O) Immunoblot showing loss of EBF1 induces cell apoptosis measured by cleaved
Caspase-3 in unsorted EBF1-KO Granta519-Cas9 three, six, and nine days post lentiviral
transduction. Calnexin is a loading control.
(P) Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery
rate (FDR) (y axis) in EBF1-KO versus Ctrl Granta519-Cas9 cells three days post sgRNA
transduction. Each point depicts an accessible element. Elements with significantly
decreased or increased accessibility in EBF1-KO cells are marked in blue and red,
respectively. Significance cutoff: DESeq2 FDR < 1E-3 and log2(fold change) => 1.
(Q) Immunoblot showing ICN1 and ectopic EBF1 expression levels in Notch-addicted TALL HPB-ALL and KOPTK1 cells transduced with TRE3G-EBF1 and pINDUCER21-EBF1
plasmids, respectively. Doxycycline: 0.5 μg/mL for 72 hours; GSI: 1 μM for 24 hours.
Representative of two independent biological replicates. b-Actin is a loading control.

(R) Relative cell growth (CellTiter-glo) of HPB-ALL-TRE3G-EBF1 and KOPTK1-pInd21EBF1 cells plated with the indicated doses of GSI with or without 0.5 μg/mL doxycycline
for 6 days. Representative experiment of 2 independent biological replicates with 5
technical replicates per dose.
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Figure S3-7: EBF1 and TCF7 expression levels are associated with immature and
mature T-ALL subtypes, respectively. Related to Figure 3-7.
(A) Boxplots showing the log2 fold change of normalized HiC contact frequencies in GSIresistant versus parental DND41 (left) and EBF1-KO versus Ctrl DND41-Res-Cas9 (right,
second biological replicate) as a function of whether GSI-resistant accessible elements
are EBF1 early targets. p-values: Wilcox rank sum t-test.
(B) Heatmaps showing normalized HiC interactions, from top to bottom, in the second
biological replicate of Ctrl or EBF1-KO DND41-Res-Cas9; and parental or GSI-resistant
DND41. Each column is a loop connected to EBF1 early targets with decreased contact
frequency in EBF1-KO versus Ctrl DND41-Res-Cas9 (log2 fold change < -0.5). Rows are
sorted in descending order of contact frequencies in Ctrl DND41-Res-Cas9. p-values:
paired t-test.
(C) Expression of MYC, CD79A and PHLDA1 in parental and GSI-resistant cells
measured by RNA-seq in Ctrl or EBF1-KO DND41-Res-Cas9. FDR: DESeq2.
(D), (E): Normalized HiC contact matrices in parental (top), four-week-GSI-treated
(middle) and GSI-resistant cells (bottom) showing gradual loss and gain of TAD boundary
insulation potential at T-cell receptor alpha (TCRA) (D) and Immunoglobulin J chain (IGJ)
(E) loci. Gray arrows: differential boundaries.
(F) The first principal component (PC1) values of HiC contact Pearson correlation matrices
at the IKZF2 locus in parental, four-week-GSI-treated and GSI-resistant cells showing
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gradual compartment switching from A (>0) to B (<0). Bottom track indicating IKZF2 gene
position, expression fold change and FDR were determined by DESeq2.
(G) Known positive and negative EBF1 regulators are differentially expressed in parental,
four-week-GSI-treated and GSI-resistant cells, but not in EBF1-KO Cas9-expressing GSIresistant DND41 cells (DND41-Res-Cas9). Log2 fold change and FDR for gene
expression were determined by DESeq2.
(H) Dark exposure of Figure 7I showing gradual increase of EBF1 expression in DND41
during GSI treatment.
(I) Distances between EBF1 and Lamin-B1-marked nuclear envelope do not significantly
change in EBF1-KO DND41-Res-Cas9 compared to Ctrl. Left: boxplots of the closest
distance between EBF1 probe and nuclear lamina in the same cell comparing 95 and 99
nuclei in Ctrl and EBF1-KO cells. Mean (+/- S.D.) distance in Ctrl and EBF1-KO cells are
1.61 (+/- 1.41) µm, and 1.67 (+/- 1.46) µm, respectively (Wilcox p-value = 0.78).
Representative Ctrl (Middle) and EBF1-KO (right) DND41-Res-Cas9 cells showing EBF1
remains at the nuclear interior six days post sgRNA lentiviral transduction.
(J) EBF1 and TCF7 (gene encoding for TCF1) expression levels are positively and
negatively associated with immature/early thymic progenitor (ETP) T-ALL subtypes,
respectively. Normalized gene expression of EBF1, TCF7 and KIT from two independent
T-ALL patient cohorts GSE26713 and GSE28703 (Homminga et al., 2011; Zhang et al.,
2012).
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CHAPTER 4: PERSPECTIVES AND FUTURE DIRECTIONS
4.1 Limitations in Methodology
In both of my studies, I primarily employed in vitro cell line systems for in-depth molecular
examination of GSI-sensitivity and GSI-resistance, as well as the roles of NOTCH1, EBF1
and TCF1 in genome folding regulation. Cell line models are excellent venues as they’re
not limited by sample availability, cell number and genetic manipulation approaches, yet
they generally lack physiological relevance to the actual diseases. Many hallmarks of
cancer, such as cellular signaling and microenvironment are absent from the cell culture
studies. Thus, to explore the contribution of oncogenic NOTCH1 to chromatin looping and
the link between EBF1 derepression and GSI-resistance, using in vivo models could better
define the clinical relevance and precisely reveal how and when they contribute to tumor
progression and treatment response.
Although GSI allows rapid and prolonged inhibition of Notch signaling, its application is
limited to only a few cell lines of the diseases studied here. Out of six NOTCH1-mutated
T-ALL lines where GSI is known to be cytotoxic (DND41, KOPTK1, Cuttl-1, HPB-ALL,
TALL-1, ALL-SIL) and I attempted to generate GSI-resistant cells, only DND41 exhibits
EBF1 activation during GSI-resistance acquisition (detailed discussion in section 4.5). GSI
is also not applied in clinical settings due to non-specificity and severe gastrointestinal
toxicity. It has been previously shown that combination therapy of GSI and glucocorticoids
in T-ALL can improve its antileukemic effect and reduce its gut toxicity in vivo (SanchezMartin et al., 2017). On the other hand, dominant negative form of MAML1 allows
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formation of inactive Notch complex on the chromatin by preventing recruitment of histone
acetyltransferase (Maillard et al., 2008). Therefore, using other ways of Notch inhibition in
both cell line and mouse models that can circumvent the limitations of GSI will allow us to
test the function of Notch signaling in genome folding in a wider range of systems.
The main genetic approach used in my studies is CRISPR-based methods starting from
72 hours post sgRNA transduction. The use of rapid protein degradation technologies,
which could separate immediate from secondary effects of differential transcription factor
activity, will enable closer examination of their role in genome folding regulation. Further
refined time-course studies could more precisely dissect the kinetics of adaptation to GSI
treatment and elucidate underlying mechanisms of transcriptional reprogramming and
EBF1 derepression during GSI-resistance acquisition.
4.2 Functions of 3D Cliques
Without chromatin conformation capture techniques, the association between regulatory
elements and promoters is mainly determined by proximity (Wang et al., 2016). This
method has its merits especially when combined with motif analysis and GWAS (Brown
et al., 2013; McLean et al., 2010), but in many cases it can be misleading. A classic
example is the obesity-associated variants within FTO that do not associate with the
expression of FTO but connects to the IRX3 gene ~0.5 Mb away and drive its expression
(Smemo et al., 2014). In cancer cells, where genomic rearrangements and mutations are
frequent, 3D genome information is particularly useful in identifying the correct regulatory
elements of pro-survival genes. For instance, in Notch mutated T-ALL, the H3K27ac peaks
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closest to MYC are ~50 Kb downstream overlapping with the long non-coding RNA gene
PVT1, but the enhancers driving MYC expression are ~1.3 Mb downstream of the MYC
promoter (Figure 3-2) (Yashiro-Ohtani et al., 2014). Similarly in acute myeloid leukemia,
the MYC enhancer clusters are located 1.7 Mb downstream from the promoter (Shi et al.,
2013). Our ability to generate high-resolution genome-wide and locus-specific 3D genome
maps in drug-naïve and drug-resistant cells allows us to link the mega-base away
enhancers to their target genes, and more importantly, examine the changes in their
activity and looping levels in association with differential gene expression.
However, identifying single enhancer-promoter connection does not necessarily provide
the full picture of the complex regulatory network around key oncogenes such as MYC.
The individual enhancers at MYC locus in TNBC are not the strongest enhancers, and
each only contributes mildly to the expression of MYC (Figure 2-5). Our 3D clique analysis
reveals that the MYC enhancer clusters are closely positioned and functionally
cooperating in the nuclear space (Figure 2-6). Besides MYC, the top-ranking 3D cliques
in TNBC and MCL encompass other genes potentially important for the disease such as
SOX9, IL10RA and PAX5 (Figures 2-6, S2-6). Intriguingly, the rank of the MYC clique is
the same in parental and GSI-resistant T-ALL cells (data not shown) where the cells
switched from using two enhancers to one stronger enhancer to maintain the expression
of MYC (Figure 3-2), suggesting that it is not just the number of enhancers, but the
strength of enhancers and their connection with the promoter that matters in regulating
gene expression.
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This further raises the question of how each enhancer element contributes to the function
of the whole clique. The sequencing-based 3D genome assays implemented here can
measure enhancer-promoter contacts at kilobase resolution, but their outputs are
aggregation or average of millions of cells. As a first attempt to examine the contact
between MYC promoter and individual enhancer in single cells of TNBC, I performed
three-color Oligopaint DNA FISH with probes labeling the MYC promoter (yellow),
enhancer 1 (E1, cyan) and enhancer 4 (E4, magenta). Notice that the enhancer ~65kb to
MYC promoter E5 was not used in this experiment due to potential limitation of resolution
in confocal microscopy. In agreement with sequencing data (Figure 4-1A), measurement
of distances between promoter and enhancer foci showed that contact frequencies
between MYC, E1 and E4 reduced and the overall size of MYC clique increased in 794
GSI-treated cells compared to 719 untreated cells (Figure 4-1B and 4-1C). Around 30%
of the cells have both enhancers positioned close to MYC (< 500 nm) and 40% have either
enhancer in proximity to the MYC promoter, while the percentage of cells with neither
enhancer-promoter contact increased by 10% upon GSI treatment (Figure 4-1B and 41D). These data suggest that the positioning of E1 and E4, two out of five enhancer
clusters 5’ of MYC, is dynamic and variable across the population of TNBC cells. In my
post-graduation work, I will more comprehensively investigate the MYC 3D clique by 1)
performing three-color Oligopaint DNA FISH with other enhancer/enhancer or
enhancer/promoter combinations to examine point-to-point contacts within the clique 2)
performing sequential DNA FISH labeling of the MYC 5’ region to reconstruct the folding
of MYC clique 3) performing DNA FISH in combination with genetic approaches to silence
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or disrupt enhancers and in combination with MYC RNA FISH to functionally associate the
activity and looping of enhancers with MYC transcriptional output.
4.3 Putative Mechanisms of How Notch Regulates Chromatin Loops
Knowing that Notch inhibition and reactivation can rapidly modulate enhancer-promoter
contacts, the question remains what mechanisms Notch uses to mediate looping, and the
followings are my speculated models. Firstly, based on the genomic data (Figure 4-1A),
the Notch binding sites on the enhancers can potentially serve as anchors for pausing
loop extrusion, and the stronger the Notch binding, the more likely that loop extrusion
pauses at the enhancer and hence the higher the 4C signal. Loss of Notch binding leads
to more free extrusion at the locus which corresponds to decreased 4C signals on E1, E2
and E5 but increased signals between enhancers. This is not due to CTCF loading as only
E2 and the promoter are bound by CTCF (data not shown). To test this hypothesis, I will
first perform ChIP-seq of SMC1, NIPBL and WAPL with GSI treatment and examine
whether loading or removal of the cohesin complex has changed due to GSI treatment.
Furthermore, I will use inducible dominant-negative MAML1 to test whether the presence
or activation of Notch transcription complex is required for the maintenance of enhancerpromoter loops. If the presence of Notch complex is sufficient for looping, then dnMAML1
should not affect the level of enhancer-promoter loops. If acetylation of the enhancers is
required for looping, then inhibition of the histone acyltransferase P300 should have the
same effect on looping as Notch inhibition. Completing these experiments will elucidate
whether Notch regulates looping, at least at the MYC locus, through cohesin, enhancer
activation or other mechanisms.
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Another possible model is that the MYC enhancers and promoter form a phase-separated
condensate upon intra-cellular Notch activation, which is dissolved when Notch is
inhibited. The N terminus of intracellular NOTCH1 (ICN1) encompasses an intrinsically
disordered RAM (recombination binding protein-Jκ-associated molecule) region that
interacts with the DNA-binding factor RBPJ (Sherry et al., 2017). Furthermore, the first
ankyrin repeat of the ankyrin repeat (ANK) domain that is necessary and sufficient for
recruitment of MAML1 to the RBPJ-ICN complexes is also disordered (Bondos et al.,
2022; Zweifel et al., 2003). To test whether MYC clique forms a Notch-dependent phaseseparated unit in TNBC, I will perform immunofluorescence with members of the Notch
complex in combination of Oligopaint DNA FISH labeling the MYC promoter and
enhancers with and without GSI treatment. Furthermore, I can test whether the RAM and
ANK domains are sufficient for inducing phase-separation by using inducible systems of
these domains in cells that do not express ICN1 or in vitro. These experiments will allow
us to understand whether Notch has a role in phase separation in general, and whether
Notch can bring larger aggregates of regulatory elements in space for MYC promoter to
access.
4.4 Selection versus Adaptation
It has always been controversial whether cells that become resistant to drug treatment are
intrinsically insensitive to the drug or gradually adapted to the treatment. In our studies of
GSI-resistant T-ALL, we observed both events. Using single-cell RNAseq (Figure 4-2A)
and RNA FISH (Figure 4-2B), we identified a small subset of parental T-ALL cells that are
transcriptionally similar to the resistant cells (Schwartz et al., 2020), suggesting that a
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subclone of parental cells could contribute to the final GSI-resistant population. However,
single-cell ATACesq revealed that the chromatin accessibility profile on the two MYC
enhancers are heterogenous, and most parental and resistant cells have both enhancer
accessible, suggesting that it is not just selection of a small clone that solely depends on
E2 (Figure 4-2C). Furthermore, our GSI reversal experiment (Figure 3-2I and 3-2J) also
suggest that the Notch-bound enhancer can be reactivated and repositioned to the MYC
promoter when Notch is reintroduced, suggesting that the chromatin structures in GSIresistant cells are not predetermined or fixed. One potential experiment to test whether
resistance is acquired or selected is to barcode individual parental cells. By sampling the
population throughout the time course of 12-week GSI treatment, we can examine whether
one or a few single cells predominantly contribute to the resistant population, or a mixture
of parental cells gradually adapted their chromatin activities to acquire GSI-resistance.
4.5 Activation of Lineage-determining Factors as a Mechanism of Drug Resistance
The intriguing case of T to B cell lineage switching under Notch inhibition in GSI-resistant
DND41 cells shows an example of how cancer cells can take advantage of their
developmental status to evade targeted therapies. However, among the GSI-sensitive TALL cell lines that I tested, DND41 is the only one that exhibits EBF1 activation during
resistance acquisition. Interestingly, another GSI-sensitive T-ALL line KOPTK1 increases
chromatin accessibility and H3K27ac at regions enriched for the recognition sequences of
LEF1 and TCF1 when it acquires GSI-resistance (Figure 4-3A and 4-3B). Similar to
DND41, Notch signaling pathway and its target genes remain inactive, but MYC
expression recovered in the GSI-resistant KOPTK1 cells (Figure 4-3C and 4-3D). RNA185

seq and immunoblotting further confirmed higher levels of LEF1 and TCF1 in the resistant
cells (Figure 4-3C and 4-3D), suggesting that in this cell line, the acquisition of GSI
resistance is possibly through reinforcement of the T lineage transcription profile.
Besides T-ALL, I also attempted to generate GSI-resistant MCL and TNBC cells. In GSIresistant MCL line Rec1, intracellular NOTCH1 is reactivated potentially through
acquisition of secondary mutations (data not shown), as these cells are known to have
highly unstable genomes prone to structural variations (Ryan et al., 2015). In TNBC line
MB157, GSI-resistance cannot be established with the same method applied in T-ALL and
MCL. My speculation is that Notch1 is a crucial factor for determining T cell development
and its loss in T-ALL cells affects their identities at various degrees depending on where
these cells originated from in the developmental trajectory. In MCL and TNBC where
NOTCH1 is not the critical player of lineage commitment and maintenance, the impact of
oncogenic Notch is less on cell identity, but on other aspects such as activating aberrant
enhancers that are silent in the normal counterparts of these cancer cells. Therefore, to
compensate for the loss of oncogenic Notch signaling, cancer cells may activate
alternative factors with similar function of Notch, or activate other pro-survival pathways
to replace Notch signaling. Inhibition of cell identity or differentiation related pathways,
such as B-cell receptor pathway inhibition in MCL (e.g. ibrutinib) or estrogen receptor
pathway inhibition in ER+ breast cancers (e.g. tamoxifen) could lead to similar effects like
Notch pathway inhibition in T-ALL, and my future research projects aim to investigate
whether acquisition of resistance to these targeted therapies can be generally associated
with lineage switching and reorganization of genome topology.
186

4.6 Figure Titles and Legends

Figure 4-1: MYC clique enlarges in space upon Notch inhibition.
(A) Frequency of interactions among MYC promoter and the Notch-bound enhancers
significantly decreased after Notch inhibition. Top: normalized UMI 4C-seq interactions
from the MYC promoter viewpoint in DMSO-treated and 72-hour GSI-treated MB157 cells.
Middle: ChIP-seq tracks showing NOTCH1 and H3K27ac load at MYC locus marked with
matching colors for the position of probes against MYC promoter (yellow), MYC enhancer
1 (E1, cyan), and MYC enhancer 4 (E4, magenta) sequences for a 3-color DNA-FISH.
Bottom: normalized SMC1a HiChIP signals among enhancers and promoters in DMSOtreated and 72-hour GSI-treated MB157 cells.
(B) Representative cells and magnified images for 3-color, MYC promoter (yellow)-E1
(cyan), and MYC promoter (yellow)-E4 (magenta), in DMSO and 72hr GSI treated cells.
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(C) Distances between MYC, E1 and E4 probes significantly increased in GSI treated
cells. Left: cumulative distribution plots of the closest distance between MYC and E1
probes in the same cell are compared between 719 DMSO and 794 GSI-treated cells.
Mean (+/- S.D.) distance in DMSO and GSI-treated cells is 0.546 (+/- 0.318) µm, and
0.797 (+/- 0.649) µm, respectively (Kolmogorov-Smirnov p-value < 2.2E-16). Right:
cumulative distribution plots of spatial perimeter formed by MYC, E1 and E4 probes. Mean
(+/- S.D.) in DMSO and GSI-treated cells is 1.699 (+/- 0.707) µm, and 2.529 (+/- 1.591)
µm, respectively (Kolmogorov-Smirnov p-value < 2.2E-16).
(D) Barplots depicting the fraction of MYC promoters contacting both, either or neither E1
and E4 in DMSO and GSI-treated cells. Contact is defined as the 3D Guassian distance
between the centroid of two foci smaller than 500nm.
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Figure 4-2: Rare resistant-like parental T-ALL cells exist but do not dominate the
GSI-resistant population.
(A) TooManyCells tree of DMSO and GSI treated parental and GSI-resistant DND41 cells
(n = 7,371 cells). Magnified resistant-like subtree in insert. Reanalyzed from (Schwartz et
al., 2020).
(B) Left: cell images of RNA FISH signals for GAPDH (pseudo-color red) and MYC
(pseudo-color yellow) in DMSO-treated parental (top) and GSI-resistant (bottom) cells.
Top 3rd and 4th columns showing two parental cells with high MYC and low MYC
expression, respectively. Bottom 3rd and 4th columns showing two resistant cells with
high MYC expression. Cell nuclei in purple. Right: box-Whisker plots showing single-cell
MYC and GAPDH RNA FISH signal distributions for DMSO-treated parental (n = 250
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cells), GSI-treated parental (n = 261 cells; two-tailed t test, MYC: p = 1.5E−11), and GSIresistant (n = 222 cells; two-tailed t test, MYC: p = 2E−4) populations. NS: p > 0.005.
Adapted from (Schwartz et al., 2020).
(C) Single-cell ATAC-seq reveals heterogenous accessibility profiles at the two MYC
enhancers in parental and resistant DND41 cells. Top: ChIP-seq of NOTCH1 in parental
cells and aggregated scATAC-seq signals in parental and GSI-resistant DND41 at the two
distal MYC enhancers. Middle: scATAC-seq reads from 3,575 parental and 4,612 resistant
cells overlapping with peaks called from aggregated data. Bottom: Venn diagram depicting
the percentage of cells with at least one read on the peaks at E1 or E2 in parental and
resistant cells. Reanalyzed from (Schwartz et al., 2021).
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Figure 4-3: T-ALL line KOPTK1 acquire GSI-resistance by reinforcing T lineage gene
expression.
(A) Volcano plot showing ATAC-seq signal fold enrichment (x axis) versus false discovery
rate (FDR) (y axis) in GSI-resistant and parental KOPTK1 cells. 2,719 and 4,697 elements
with decreased and increased accessibility in GSI-resistant cells are marked in blue and
red, respectively. Significance cutoff: DESeq2 FDR < 1E-5 and log2(fold change) => 1.
(B) Heatmaps displaying normalized ATAC-seq and H3K27ac for elements with
significantly decreased (top) or increased (bottom) accessibility in GSI-resistant compared
to parental KOPTK1, respectively. Bin size: 50 bp.
(C) HOMER motif enrichment at the sequences with significantly decreased (top) or
increased (bottom) accessibility in GSI-resistant compared to parental KOPTK1.
(D) Immunoblot showing that ICN1 is inhibited in short-term GSI treated and GSI-resistant
KOPTK1, while LEF1/TCF1 protein levels increase in GSI-resistant cells.
(E) Normalized RNA-seq reads depicting inhibition of Notch target genes, recovery of
MYC expression and increase of LEF1 and TCF7 in GSI-resistant KOPTK1. FDR values
are determined by DESeq2.
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CHAPTER 5: METHODS AND MATERIALS
4.1 Experimental Method Details
Cell line models
DND41 (cat# ACC525) and HPB-ALL (cat# ACC483) were purchased from LeibnizInstitute DSMZ-German Collection of Microorganisms and Cell Lines. MB157 (cat# CRL7721), HCC1599 (cat# CRL-2331), HEK293T (cat# CRL-11268) and Jurkat E6-1 (cat#
TIB-152) were purchased from ATCC. Granta519 and Rec-1 were from the Broad Novartis
Cancer cell line encyclopedia (Ryan et al., 2017). KOPTK1 was a generous gift from Dr.
Jon Aster. HCC1599, Rec-1, DND41, Jurkat E6-1, HPB-ALL and KOPTK1 were cultured
in RPMI 1640 (Corning, cat# 10-040-CM) supplemented with 10% fetal bovine serum
(Hyclone, cat# SH30070.03), 2 mM L-glutamine (Corning, cat# 25-005-CI), 100 U/mL and
100 μg/mL penicillin/streptomycin (Corning, cat# 30-002-CI), 100 mM nonessential amino
acids (Gibco, cat# 11140-050), 1mM sodium pyruvate (Gibco, cat#11360-070) and 0.1mM
of 2-mercaptoethanol (Sigma, cat# M3148). MB157, HEK293T and Granta519 were
cultured in DMEM (Corning, cat# 10-013-CV) supplemented with 10% fetal bovine serum
(Hyclone, cat# SH30070.03) and 100 U/mL and 100 μg/mL penicillin/streptomycin
(Corning, cat# 30-002-CI). Adherent cells (MB157 and 293T) were cultured on 100 mm or
150 mm dishes and suspension cells (DND41, HPB-ALL, HCC1599, Jurkat E6-1,
Granta519, Rec-1, and KOPTK1) were cultured in T-25, T-75 or T-175 flasks. All cell lines,
including the GSI-resistant, Cas9-expressing, and doxycycline-inducible cell lines
described below, were grown at 37°C and 5% CO2 and were used at a low passage
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number (<12) and subjected to regular mycoplasma tests and short tandem repeat (STR)
profiling.
GSI-Washout assay
For GSI washout studies of ChIP-seq, RNA-seq and ATAC-seq in MB157, HCC1599, Rec1 cells in Chapter 2, cells were treated with the GSI compound E (1 μM, Calbiochem cat#
565790) for 72 hours, washed, and then cultured for 5 hours in media containing 1μM GSI
(mock washout) or DMSO (washout) as previously described (Weng et al., 2006). For
HiChIP recovery assay GSI was removed after 72 hours and cells were then recovered
for 3 days. Following washout, cells were harvested from culture, cross-linked for ChIPseq or HiChIP and frozen in -80°C for further use.
Generation of GSI-resistant DND41
To generate GSI-resistant DND41 in Chapter 3, parental DND41 was treated with 125nM
gamma-secretase inhibitor (GSI) compound E (Calbiochem cat# 565790) for more than
12 weeks with regular refreshment of media and maintained in 125nM GSI. To generate
GSI-resistant-reversed cells, GSI-resistant DND41 were cultured in media without GSI for
6-8 weeks. The process of GSI-resistant DND41 generation was independently repeated
by different personnel ten times and activation of EBF1 was observed in all replicates.
Lentiviral packaging
Lentivirus was produced in HEK293T cells as previously described (Petrovic et al., 2019).
Briefly, 4.5x106 HEK293T cells were plated in 8 mL DMEM media in 10 cm dishes 12-16
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hours before transfection. The lentiviral constructs, packaging plasmid (pCMVdelta) and
envelope plasmid (VSV-G) were co-transfected using FuGene HD (Promega, cat#
E2311). The cells were returned to the incubator for 6-8 hours before replacement with 6
mL media. Lentiviral supernatants were harvested 48 hours post-transfection, subjected
to 0.45 μm filtration and stored at -80°C.
CRISPR-Cas9 Editing
CRISPR/Cas9 system was used for knocking down MYC and CCND1 enhancers in
Chapter 2 and knocking out MYC, LEF1, TCF1 and EBF1 in Chapter 3. Codon-optimized
version of Cas9 carrying puromycin resistance gene (Cas9-puro) and sgRNA vectors
carrying GFP (LRG2.1) or mCherry (LRmCherry2.1) (Grevet et al., 2018) were used.
MB157, Parental DND41, GSI-resistant DND41, Jurkat E6-1 and Granta519 cells were
transduced with Cas9-puro lentivirus by spinfection at 2000 rpm for 90 min at 22°C in the
presence of 6 μg/mL polybrene (Sigma-Aldrich, cat# H9268). Transduced DND41 cells
were selected 3 days after spinfection with incremental 0.1-1 μg/mL puromycin until most
cells are viable and maintained in 1 μg/mL puromycin. Transduced MB157, Jurkat E6-1
and Granta519 cells were selected and maintained with 1-4 μg/mL puromycin. Expression
of Cas9 was confirmed with western blot (CST cat# 14697S).
For targeting MYC enhancers MB157-Cas9 cells were subsequently transduced with
lentiviruses produced with LRmCherry2.1 encoding g7 and g16 (E1), LRG2.1 encoding
g23 and g3 (E5) or LRmCherry2.1 encoding g7 and g16 and LRG2.1 encoding g23 and
g3 for dual targeting of MYC enhancers (E1 + E5). For targeting CCND1 enhancers
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MB157-Cas9 cells were subsequently transduced with lentiviruses produced with LRG2.1
encoding g2 (E1), LRmCherry2.1 encoding g6 (E2), or LRmCherry2.1 encoding g6 and
LRG2.1 encoding g2 for dual targeting of CCND1 enhancers (E1 + E2). In control condition
MB157-Cas9 cells were transduced with LRG2.1 or LRG2.1 and LRmCherry2.1. Cells
were sorted on BD FACS Aria II using 100μm nozzle at 20 psi for expression of GFP,
mCherry or both on day 4 and harvested for RNA extraction and Western blotting.
sgRNA targeting MYC, LEF1, TCF7 or EBF1 exons were designed with UCSC genome
browser CRISPR Targets Track and Benchling (https://www.benchling.com/). A total of 5,
8, 16 and 8 sgRNAs were designed for MYC, LEF1, TCF7 and EBF1, respectively. MYC
and LEF1 targeting sgRNAs were cloned into LRG2.1 while TCF7 and EBF1 sgRNAs
were cloned into LRmCherry2.1. The efficacy of each sgRNA was determined by TIDE
assay and western blot with antibodies against MYC Y69 (Abcam cat# ab32072), LEF1
(D6J2W) (CST cat# 76010S), TCF1 (C46C7) (CST cat# 2206S) and EBF1 (EMD Millipore
cat# ABE1294 or AB10523). MYC-E3g5, LEF1-g3, TCF7-g5 and EBF1-g7 were used in
the subsequent experiments.
For targeting MYC, Cas9-expressing parental DND41 (DND41-Cas9) and GSI-resistant
DND41 cells (DND41-Res-Cas9) were transduced with lentivirus produced with LRG2.1MYC-E3g5 using the spinfection method above. For targeting LEF1 and TCF7 individually
and simultaneously, DND41-Cas9 or Jurkat-E6-1-Cas9 cells were transduced with
lentivirus produced with LRG2.1-LEF1-g3 and LRmCherry2.1-TCF7-g5 individually or with
a mixture of 1:1 ratio using the spinfection method above. For targeting EBF1, DND41Res-Cas9 or Granta519-Cas9 cells were transduced with lentivirus produced with
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LRmCherry2.1-EBF1-g7 using the spinfection method above. In control condition, Cas9
expressing cells were transduced with LRG2.1 and/or LRmCherry2.1.
Ectopic induction of LEF1, TCF1 and EBF1
LEF1 CDS with attB1/2 overhang was produced by PCR from cDNA of parental DND41.
TCF7 CDS with attB1/2 overhang was produced by PCR from pENTR221-TCF7 (addgene
cat# 79498). These two CDS were then cloned into pDONR221 with attP1/2 using
Gateway cloning BP reactions (Invitrogen cat# 11789020) to produce pDONR221-LEF1
and pDONR221-TCF7 plasmids. pDONR221-EBF1 was purchased from DNASU (cat#
HsCD00296820). pInducer20 (Addgene cat# 44012) or pInducer21 (Addgene cat# 46948)
was then used with pDONR221-LEF1, -TCF1 and -EBF1 in LR reactions (Invitrogen cat#
11791020) to produce pInducer20-LEF1, pInducer20-TCF1, pInducer20-EBF1 and
pInducer21-EBF1. TRE3G-TRF1-puro and CMV-rtTA3G-blast plasmids were generous
gifts from the Greenberg lab. 5 μg TRE3G-TRF1-puro was digested with SalI-HF (NEB
cat# R3138S) and AscI (NEB cat# R0558S) at 37 °C for 2 hours to produce TRE3G-puro
backbone. EBF1 CDS with proper overhang was amplified from pInducer20-EBF1 with
primers designed by NEBuilder (https://nebuilder.neb.com/#!/). TRE3G-puro backbone
and EBF1 CDS were assembled with NEBuilder HiFi DNA Assembly Cloning Kit (cat#
E5520S) to produce TRE3G-EBF1-puro. All plasmids were subject to Sanger sequencing
validation using Genewiz (https://www.genewiz.com/). MB157 cells were transduced with
lentivirus produced with pInducer20-LEF1, pInducer20-TCF1 and pInducer20-EBF1 and
selected under 1.2 mg/mL G418 (Gibco cat# 10131027) for 7 days. To ectopically express
LEF1, TCF1 and EBF1, 10 μg/mL doxycycline was added for 72 hours and MB157196

pInducer20 cells were harvested to perform western blot, ATAC-seq, RNA-seq, ChIP-seq
and SMC1 HiChIP. HBP-ALL cells were transduced with lentivirus produced with TRE3GEBF1-puro and CMV-rtTA3G-blast and selected under 1 μg/mL puromycin (cat#
A1113803) and 10 μg/mL blasticidin (cat# A1113903) for 14 days. KOPTK1 cells were
transduced with lentivirus produced with pInducer21-EBF1 and sorted for top 10% GFP
positive cells three days post transduction. To ectopically express EBF1 in HPB-ALLTRE3G-EBF1 and KOPTK1-pInd21-EBF1, 0.5 μg/mL doxycycline was added for 72
hours, and then cells were harvested to perform western blot in two independent biological
replicates.
Assay for Transposase-Accessible Chromatin (ATAC-seq)
ATAC-seq was performed as previously described (Buenrostro et al., 2013) and three
replicates were performed for each condition. Briefly, 50,000 cells were pelleted at 800 x
g and washed with 50 μl of ice cold 1 x PBS (Corning cat# 21031CV), followed by 2min
treatment with 50 μl lysis buffer (10 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 10 mM NaCl, 0.1%
Igepal cat# CA-630). Pelleted nuclei were resuspended in 50 μl of transposition buffer (25
μl of 2 x TD buffer, 22.5 μl of molecular biology grade water and 2.5 μl Tn5 transposase
(Illumina cat# FC-121-1030) to tag the accessible chromatin for 45min at 37°C.
Tagmented DNA was purified with MinElute Reaction Cleanup kit (Qiagen cat# 28204)
and amplified with 5 PCR cycles. Additional number of PCR cycles was determined from
the side reaction and ranged from 10-12 total cycles of PCR. Libraries were purified using
QiaQuick PCR purification kit (Qiagen cat# 28106) and eluted in 20 μl EB buffer. Indexed
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libraries were assessed for nucleosome patterning on TapeStation 4150 (Agilent) and
paired-end sequenced (38bp+38bp) on Illumina NextSeq 550.
For comparison of chromatin accessibility in parental, GSI-resistant and four-week-GSItreated DND41 cells, parental DND41 was treated with DMSO or 125 nM GSI for 24 hours
and GSI-resistant cells were refreshed with media containing 125 nM GSI for 24 hours,
and DAPI-negative single live cells in four-week-GSI-treated DND41 were sorted on BD
FACSAria Fusion with 100 μm nozzle and immediately proceeded to ATAC-seq. For
assessing the impact of LEF1 or TCF1 loss on parental DND41 genome, DND41-Cas9
cells carrying LRG2.1-LEF1-g3 or LRmCherry2.1-TCF7-g5 were sorted 6 days post
transduction. To assess the impact of LEF1 and TCF1 loss on parental DND41 genome,
DND41-Cas9 carrying LRG2.1-LEF1-g3 and LRmCherry2.1-TCF7-g5 were sorted 3, 6
and 9 days post transduction. DND41-Cas9 carrying LRG2.1 and LRmCherry2.1 were
sorted 3 days post transduction as control. Jurkat-E-6-1-Cas9 with LRG2.1-LEF1-g3
and/or LRmCherry2.1-TCF7-g5 and control cells were sorted 6 days post transduction. To
assess the impact of EBF1 loss on GSI-resistant DND41 genome, DND41-Res-Cas9 with
LRmCherry2.1-EBF1-g7 were sorted 3, 6 and 9 days post transduction and control cells
were sorted 3 days post transduction. Granta519-Cas9 with LRmCherry2.1-EBF1-g7 and
control cells were sorted 3 days post transduction. Cell sorting was done on BD FACSAria
Fusion with 100 μm nozzle gating for single live cells with DAPI staining and top 50% GFP
and/or mCherry expression. To assess the impact of ectopic LEF1, TCF1 and EBF1
expression on MB157 genome accessibility, MB157 cells and doxycycline induced
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MB157pInducer20-LEF1, TCF1 and EBF1 cells were sorted on BD FACSJazz with 100
μm nozzle gating for single live cells with DAPI staining.
RNA sequencing
Strand-specific RNA-seq was performed in the following cells with three replicates per
condition: 1) parental and GSI-resistant-reversed DND41 treated with DMSO or 125 nM
GSI for 24 hours, GSI-resistant DND41 refreshed with media containing 125 nM GSI for
24 hours, and FACS-sorted single live cells in four-week-GSI-treated DND41; 2) MB157
and induced MB157pInducer20-TCF1 and -EBF1; 3) DND41-Res-Cas9 control and
LRmCherry2.1-EBF1-g7 cells sorted 6 days post transduction. In all experiments, 35x10^5 cells were washed with 1 x PBS and lysed with 350 μl RLT Plus buffer (Qiagen)
supplemented with 2-mercaptoethanol, vortexed briefly and immediately proceeded to
RNA isolation with RNeasy Plus Micro Kit (Qiagen #74034). RNA integrity numbers were
determined using TapeStation 4150 (Agilent), and all samples used for RNA-seq library
preparation had RIN numbers greater than 9.5. 300-800 ng of total RNA was used, and
libraries were prepared using the SMARTer Stranded Total RNA Sample Prep Kit-HI
Mammalian (Clontech cat# 634873). Libraries were paired-end sequenced (38bp+38bp)
on Illumina NextSeq 550.
Chromatin Immunoprecipitation Sequencing (ChIP-seq)
ChIP-seq for histone marks was performed as previously described (Petrovic et al., 2019).
Briefly, 1 x 10^7 cells were crosslinked with 1% formaldehyde and lysed. Nuclei were
extracted and resuspended in 1% SDS and sonicated using Brandson 450 sonicator with
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25% amplitude, 0.5s on, 1s off for a total of 4min 30s on. Solubilized chromatin was then
diluted and cleared with IgG (CST cat# 2729S) and recombinant protein G–conjugated
Agarose beads (Invitrogen #15920-010) for 1 hour at 4°C. The cleared supernatant was
subsequently immunoprecipitated with antibodies recognizing H3K27ac (Active Motif cat#
39133) or H3K4me1 (Abcam cat# ab8895) overnight at 4°C. Buffers in all steps above
were supplemented with protease inhibitors (Roche cat# 11697498001). Antibodychromatin complexes were captured with recombinant protein G–conjugated Agarose
beads, washed with low salt wash buffer, high salt wash buffer, LiCl wash buffer and TE
buffer with 50mM NaCl and eluted. Input sample was prepared by the same approach
without immunoprecipitation.
ChIP-seq for transcription factors was performed as previously described (Bossen et al.,
2015). Briefly, Dynabeads Protein G (ThermoFisherScientific cat# 10003D) was incubated
with antibodies recognizing MAML1 (D3K7B) (CST cat# 12166S), TCF1/TCF7 (C46C7)
(CST cat# c2206S), LEF1 (D6J2W) (CST cat# 76010S), EBF1 (Boller et al., 2016),
SMC1a (Bethyl, cat# A300-055A), YY1 (Active motif cat# 61779) and CTCF (EMD
Millipore cat# 07-729) for 8-12 hours in PBS+0.5% BSA at 4°C. 4 x 10^7 cells were
crosslinked with 1% formaldehyde and 1.5mM EGS (ThermoFisherScientific cat# 21565)
and sonicated using Brandson 450 sonicator with 17% amplitude, 10s on, 1min off for 10
times. Lysate was then cleared by centrifuging for 5min at 16 Kg, 4°C and incubated with
antibody-bound beads and 1% Triton Tx-100 (Roche cat# 10789704001) overnight at 4°C.
Buffers in all steps above were supplemented with protease inhibitors (Roche cat#
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11697498001). Antibody-chromatin complexes captured on beads were then separated
on magnet and washed with wash buffer 1, 2, 3, LiCl wash Buffer and TE buffer and eluted.
Following elution of histone mark and transcription factor samples, RNase (Roche cat#
10109169001) and Proteinase K (Invitrogen cat# 25530-049) treatments were performed,
and reverse crosslinked at 65°C overnight. DNA was purified with QiaQuick PCR
Purification Kit (Qiagen, cat# 28106). Libraries were then prepared using the NEBNext
Ultra II DNA library Prep Kit for Illumina (NEB cat# E7645S) with single (NEB cat# E7335,
cat# E7710) or dual (NEB cat# E7600, cat# E7780) indexing. Two replicates were
performed for each condition. Indexed libraries were validated for quality and size
distribution using a TapeStation 4150 (Agilent), quantified by KAPA Library Quantification
Kit (Roche cat# KK4824) and paired-end sequenced (38 bp+38 bp) on Illumina NextSeq
550.
CUT & RUN
CUT & RUN was performed as described (Skene and Henikoff, 2017). Briefly, 5x10^5
cells were immobilized on Concanavalin-coated magnetic beads (Bangs Laboratories cat#
cBP531) and incubated with Tri-Methyl-Histone H3 (Lys27) (C36B11) antibody (CST cat#
9733S) overnight at 4°C. Beads were washed with digitonin wash buffer and mixed in pAMNase (gift from Henikoff lab) at 4°C for 1 hour. After activation by Ca2+ on wet ice for
30min, 2XSTOP buffer was added and incubated 37°C for 10min to release CUT & RUN
fragments from the insoluble nuclear chromatin. DNA was then extracted from the
supernatant using Phenol-chloroform-isoamyl alcohol 25:24:1 (PCI; Invitrogen cat#
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15593049) method. Library construction, quantification and sequencing were done as
described above for ChIP-seq.
In situ HiC
In situ HiC was performed in parental, GSI-resistant and FACS-sorted single live fourweek-GSI-treated DND41 cells, and DND41-Res-Cas9 control and LRmCherry2.1-EBF1g7 cells sorted 6 days post transduction. Briefly, 1-2x10^6 cells were washed with 1xPBS
containing 3% BSA and fixed with 2% formaldehyde and proceeded with Arima-HiC Kit
per manufacturer’s instructions. Samples passing Arima-QC1 were used for library
construction with Accel-NGS 2S Plus DNA Library Kit (Swift cat# 21024) and 2S SET A
INDEXING KIT (Swift cat# 26148) and assessed with Arima-QC2. Samples passing
Arima-QC2 were subsequently PCR amplified based on Arima-QC2 calculations,
quantified with TapeStation 4150 (Agilent) and KAPA Library Quantification Kit (Roche
cat# KK4824) and paired-end (38bp+38bp) sequenced on Illumina NextSeq 550.
SMC1 HiChIP
SMC1 HiChIP was performed in parental and GSI-resistant DND41 (2 replicates each)
and induced MB157pInducer20-TCF1 and EBF1 cells (1 replicate each) as previously
described (Petrovic et al., 2019). DMSO and GSI-washout treated MB157 HiChIP samples
were previously published (Petrovic et al., 2019). Briefly, 2 x 107 cells were crosslinked
with 1% formaldehyde (Thermo Fisher Scientific, cat# 28908) for 10 min and subsequently
quenched with 0.125M glycine (Invitrogen, cat# 15527-013). Chromatin was digested
using MboI restriction enzyme (NEB, cat# R0147), followed by biotin incorporation with
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Biotin-14-dATP (Invitrogen, cat# 19524-016 or Jena Bioscience cat# NU-835-BIO14-S).
DNA was then ligated with T4 ligase (NEB cat# M0202L) and sonicated on Covaris LE220.
Sheared chromatin was 4-fold diluted with ChIP dilution buffer (16.7mM Tris pH 7.5,
167mM NaCl, 1.2mM EDTA, 0.01% SDS, 1.1% Triton X-100), cleared with IgG (CST cat#
2729S) and then incubated with anti-SMC1 antibody (Bethyl, cat# A300-055A) at 4°C
overnight. Chromatin-antibody complexes were captured by Protein-A magnetic beads
(Pierce, cat# 88846) and subsequently washed with Low Salt Wash Buffer, High Salt
Wash Buffer, LiCl Wash Buffer and eluted. DNA was purified with MinElute PCR
Purification Kit (Qiagen, cat# 28004) and quantified using Qubit dsDNA HS Assay Kit
(Invitrogen, cat# Q32851). 50-150ng was used for capture with Dynabeads MyOne
Streptavidin C-1 (Invitrogen, cat# 65001) and an appropriate amount of Tn5 enzyme
(Illumina, cat# FC-121-1030) was added to captured DNA to generate sequencing library.
Paired-end sequencing (38 bp+38 bp) was performed on Illumina NextSeq 550.
UMI 4C-seq
UMI 4C-seq was performed for parental and GSI-resistant-reversed DND41 treated with
DMSO or 125 nM GSI for 24 hours and GSI-resistant DND41 refreshed with media
containing 125 nM GSI for 24 hours. Method was previously described (Cho et al., 2018)
with minor modifications. 5-10 x 10^6 cells were crosslinked with 1% formaldehyde and
lysed with ice-cold Hi-C Lysis buffer (10 mM Tris-HCl pH 8.0, 10 mM NaCl, 0.2% NP-40,
1X protease inhibitors) at 4°C for 30 minutes. Pelleted nuclei were resuspended in 0.5%
SDS at 62°C for 10min and then quenched with Triton X-100 at 37°C for 15 min. Chromatin
was then digested with MboI (NEB cat# R0147) at 37°C for 2 hours and ligated with T4
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DNA Ligase (NEB cat# M0202) at room temperature for 4 hours with rotation. Pelleted
nuclei were resuspended in 200 μL of Proteinase K Buffer (10 mM Tris pH 7.0, 100 mM
NaCl, 1mM EDTA, 0.5% SDS) at 55°C for 1hr, reverse crosslinked at 67°C overnight, and
treated with RNase A before DNA precipitation by ethanol and NaAc. 10 μg of eluted DNA
was sonicated on Bioruptor for 5 cycles of 30sec on, 60sec off followed by sequential
incubation with end repair mix (NEB cat# E6050), Klenow exo- (NEB cat# M0212) and
CIP (NEB cat# M0290). DNA was ligated with Illumina forked indexed adapters (Roche
cat# 7141530001) with Quick Ligase (NEB cat# M2200L) at room temperature for 30min
and denatured at 95°C for 2min to release the non-ligated strand of the adapter. Singlestranded DNA was quantified by Qubit ssDNA Assay Kit (Invitrogen cat# Q10212) and
200ng of 4C DNA template was amplified by nested PCR using primer sets targeting MYC
promoter. 3-5 replicates were performed for each condition. Indexed libraries were
validated for quality and size distribution using a TapeStation 4150 (Agilent), quantified by
KAPA Library Quantification Kit (Roche #KK4824) and paired-end sequenced (38 bp+38
bp) on Illumina NextSeq 550.
Cancer-associated gene panel sequencing
Ultra-deep genomic sequencing of parental and GSI-resistant DND41 cells was performed
using CLIA-approved clinical assay used for sequencing of cancer patients at the Hospital
of the University of Pennsylvania. Briefly, genomic DNA of parental and GSI-resistant
DND41 cells was extracted (296.6 and 293.5 ng respectively) using DNeasy Blood &
Tissue Kits (Qiagen cat# 69506) and sheared with Covaris LE220-plus ultrasonicator to
achieve an average length of 200 bp. Whole genome libraries were generated with a Kapa
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Hyper Prep kit (Roche cat #07962363001) targeting the full-coding regions of 505 cancerassociated genes. The target-enriched libraries were then PCR amplified and paired-end
sequenced (150bp + 150bp) on Illumina NovaSeq 6000.
Oligopaint DNA FISH and Lamin-B1 IF
Oligopaint libraries for DND41 were designed using the OligoMiner pipeline (Beliveau et
al., 2018) using the default parameters and synthesized with CustomArray (GenScript).
42 nucleotide sequences with homology to the regions of interest were mined from the
hg19 genome. Each probe library targeted a 50Kbp, 75Kbp or 100Kbp region for EBF1
and MYC, IKZF2 and TCRA loci, respectively. DNA secondary oligos conjugated with
Alexa-488, Atto-565 and Alexa-647 were purchased from IDT with high-performance liquid
chromatography (HPLC) purification. Probe amplification primers and bridges were
purchased from IDT with standard desalting.
Parental, GSI-resistant, FACS-sorted single live cells in two-, five- and nine-week-GSItreated DND41 cells, and DND41-Res-Cas9 control and LRmCherry2.1-EBF1-g7 cells
sorted 6 days post transduction were settled on poly-L-lysine-treated glass slides
(ThermoScientific cat# P4981-001) for 30min in a humidified chamber and fixed for 10min
in 4% formaldehyde at room temperature, followed by permeabilization in 0.5% Triton X100 for 15min. For combined Lamin-B1 immunofluorescence, slides were block with 10%
BSA in 1x PBS for 1 hour and incubated with 100 μl PBS + 5% donkey serum + 1μl LaminB1 antibody (Abcam cat# ab16048) at room temperature for 2 hours. After washing with
1 x PBS 3 x 5min, slides were incubated in 100 μl PBS + 5% donkey serum + 1μl
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secondary antibody (Invitrogen cat# A10042) at room temperature for 2 hours, washed
with 1 x PBS 3 x 10min, and fixed again with 4% formaldehyde. For DNA FISH, slides
were washed with 70%, 90%, and 100% ethanol for 2min each and slightly dried before
treated with SSCT (2 x SSC, 0.1% Tween) + 50% formamide for 5min at room
temperature, 2.5min at 92°C and 20min at 60°C. 10-50 pmol of primary Oligopaint probes
in hybridization buffer (10% dextran sulfate, 2xSSCT, 50% formamide, 4% PVSA, 5.6mM
dNTPs, 10μg RNase A) were then added to the cells, covered with a coverslip, and sealed
with rubber cement. Cells were denatured at 92°C for 2.5min and incubated at 37°C
overnight in a humidified chamber. Approximately 16-18 hours later, coverslips were
removed with a razor blade, and slides were washed in 2×SSCT at 60°C for 15min and
room temperature for 10min, and 0.2×SSC at room temperature for 10min. 10pmol of
secondary probes containing fluorophores (Alexa-488, Atto-565, and Alexa-647) and
2pmol bridges were added to slides in secondary hybridization buffer (10% dextran
sulfate, 10% formamide, and 4% PVSA), and covered with a coverslip sealed with rubber
cement. Slides were incubated at room temperature for 2 hours in a humidified chamber,
followed by washes in 2×SSCT at 60°C for 15 minutes, 2×SSCT at RT for 10 minutes,
and 0.2×SSC with 1:4,000 DAPI at RT for 10 minutes and mounted in SlowFade Gold
Antifade Mountant (Invitrogen cat# S36936).
Cell proliferation
Cell proliferation was measured with CellTiter Glo Luminescent Cell Viability Assay
(Promega cat# G7571) according to the manufacturer’s instructions. 1) Parental and GSIresistant DND41 cells were plated with 0, 1nM, 10nM, 100nM, 1μM, 10μM and 100μM
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GSI in 5 replicates with 2,000 cells per well on 96-well plates and luminescence was
measured on day 6. 2) Parental, GSI-resistant, FACS-sorted single live cells in four- and
eight-week GSI-treated DND41 cells were plated with 0, 10nM, 100nM, 1μM, 10μM and
100μM GSI in 5 replicates with 2,000 cells per well on 96-well plates and luminescence
was measured on day 6. 3) HPB-ALL-TRE3G-EBF1 and KOPTK1-pInducer21-EBF1 were
plated with 0, 10nM, 100nM, 1μM, 10μM and 100μM GSI and 0 or 0.5 μg/mL doxycycline
in 5 replicates with 2,000 cells per well on 96-well plates and luminescence was measured
on day 6. 4) Control and EBF1 targeted DND41-Res-Cas9 cells were sorted 3 days post
gRNA infection and plated in 5 replicates with 2,000 cells per well on 96-well plates.
Luminescence was measured 24 hours after plating (day 0) and every 3 days for a total
of 15 days. The same procedure was applied to control and LEF1+TCF1 targeted DND41Cas9 cells. Control and MYC-targeted DND41-Cas9 or DND41-Res-Cas9 cells were
measured for 6 days. For control and EBF1 targeted Granta519, cells were plated at 1,000
per well and measured for a total of 12 days. Statistics for cell growth changes were
calculated using Student’s t-test.
Cell apoptosis
Parental and GSI-resistant DND41 cells were treated with 125nM GSI for 6 days. Control
and EBF1 targeted DND41-Res-Cas9 or Granta519-Cas9 cells were sorted 3 days post
transduction and cultured for 3 days (day6). For each replicate, 5 x 10^5 cells were
washed in 1 x PBS and resuspended in 100 μl 1 x Annexin V binding buffer (BD cat#
556454). 5 μl V450-Annexin V (BD cat #560506) was added and incubated in the dark at
room temperature for 15min. 400 μl of 1 x Annexin V binding buffer containing 1:1000 TO207

PRO3 (ThermoFisherScientific cat# R37170) was added and immediately proceeded to
Flow cytometry analysis on BD LSR II. Experiments were repeated three times with 3-5
replicates per condition.
Quantitative RT-PCR
Primers were designed using Primer-BLAST software. RNA was extracted with RNeasy
Plus Micro Kit (Qiagen cat# 74034) and synthesized to cDNA with SuperScript III
(Invitrogen cat# 18080093). Quantitative PCR was performed on an Applied Biosystem
ViiA 7 real-time PCR System using Power SYBR Green PCR Master Mix (Applied
Biosystems cat# 4367659). Relative expression level was calculated by the 2^-(ΔΔCt)
method using EEF1A1 as internal control. Statistics was calculated using a Student’s t
test.
Western blot
0.2-1 x 10^6 cells were washed in ice cold 1xPBS and lysed with whole lysis buffer (2%
SDS, 60mM Tris) supplemented with proteinase inhibitors. Protein concentration was
determined with DC Protein Assay Reagents Package (Bio-rad cat# 5000116) and 5-20
μg proteins were used for SDS-PAGE electrophoresis in tris-mes-sds running buffer
(Genescript cat# M00654, cat# M00677). Gels were then transferred to methanol
activated PVDF membrane (Cytive cat# 10600023), blocked with 5% skim milk in 1xTBST
at room temperature for 1 hour, and incubated with primary antibodies at 1:1,000 to
1:20,000 dilutions in 5% skim milk at 4°C overnight. After washing with 1xTBST 3x10min,
secondary antibodies (Millipore cat# 401315-2ml, cat# 401215-2ml) were added at
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1:3,000 or 1:6,000 dilution in 5% skim milk and incubated at room temperature for 1 hour.
Following 3x15min wash in 1xTBST, imaging was done with ECL Prime Western Blotting
Detection Reagents (Cytiva cat# RPN2232) and autoradiography films.
4.2 Quantification and Statistical Analaysis
The statistical significance of differences between measurements was determined by
Wilcoxon rank sum test using R (version 3.6.1) wilcox.test function, unless otherwise
stated. Statistical details of experiments can be found in figure legends. Visualizations
were done with R.
Definition of regulatory elements
The following definitions of regulatory elements were used throughout the manuscript.
Promoters: promoters were defined as ± 2.5 kilobases (Kbp) from the transcription start
site (TSS) of each expressed gene. Enhancers: Enhancers were defined as H3K27ac
peaks excluding the ones overlapping with promoters.
Gene annotation
A total of 2,828,317 Ensembl transcripts in GRCh37.75 assembly were downloaded in gtf
format. For each Ensembl gene id (ENSG), the longest transcript (ENST) was used to
assign a unique transcriptional start site and gene position. After exclusion of genes
annotated as rRNA or on chromosome M, 57,209 gene annotations were used in RNAseq analysis.
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ATAC-seq data analysis
Alignment
Reads from ATAC-seq experiments were trimmed with Trim Galore (version 0.4.1) with
parameters -q 15 --phred33 --gzip --stringency 5 -e 0.1 --length 20. Trimmed reads were
aligned to the Ensembl GRCh37.75 primary assembly including chromosome 1-22, chrX,
chrY, chrM and contigs using BWA (version 0.7.13) (Li and Durbin, 2009) with parameters
bwa aln -q 5 -l 32 -k 2 -t 6. Paired-end reads were group with bwa sampe -P -o 1000000.
Reads mapped to contigs, ENCODE blacklist and marked as duplicates by Picard (version
2.1.0) were discarded and the remaining reads were used in downstream analyses and
visualization.
Peak calling and Differential accessibility analysis
Peaks in each aligned replicate were identified using MACS2 (version 2.0.9) (Zhang et al.,
2008) with parameters --nomodel --nolambda --format=BAM -g hs -p 1E-5 --bw=300 -keep-dup=1. All peaks from replicates of each experiment were combined using bedtools
‘merge’ function and the union of peaks was quantified over each aligned bam file using
bedtools ‘coverage’ and normalized to RPKM. Differential accessibility analysis was
performed using DEseq2 (Love et al., 2014) with parameters test = "Wald", betaPrior = F,
fitType = "parametric". For comparison of parental and GSI-resistant DND41, significance
cutoff was log2 fold change > 1 or < -1 and FDR < 1E-5. For MB157, MB157pInducer20LEF1, TCF1 and EBF1, significance cutoff was log2 fold change > 0.5 or < -0.5 and FDR
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< 0.05. For control and LEF1/TCF1/EBF1 targeted Cas9 expressing cells, significance
cutoff was log2 fold change > 1 or < -1 and FDR < 1E-3.
Motif Analysis
Motif enrichment was performed with HOMER (version 4.8) (Heinz et al., 2010)
findMotifsGenome.pl with parameters ‘hg19 -mask -size given -len 8,9,10,11,12’. For
parental/GSI-resistant DND41, regions significantly gained accessibility were used as
foreground and regions significantly lost accessibility were used as background and vice
versa. For MB157pInducer20-LEF1, -TCF1 and -EBF1, regions significantly gained
accessibility were used as foreground and equal number of randomly sampled regions
without

significantly

differential

accessibility

were

used

as

background.

For

LEF1/TCF1/EBF1 targeted Cas9 expressing cells, regions with significant loss of
accessibility were used as foreground and regions significantly gained accessibility or did
not change accessibility were used as background. Motif logos and associated p-values
determined by HOMER were reported.
ChIP-seq and CUT&RUN data analysis
Reads from ChIP-seq and CUT&RUN experiments were aligned with the same procedure
as ATAC-seq above. Aligned bam files of the two replicates of each condition were merged
using samtools (version 1.3) (Li et al., 2009) ‘cat’ command for peak calling and
quantification. For each merged library, fragment length was estimated with HOMER
‘makeTagDirectory’. Peaks were identified using MACS with parameters -p 1E-3 -g hs -nomodel --shiftsize=0.5*fragment_length --format=BAM --bw=300 --keep-dup=1 and with
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corresponding input control. Log2 fold change of SMC1, CTCF and YY1 load was
calculated as log2 RPKM of GSI-resistant vs parental. Significance of change was
determined by using ‘enrichR’ and ‘getQvalues’ functions from normr R package (Helmuth
and Chung, 2018) using parameters minP = 1, eps = 0.00001, iterations = 10, procs = 12.
The criteria for differential SMC1 peaks were log2 fold change > 1 or < -1 and FDR < 1E5; differential YY1 and CTCF peaks were log2 fold change > 0.5 or < -0.5 and FDR < 1E5. Super-enhancers were defined by implementing previously described methods(Whyte
et al., 2013) in R and applying it to H3K27ac peaks.
For comparing protein loading at accessible regions, the union of ATAC-seq peaks were
quantified on merged ChIP-seq bam files using bedtools ‘coverage’ and normalized to
RPKM. For tag density plots, HOMER ‘annotatePeaks.pl’ was used on merged libraries
and visualized with R function ‘pheatmap’. Bin size of 50bp was used in Figures 4B, 4D,
4E, 5B and 7A. Bin size of 250bp was used in Figure S4B. For merged libraries genome
tracks, bedgraph of reads normalized to reads per million (RPM) were generated with
bedtools genomecov. Selected genomic loci were visualized with R package Sushi
(version 1.18.0) (Phanstiel et al., 2014) function ‘plotBedgraph’. Genome-wide uploadable
bigWig files were generated with UCSC tools (version 329) (Kent et al., 2010)
‘bedGraphToBigWig’.
HiC and SMC1 HiChIP analysis
Alignment and significant interaction calling
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Raw reads for each HiC sample were processed with HiC-Pro (version v2.5.0) (Servant
et al., 2015) to obtain putative interactions with default parameters except
LIGATION_SITE and GENOME_FRAGMENT provided by Arima. Raw reads for each
SMC1 HiChIP sample were processed with HiC-Pro to obtain putative interactions with
default parameters except LIGATION_SITE = GATCGATC and GENOME_FRAGMENT
generated for MboI restriction enzyme. Valid pairs (VI), self-circle (SC) and dangling-end
(DE) interactions in cis were used as input for significant interaction calling in ‘.bedpe’
format. Mango (version 1.2.0) (Phanstiel et al., 2015) step 4 identified putative significant
interaction anchors by MACS peak calling with MACS_qvalue = 0.05 and MACS_shiftsize
= 75. Mango step 5 identified significant interactions with default parameters except
maxinteractingdist = 2000000 and MHT = found. Only significant interactions with PETs
>= 4 were used in the following analyses.
Long-range regulatory loops
Long-range regulatory loops were defined using SMC1 HiChIP significant interactions. For
parental and GSI-resistant DND41, significant interactions with SMC1 ChIP-seq and
ATAC-seq peaks on both loop anchors and are present in at least two out of four HiChIP
samples are considered reproducible. Reproducible loops were classified into enhancerenhancer (EE), enhancer-promoter (EP) promoter-promoter (PP), CTCF-CTCF and other
interactions based on the presence of enhancers, promoters and CTCF peaks at the
summit of the two anchors +/- 5 Kbp. To identify differential long-range interactions
between parental and GSI-resistant DND41, annotated reproducible loops were quantified
on .bedpe files of HiC and HiChIP experiments and normalized to contacts per million, i.e.
213

divided by the number of reproducible interactions timed 1E6. Log2 fold change was
calculated as log2 GSI-resistant vs parental of normalized interactions. Significance of fold
change was determined by using ‘enrichR’ and ‘getQvalues’ functions from normr R
package (Helmuth and Chung, 2018) using parameters minP = 1, eps = 0.00001,
iterations = 10, procs = 12. The criteria for differential contact were log2 fold change > 0.5
or < -0.5 and FDR < 0.05. Only contacts significantly increased or decreased in both HiC
and HiChIP are considered reproducibly differential. For DMSO-treated and GSI-washout
MB157 (Petrovic et al., 2019), MB157pInducer20-TCF1 and MB157pInducer20-EBF1,
reproducible long-range contacts were defined as significant contacts that are present in
at least two out of the four HiChIP samples. The same annotation and normalization
process was applied for these contacts. Fold change and significance were calculated as
MB157pInducer20-TCF1 or MB157pInducer20-EBF1 vs GSI-washout MB157. The
criteria for differential contact in MB157 were log2 fold change > 1 or < -1 and FDR < 1E5. The criterion for differential contact in EBF1-KO vs Ctrl DND41-Res-Cas9 was log2
(EBF1-KO / Ctrl) < -0.5. Rows in Figure 7D were sorted in descending order of contact
frequencies in Ctrl DND41-Res-Cas9. Pileup plots of differential or invariant long-range
contacts were calculated using coolpup.py with --rescale --local on .cool files (described
below) and visualized with plotpup.py (Flyamer et al., 2020). 100 bin scaling was used in
Figures 2A, 2D. Normalized interactions at selected loci were visualized with R package
Sushi (version 1.18.0) (Phanstiel et al., 2014) function ‘plotBedpe’.
Pileup plots of normalized HiC contact maps in Figure 4G depict pairwise contact between
accessible elements with loss of TCF1 and SMC1 (left); gain of EBF1 and SMC1 (middle);
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loss of TCF1 and gain of EBF1 and invariant SMC1 (right) in GSI-resistant cells. Each
heatmap showing +/- 100 Kbp flanking the center with 5 Kbp resolution.
TAD boundary identification
For DND41, the valid pairs (allValidPairs files) of both HiC and SMC1 HiChIP from HiCPro (Servant et al., 2015) were used to generate .cool files using hicpro2higlass.sh in HiCPro. Genome-wide insulation scores and boundary scores were calculated using balanced
interaction matrices with 5 Kbp bin size and 100 Kbp window size using cooltools
‘diamond-insulation’

function

(https://cooltools.readthedocs.io/en/latest/).

Bins

with

boundary score > 0.3 in at least half of the HiC and HiChIP samples were considered valid
boundaries. Boundaries with (parental – GSI-resistant) boundary score >= 0.4 and
(parental – GSI-resistant) insulation score <= -0.1 are considered less insulated in GSIresistant cells, and bins with (parental – GSI-resistant) boundary score <= -0.4 and
(parental – GSI-resistant) insulation score > 0.1 are considered more insulated in GSIresistant cells. Adjacent differential boundaries are merged. Only differential boundaries
identified in both HiC and HiChIP were considered reproducibly differential. Pileup plots
of differential or invariant boundaries were calculated using coolpup.py (Flyamer et al.,
2020) with --pad 500 --local on .cool files and visualized with plotpup.py.
Z-scored contact map
To emphasize the boundaries identified by insulation score, z-score transformation on 25
Kbp-resolution square root vanilla coverage (VC_SQRT) normalized contact map was
applied per chromosome per sample as described(Crane et al., 2015) using R function
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loessFit with parameters iter = 100, span = 0.02. Selected loci on transformed maps were
visualized using R package Sushi (version 1.18.0)(Phanstiel et al., 2014) function ‘plotHic’.
Differential Compartment calling
Resolutions from 50 Kbp to 200 Kbp for A/B compartment detection were tested. Given
the consistency of results at this resolution range, we used HOMER (Heinz et al., 2010)
to identify differential A/B compartments at 100 Kbp resolution. Briefly, HOMER
‘analyzeHiC’ function was used to create distance-normalized pairwise contact correlation
matrix, and calculate its first principal component (PC1) for each experiment. H3K27ac
ChIP-seq signal was used to guide HOMER and avoid arbitrary PC1 sign assignment.
After PC1 calculation, getHiCcorrDiff.pl was used to directly calculate the difference in
contact correlation profile of each loci between parental and GSI-resistant conditions as
measured by HiC and HiChIP separately. Then findHiCCompartments.pl with stringent
criteria of absolute differential correlation less than 0.4 and absolute differential PC1
greater than 0.4 was used to determine if a region shifted its compartment according to
both HiC and HiChIP measurements. To ensure reproducibility, only regions that were
designated as changed compartment by both HiC and HiChIP were considered for
subsequent analysis.
UMI 4C-seq analysis
UMI 4C-seq data was processed with Juicer (version 1.5) (Durand et al., 2016) with
parameters -g hg19 -s MboI to generate .hic files. Unnormalized contact matrices of 5 Kbp
resolution were extracted from .hic files using Juicer tools ‘dump’ function. The bin
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containing the TSS of MYC was determined as “viewpoint”. To visualize interactions
surrounding the viewpoint, the row of the viewpoint in the contact matrix with the columns
within 10 bins upstream and 410 bins downstream of the viewpoint were extracted and
contact frequencies were normalized by the total number of contacts in this range. Mean
+/- S.D. normalized contacts in each condition were plotted with R package ggplot2.
RNA-seq data analysis
RNA-seq data was aligned to Ensembl GRCh37.75 primary assembly including
chromosome 1-22, chrX, chrY, chrM and contigs using STAR (version 2.5) (Dobin et al.,
2013) with parameters --outFilterIntronMotifs RemoveNoncanonicalUnannotated -alignIntronMax 100000 --outSAMstrandField intronMotif --outSAMunmapped Within -chimSegmentMin 25

-

-chimJunctionOverhangMin 25. Strand-specific read counts were quantified using
Subread (version 1.5.1) featureCounts with parameters -t exon -g gene_id -s 1 -T 6 and
used as input to differential gene expression analysis. Read counts were normalized to
reads per million per kilobase (RPKM) for each gene. Expressed genes were determined
as genes with > 1 RPKM in at least half of the samples in each experiment.
Pairwise differential gene expression analysis was performed using DEseq2 (Love et al.,
2014) with parameters test = "Wald", betaPrior = F, fitType = "parametric". For DND41
cells, significance cutoff was log2 fold change > 0.5 or < -0.5 with FDR < 0.05. In
comparison to DMSO-treated parental cells, genes that did not change significantly in 24hr
GSI treatment but significantly decreased or increased in GSI-resistant cells were
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determined as downregulated or upregulated in GSI-resistant cells, respectively.
Downregulated genes with TCF1-bound promoter or connected enhancer in parental cells
were considered TCF1 target genes. Upregulated genes with EBF1-bound promoter or
connected enhancer in GSI-resistant cells were considered EBF1 target genes. Genes
that significantly decreased expression in 24hr GSI versus DMSO parental cells but
significantly increased in GSI-resistant cells compared to 24hr GSI were determined as
recovered. For differential analyses between MB157 and MB157pInducer20-TCF1 or
MB157pInducer20-EBF1 cells, genes that showed log2 fold change > 0.5 or < -0.5 with
FDR < 0.01 were considered differentially expressed. Genes upregulated in
MB157pInducer20-TCF1 with TCF1-bound promoter or connected enhancer were
considered TCF1 targets in MB157. Genes upregulated in MB157pInducer20-EBF1 with
EBF1-bound promoter or connected enhancer were considered EBF1 targets in MB157.
Expressed genes in GSI-resistant versus parental DND41 were ranked by log2 fold
change and used to conduct gene-set enrichment analysis (GSEA) (Subramanian et al.,
2005) with 100,000 permutations against the GO and C7 gene sets from Molecular
Signatures Database (MSigDB, version 6.1) (Liberzon et al., 2015), and EBF1 targets
defined in MB157pInducer20-EBF1. Expressed genes in MB157pInducer20-EBF1 versus
MB157 were ranked by log2 fold change and used to conduct GSEA against EBF1 targets
defined in pro-B cells (Nechanitzky et al., 2013) and EBF1 targets defined in DND41 cells.
Expressed genes in EBF1-targeted versus control DND41-resistant-Cas9 were ranked by
log2 fold change and used to conduct GSEA against EBF1 targets defined in DND41.
Genes that recovered in GSI-resistant DND41 (Fig S2H), TCF1 targets in DND41 (Fig
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S4I), EBF1 targets in DND41 (Fig S4K), EBF1 targets in MB157pInducer20-EBF1 (Fig
S5I) and TCF1 targets in MB157pInducer20-TCF1 (Fig S5J) were used for pathway and
gene-ontology

enrichment

analyses

(http://www.gsea-

msigdb.org/gsea/msigdb/annotate.jsp). Selected pathways and gene-ontology sets with
FDR < 1E-3 were visualized in R.
Single nucleotide variant and Copy number alteration analyses
Single nucleotide variants and copy number alteration analyses were performed using
CLIA-approved clinical pipeline used for analysis of cancer patients at the Hospital of the
University of Pennsylvania. Very briefly, reads from cancer gene panel sequencing were
aligned to GRCh38 using BWA (Li and Durbin, 2009) and subjected to GATK (McKenna
et al., 2010) base quality score recalibration and duplicate read removal. Samples
achieving an average of 500x mean coverage across the 505 targeted cancer associated
genes were used in subsequent analyses. Small variant discovery and read filtration were
performed according to GATK best practice recommendations (DePristo et al., 2011; Van
der Auwera et al., 2013) and copy number segments were called using CNVKit (Talevich
et al., 2016). Single nucleotide variations, insertions, deletions and copy number variations
were then annotated using Variant Effect Predictor (McLaren et al., 2016). Resulting
variations were further filtered with internally validated quality control metrics evaluating
coding alterations greater than 50x coverage at a given loci and variant allele frequency
higher than 4%, as well as any copy number alterations. Lastly, the variant call set was
evaluated for clinical significance based on standards and guidelines by the Association
for Molecular Pathology (Li et al., 2017), and manually assessed by a variant reviewer.
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Immunofluorescence and DNA FISH imaging and analysis
MYC and TCRA three-color DNA FISH slides were imaged on a Leica SP8 using a 40x
oil immersion objective with pixels of 135 x 135 nm and z spacing of 350 nm. We obtained
stacks representing 10μm in total axial thickness. Analysis was carried out on the raw
images in a semi-automated manner on a cell-by-cell basis as previously described
(Fasolino et al., 2020; Raj et al., 2008). Briefly, the DAPI signal was used for manual nuclei
segmentation. The exact numbers of nuclei analyzed per cell type and locus are as
follows: 2,515 nuclei for the TCRA in parental DND41, 3,418 nuclei for the TCRA in GSIresistant DND41, 1,652 nuclei for the MYC locus in DMSO-treated parental DND41, 1,323
nuclei for the MYC locus in short-term GSI-treated parental DND41, 1,694 nuclei the MYC
locus in GSI-resistant DND41. Spots for each of the 3 channels (Alexa-488, Atto-565, and
Alexa-647) were individually detected using a linear filter approximately conforming to a
Laplacian convolved with a Gaussian. A plot of the number of spots as a function of the
threshold value enabled human-directed thresholding of spots for each of the 3 channels
individually. For each spot, the brightest z slice was used as the z coordinate. Centroid
positions for each spot in xy were found by fitting a Gaussian. X, Y, and Z coordinates
were extracted, and pairwise Euclidean distances between nearest neighbors were
calculated. The Kolmogorov-Smirnov test was used to compare differences in the
cumulative distribution functions, and the Wilcoxon rank sum test was used to compare
differences in the medians. Representative images were carried out on a Leica SP8 using
a 63x oil immersion objective and individually adjusted brightness, contrast, minimum,
maximum and smoothing in Fiji (https://imagej.net/Fiji).
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IKZF2 (Alexa-488) and EBF1 (Alexa-647) DNA FISH combined with Lamin-B1 IF (Alexa568) were imaged on a Leica SP8 using a 63x oil immersion objective with pixels of 85 x
85 nm and z spacing of 350 nm in a total of 10 μm. Analysis was performed with Imaris
(https://imaris.oxinst.com/). Briefly, the DAPI signal was used for automatic nuclei
segmentation and relatively round shaped nuclei were selected. For each nucleus, LaminB1 signal was automatically detected with mild pruning and masked from the inner nuclear
space. DNA FISH signal was automatically detected and the shortest Euclidean distances
from the centroid of DNA FISH spot to the masked Lamin-B1 signal were calculated.
Negative values were corrected as zero as they represented that DNA FISH targeted
sequences were buried within nuclear lamina. The Kolmogorov-Smirnov test (IKZF2) or
Wilcoxon rank sum test (EBF1) was used to compare differences in the cumulative
distribution functions or medians, respectively. The exact numbers of alleles or nuclei
analyzed per cell type and locus are as follows: 126 and 157 alleles for the IKZF2 locus in
parental and GSI-resistant DND41; 98, 98, 97 and 99 nuclei for EBF1 in parental, twoweek-, five-week- and nine-week-GSI-treated DND41; 95 and 99 nuclei in Ctrl and EBF1KO DND41-Res-Cas9 cells.
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